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AIM AND OUTLINE  
 
Essential mineral elements show natural variations in their isotopic composition as a result of 
isotope fractionation accompanying physical processes and/or (bio)chemical reactions, i.e. 
isotopes of the same element do not take part with exactly the same extent to these 
processes/reactions. For tracing down and quantifying the resulting small differences in 
isotopic composition, multi-collector inductively coupled plasma-mass spectrometry (MC-
ICP-MS) is the preferred technique. MC-ICP-MS combines a highly efficient ion source, with 
simultaneous monitoring of the isotopes of interest, thus providing highly precise isotope ratio 
data (relative standard deviation down to 0.002%). 
Currently, high-precision isotopic analysis of essential mineral elements, in particular iron 
(Fe), is gaining attention as a potential tool for providing insight into metabolism and for 
tracing down related diseases. Therefore, the overall aim of this work has been to contribute 
to the development of analytical methods based on ICP-mass spectrometry for iron isotopic 
analysis of human whole blood and serum for biomedical applications. Specifically, the 
possibility to simplify the sample preparation by analyzing whole blood samples without prior 
chromatographic separation of iron from the blood matrix, as well as, the potential use of a 
novel whole blood volumetric absorptive microsampling (VAMS) technique followed by a 
miniaturized chromatographic iron isolation procedure were investigated. Another part of this 
work focused on obtaining an improved insight into the mechanism of natural isotope 
fractionation accompanying intestinal absorption of iron using enterocyte-like cells in vitro 
and into the possible effect of the aging process of erythrocytes (separated according to their 
density) on their iron isotopic composition. Finally, high-precision serum iron isotopic 
analysis was assessed as a potential tool to distinguish different disorders related to iron 
metabolism in patients with renal insufficiency. For the ease of reading, the chapters were 
placed in order of analytical development and application rather than in chronological order. 
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In Chapter 1, a brief introduction on iron metabolism and related disorders is provided. The 
literature on the iron isotopic composition of human body fluids, and the use of animal 
models for the understanding of iron metabolism is presented. The principles of ICP-MS and, 
particularly, of MC-ICP-MS instrumentation, are also provided. 
Iron isotopic analysis is valuable for nutritional studies, e.g., for studies focused on the 
development of novel types of iron supplements. In general, isotopically labeled supplements 
are used to decipher the actual iron intestinal absorption. In Chapter 2, the iron isotopic 
analysis of whole blood by single-collector sector-field ICP-MS in the context of a human 
absorption study is described. It has been demonstrated that, although the precision obtained 
using SF-ICP-MS is lower than that achieved with MC-ICP-MS, iron isotope ratios obtained 
via SF-ICP-MS show a precision that is adequate to be used in this context, even when 
sample preparation is limited to acid digestion and adequate dilution. The isotopic 
composition of iron in whole blood obtained using both techniques were in a good agreement. 
However, SF-ICP-MS cannot replace MC-ICP-MS for measurements of natural Fe isotope 
variations due to significantly lower precision. 
As described in Chapter 1, a clear link between the Fe isotopic composition of whole blood 
and an individual’s iron status has been established. Thus, the Fe isotopic composition 
provides valuable clinical information and to fully exploit this, the development of simple and 
reliable methodologies for the high-precision isotopic analysis of biological fluids, providing 
high sample throughput, are required. In general, the reference procedure for sample 
preparation prior to Fe isotopic analysis via MC-ICP-MS consists of acid digestion and the 
chromatographic isolation of the target analyte from the blood matrix. This procedure is 
laborious, time-consuming and costly. In Chapter 3, the possibility of Fe isotopic analysis of 
whole blood by MC-ICP-MS without isolation of the analyte element, i.e. directly after acid 
digestion and adequate dilution of the sample digest, was evaluated. The influence of the main 
mineral matrix elements and the effect of potentially remaining organic compounds were 
systematically evaluated. The results obtained for whole blood samples analyzed directly after 
acid digestion compared well to those after chromatographic Fe isolation. This approach can 
be suggested for specific clinical applications that require a prompt response.  
Routine use of the approach proposed in Chapter 3, can result in overburdening of the MC-
ICP-MS instrument. Therefore, in Chapter 4, an alternative approach to increase sample 
throughput has been proposed, based on the use of a novel whole blood volumetric absorptive 
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microsampling technique (VAMS), which overcomes the issues associated with the 
hematocrit level and sample inhomogeneity that occur in dried blood spots analysis. This fast, 
inexpensive, minimally invasive and straightforward sample collection technique allows to 
facilitate sample acquisition by self-collection and shipping of finger-prick whole blood 
samples by the patients, with the possibility to store the VAMS tips at different temperatures 
for a reasonable time without effect on the Fe isotope ratios. In order to simplify and optimize 
the sample preparation preceding high-precision Fe isotope ratio measurements, a 
miniaturized chromatographic isolation protocol has been developed. It provided quantitative 
recovery of the target element, thus avoiding any effect from on-column fractionation, and 
resulted in a significant reduction in the consumption of expensive ultrapure acids and proved 
beneficial in terms of time. The suitability of the VAMS device for high-precision Fe isotopic 
analysis and quantitative iron assay after storage under different conditions was studied. 
Results for simultaneously collected finger-prick and venous whole blood samples compared 
well, thus demonstrating the possibility of using VAMS for high-precision isotopic analysis 
of iron with the final aim of clinical use. 
In vitro experiments using the Caco-2 cell line are well-established to date for the study of the 
iron bioavailability and absorption. This model has been used to study the mechanisms of 
natural Fe isotope fractionation occurring during intestinal absorption at a cellular level. The 
intestinal enterocytes act as a first metabolic barrier where iron uptake from the intestinal 
lumen takes place, followed by the transfer of iron into the peripheral circulation. In     
Chapter 5, the experimental setup developed to optimize the iron uptake through the Caco-2 
cells line is described. Moreover, the analytical procedure developed was carefully checked 
for any source of analytical bias. 
In addition to the natural Fe fractionation accompanying the intestinal absorption process, 
also variations within the life span of erythrocytes could possibly occur. In comparison with 
transferrin-bound iron, which represents the iron transport compartment, erythrocyte iron 
represents the Hb-bound iron, which provides information on the functional iron 
compartment. In Chapter 6, variations of the Fe isotopic composition in density-separated 
fractions of erythrocytes, which correspond to their ages, were evaluated to investigate a 
possible effect of erythrocyte aging on the whole blood Fe isotopic composition. 
The isotopic analysis of blood serum is interesting due to the high iron turnover rate of 
transferrin as a main carrier of iron (< 5 days) in comparison to the relatively static 
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compartment of whole blood erythrocytes (~ 120 days). Iron deficiency and anemia of 
different nature are common complications of chronic kidney disease (CKD). Until now, the 
management of iron deficiency and anemia of CKD proved to be challenging due to the 
difficulties in diagnosis using standard markers, such as serum iron, serum total iron-binding 
capacity, hemoglobin or ferritin. This hampers adequate decisions concerning therapeutic 
treatment. In Chapter 7, blood serum of patients suffering from CKD stage 3 or higher and 
without chronic inflammation was analysed in order to evaluate the use of the Fe isotopic 
composition as a potential tool to reveal the Fe-related complications of the disease. 
Correlation of the Fe isotopic composition with typical parameters used in clinical practice 
has been evaluated. It has been demonstrated that for patients with renal insufficiency, serum 
Fe isotopic analysis allows iron deficiency anemia (IDA) and erythropoietin-related (EPO-
related) anemia to be distinguished from one another. 
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DOELSTELLING EN OVER ZICHT 
 
Essentiële minerale elementen vertonen natuurlijke variaties in hun isotopische samenstelling 
als gevolg van fractionatie-effecten. De term isotopenfractionatie geeft aan dat isotopen van 
een zelfde element niet in exact dezelfde mate deelnemen aan fysische processen en/of 
(bio)chemische reacties. Om de kleine verschillen in de isotopische samenstelling als gevolg 
van deze processen te kunnen bepalen, is multi-collector inductief gekoppeld plasma-
massaspectrometrie (MC-ICP-MS) de te verkiezen techniek. MC-ICP-MS combineert een 
hoog-efficiënte ionenbron met de simultane monitoring van de geselecteerde isotopen, 
waardoor isotopenverhoudingen met zeer hoge precisie kunnen gemeten worden (tot ≤ 
0.002% relatieve standaarddeviatie). 
De interesse in zeer precieze isotopenanalyse van essentiële minerale elementen, waaronder 
Fe, neemt geleidelijk aan toe en heeft als doel inzicht verschaffen in het metabolisme van 
deze elementen en metaal-gerelateerde aandoeningen te diagnosticeren. Bijgevolg was het 
algemene doel van dit werk gericht op (een bijdrage aan) de ontwikkeling van analytische 
methoden gebaseerd op ICP-massaspectrometrie voor isotopenanalyse van Fe in humaan 
volbloed en serum voor biomedische toepassingen. Meer specifiek werd de mogelijkheid om 
de monstervoorbereiding te vereenvoudigen, door het analyseren van volbloed stalen zonder 
voorafgaandelijke chromatografische afscheiding van Fe van de matrix, bestudeerd. Eveneens 
werd ook de mogelijkheid van het gebruik van een nieuwe techniek om bloed te bemonsteren 
(volumetrisch absorptieve microstaalname - VAMS van bloed verkregen via een vingerprik), 
gevolgd door een geminiaturiseerd chromatografisch procédé voor de isolatie van Fe, 
onderzocht. Een ander deel van dit werk was gefocusseerd op het verwerven van een beter 
inzicht in het mechanisme van natuurlijke isotopenfractionatie, die optreedt tijdens de 
intestinale absorptie van Fe, door middel van in vitro experimenten met enterocyt-achtige 
cellen. Eveneens werd het mogelijke effect van het verouderingsproces van erythrocyten 
(gescheiden op basis van hun dichtheid) op hun isotopische samenstelling van Fe onderzocht. 
Tenslotte werden de mogelijkheden van hoog-precieze isotopenanalyse van Fe in serum 
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onderzocht om een onderscheid te maken tussen verschillende aandoeningen gerelateerd aan 
het Fe-metabolisme bij patiënten met nierinsufficiëntie Voor het gemak van de lezer werden 
de hoofdstukken in volgorde van analytische ontwikkeling en toepassing geplaatst en niet in 
chronologische volgorde. 
In Hoofdstuk 1 wordt een korte introductie over het Fe-metabolisme en Fe-gerelateerde 
aandoeningen gegeven. Dit hoofdstuk bevat eveneens een samenvatting van de literatuur over 
de isotopische samenstelling van Fe in humane lichaamsvloeistoffen en het gebruik van 
diermodellen voor de ontrafeling van het Fe-metabolisme. De principes van ICP-MS in het 
algemeen en van MC-ICP-MS in het bijzonder worden hier ook behandeld. 
Isotopenanalyse van Fe kan ook waardevol zijn voor nutritionele studies, zoals voor studies 
die gefocust zijn op de ontwikkeling van nieuwe ijzersupplementen. Doorgaans worden 
isotopisch gemerkte supplementen ingezet om de effectieve intestinale absorptie van ijzer te 
ontrafelen. In Hoofdstuk 2 wordt een beschrijving gegeven van isotopenanalyse van Fe in 
volbloed via single-collector sector-veld ICP-MS (SF-ICP-MS) in de context van een humane 
absorptie studie. Ondanks de minder goede isotopenprecisie geboden door SF-ICP-MS dan 
door MC-ICP-MS, vertonen de isotopenverhoudingen van Fe bekomen met SF-ICP-MS toch 
een precisie die adequaat is om in deze context gebruikt te worden, zelfs na zure digestie en 
adequate verdunning als enige monstervoorbereiding. Eveneens werd er een goede 
overeenkomst gevonden tussen de isotopenverhoudingen van Fe in volbloed die bekomen 
werden na analyse via beide technieken.   
Zoals toegelicht in hoofdstuk 1, werd er een duidelijke link vastgesteld tussen de isotopische 
samenstelling van Fe in volbloed en de Fe-status. De isotopische samenstelling van Fe 
verschaft dus waardevolle klinische informatie. Om isotopenanalyse van Fe te kunnen 
inzetten in klinische studies, is niet alleen de ontwikkeling van eenvoudige en betrouwbare 
methodes voor zeer-precieze isotopenanalyse in biologische vloeistoffen vereist, maar ook 
een hoge sample throughput. Doorgaans bestaat de gehele monstervoorbereiding voorafgaand 
aan isotopenanalyse van Fe in volbloed via MC-ICP-MS uit een digestiestap met 
geconcentreerd zuur en een chromatografische afscheiding van het analietelement. Deze 
procedure is echter arbeidsintensief, tijdrovend en duur. In Hoofdstuk 3 wordt de 
mogelijkheid van isotopenanalyse van Fe in volbloed via MC-ICP-MS zonder voorafgaande 
isolatie van het doelelement, nl. isotopenanalyse volgend op een digestiestap en adequate 
verdunning, geëvalueerd. De invloed van de belangrijkste matrixelementen en het effect van 
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mogelijke restanten van organisch materiaal werden systematisch geëvalueerd. De resultaten 
die bekomen werden voor volbloed na isotopenanalyse volgend op een enkele digestiestap 
kwamen goed overeen met deze die bekomen werden na isotopenanalyse volgend op een 
digestiestap en chromatografische afscheiding. Deze monstervoorbereiding zou kunnen 
ingezet worden voor specifieke klinische toepassingen waarbij een snelle respons vereist is.  
Routinematig gebruik van de in hoofdstuk 2 voorgestelde methode kan leiden tot een 
overbelasting van het MC-ICP-MS instrument. Daarom werd in Hoofdstuk 4 een alternatieve 
methode voorgesteld om de sample throughput te verhogen. Deze techniek is gebaseerd op 
een nieuwe VAMS techniek om bloed te bemonsteren. Deze techniek overwint de problemen 
geassocieerd met de variaties in de hematocrietwaarde en de inhomogeniteit van de stalen, die 
de analyse van gedroogde bloedspots bemoeilijken. Deze snelle, goedkope en minimaal 
invasieve monstername techniek laat toe om de staalname te vereenvoudigen door 
zelfcollectie (door de patiënt) waarna de VAMS-probe met het gecollecteerde bloed voor 
analyse kan verzonden worden. In dit hoofdstuk werd eveneens aangetoond dat de VAMS-
tips bij verschillende temperaturen gedurende enige tijd bewaard kunnen worden zonder een 
effect te hebben op de isotopenverhoudingen van Fe. Om de monstervoorbereidingsprocedure 
voorafgaand aan zeer precieze isotopenanalyse van Fe te vereenvoudigen en te optimaliseren, 
werd een geminiaturiseerde chromatografische isolatieprocedure ontwikkeld. Deze methode 
bleek succesvol voor de kwantitatieve herwinning van het doelelement – waardoor het effect 
van artificiële isotopenfractionatie vermeden werd – en resulteerde in een significante 
vermindering van het verbruiik van dure ultrazuivere zuren en in een verkorting van de duur 
van de monstervoorbereiding. De geschiktheid van VAMS voor zeer precieze isotopenanalyse 
van Fe en kwantitatieve Fe bepaling werd bestudeerd na bewaring van de probes onder 
verschillende omstandigheden. Om de mogelijkheid van het gebruik van VAMS voor hoog-
precieze isotopenanalyse van Fe in klinische studies na te gaan, werd simultaan gecollecteerd 
vingerprik bloed en veneus volbloed met elkaar vergeleken. De goede overeenkomst tussen 
de betreffende resultaten toont de inzetbaarheid van de methode aan. 
In vitro experimenten met behulp van de Caco-2 cellijn worden vaak gebruikt voor het 
bestuderen van de biobeschikbaarheid en de absorptie van Fe. Dit model werd gebruikt om de 
mechanismen van natuurlijke Fe isotopenfractie die optreedt tijdens intestinale absorptie te 
bestuderen op cellulair niveau. De intestinale enterocyten gedragen zich als een eerste barrière 
waar de opname van Fe uit het darmlumen plaatsvindt, gevolgd door de overdracht van Fe 
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naar de perifere circulatie. In Hoofdstuk 5 wordt de experimentele opstelling, die ontwikkeld 
werd om de opname van Fe door de Caco-2 cellijn te optimaliseren, beschreven. Eveneens 
werd de aldus ontwikkelde analytische procedure zorgvuldig bestudeerd om elke bron van 
mogelijke afwijkingen na te gaan. 
Naast het optreden van natuurlijke Fe fractionatie tijdens het intestinale absorptieproces, 
zouden ook variaties kunnen optreden tijdens de levensduur van erythrocyten. In vergelijking 
met transferrine-gebonden Fe, wat het Fe transport-compartiment voorstelt, stelt het Fe in de 
erythrocyten, dat gebonden is in hemoglobine, het functionele Fe compartiment voor. In 
Hoofdstuk 6 werd de isotopische samenstelling van Fe in op basis van dichtheid gescheiden 
fracties van erythrocyten bepaald om het mogelijk effect van de leeftijd van erythrocyten op 
de isotopische samenstelling van Fe in volbloed te onderzoeken.  
De isotopische samenstelling van Fe in serum wekt interesse door de hoge Fe “turnover rate” 
van transferrine als belangrijkste drager van Fe (~5 dagen) in vergelijking met het relatief 
statische volbloed compartiment van erythrocyten (~120 dagen). IJzertekort en verschillende 
soorten van anemie zijn vaak voorkomende complicaties bij chronische nieraandoeningen 
(CKD). Tot dusver blijkt de behandeling van ijzertekort en anemie veroorzaakt door CKD een 
uitdaging als gevolg van de moeilijkheden bij de diagnose door middel van de traditionele 
parameters, zoals, serum ijzerconcentratie, serum totale ijzerbindingscapaciteit, hemoglobine- 
en ferritineconcentraties. Dit belemmert adequate beslissingen voor therapeutische 
behandelingen. In Hoofdstuk 7 worden de resultaten van de isotopenanalyse van Fe in serum 
van patiënten met CKD in stadium 3 of een verder stadium zonder chronische inflammatie 
toegelicht. Eveneens wordt de mogelijkheid van de isotopische samenstelling van Fe als 
hulpmiddel voor het ontrafelen van Fe-gerelateerde complicaties van de ziekte geëvalueerd. 
Er werden correlaties bestudeerd tussen de isotopische samenstelling van Fe en de klassieke 
parameters die gebruikt worden in klinisch onderzoek. Er werd aangetoond dat voor patiënten 
met nierinsufficiëntie, de isotopische samenstelling van Fe toelaat om anemie door ijzertekort 
te onderscheiden van erythropoëtine-gerelateerde (EPO-gerelateerde) anemie. 
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CHAPTER 1  
G E N E R A L  I N T R O D U C T I O N   
 
1.1 HUMAN IRON METABOLISM 
Iron (Fe) is an essential metal for almost all living organisms since it is present in a large 
number of iron-containing enzymes and proteins.1,2 These proteins play a vital role in a broad 
range of biological functions, including oxygen transport, energy production and cell 
proliferation. Despite its essentiality for a wide variety of metabolic processes, iron can also 
be toxic for living systems.3,4 Iron exists in solution in one of two oxidation states, i.e. in the 
ferrous form (Fe2+) or the ferric form (Fe3+), which can relatively easy donate or accept an 
electron, respectively. This chemical property results in a catalytic role for a multitude of 
redox reactions which are necessary to support basic metabolic functions. Due to this redox 
activity, iron is, however, also involved in the formation of harmful oxygen radicals, e.g., via 
the Fenton reaction5, that can damage the cell structure.1,3,4,6 Moreover, at physiological pH 
and oxygen tension, Fe(II) is readily oxidized to Fe(III) in solution, which rapidly forms 
insoluble Fe(OH)3. Because of this insolubility and potential toxicity, specialized mechanisms 
and molecules are involved in the uptake, transport, and storage of iron in soluble non-toxic 
forms.4 
Daily requirements of iron vary depending on an individual’s age, sex and physiological 
status. The body’s total iron content is estimated to be 55 and 45 mg per kg of body weight in 
adult men and women, respectively.4,6 A healthy individual absorbs daily approximately 1–2 
mg of iron from the diet, which compensates for non-specific iron losses, mainly by normal 
sloughing of cells in the gastrointestinal tract and the small loss of erythrocytes in urine and 
feces (~1 mg).7–9 Menstruation increases the physiological loss of iron in premenopausal 
females.8–10 Despite the low intestinal uptake, approximately 20-30 mg of iron are required 
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daily for the erythropoiesis. Therefore, in contrast to other essential elements, iron is strictly 
conserved by iron recycling from aging erythrocytes and from other sources.6,11 
 
Fig. 1-1 Iron distribution in the adult human body. 
The distribution of iron in the adult human body is shown in Fig. 1-1. The majority of the 
body’s iron (~60–70%) is found in the heme groups of hemoglobin (Hb) in circulating 
erythrocytes (red blood cells, RBCs).3,11–13 Heme iron is essential for oxygen transport in 
hemoglobin, oxygen storage in myoglobin, and in the electron transport within the 
cytochrome C oxidase complex in aerobic respiration. When erythrocytes reach the end of 
their lifespan, they are phagocytosed by the reticuloendothelial macrophages, which recycle 
iron from heme.13 The second largest pool of iron (~20-30 %) is found in its storage form, 
ferritin.6 Due to the large size of this protein (450 kDa), ferritin can store up to 4500 iron 
atoms as hydrous oxide with the ability to gain and release iron according to the physiological 
need. The majority of iron storage occurs in liver hepatocytes, reticuloendothelial cells 
(macrophages) and skeletal muscle.1 The remaining body iron (10-15%) is primarily localized 
in myoglobin (an iron- and oxygen-binding protein in the muscle tissue), cytochromes (heme-
containing proteins participating in electron transport), and a variety of iron-containing 
enzymes, involved in the oxidative metabolism and many other cell functions.10 
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Iron uptake and transport through the body require special mechanisms to diminish its ability 
to form active radicals. Iron is transported between sites of absorption, storage, and recycling 
by the plasma glycoprotein transferrin (Tf).1 Transferrin-bound iron (Fe3+) is intended to be 
delivered to the cells by binding to the specific cell surface transferrin receptor (TfR). Each 
molecule of transferrin can bind two atoms of ferric iron. Although only ~3-4 mg of iron is 
bound to transferrin (< 0.1% of the total body iron), it is the most important dynamic iron 
pool in the body with the highest rate of turnover (~25 mg per 24 h). Under healthy 
conditions, ~80% of this iron is transported to the bone marrow for hemoglobin synthesis in 
developing erythroid cells. The saturation state of serum transferrin (TSAT) plays a key role 
in the regulation of iron metabolism and hence, it is one of the indices used clinically to 
evaluate an individual´s iron status.4,6 Alterations of overall body iron amounts and/or tissue 
iron distribution can lead to human iron disorders14 (further described, section 1.1.4). 
The amount of circulating transferrin-bound iron is regulated by three coordinated processes: 
duodenal iron absorption, macrophage iron recycling, and iron storage. A general description 
of these processes is presented below. 
 
1.1.1 Intestinal iron absorption  
Due to the absence of a regulated active pathway of iron excretion, the body’s iron content is 
precisely controlled by the intestinal absorption. The majority of dietary iron absorption 
occurs in the duodenum.15 The absorption of dietary iron is highly regulated and involves its 
transport across the luminal (apical) membrane of enterocytes in the gut and across the 
basolateral membrane into the blood plasma.16 Two forms of dietary iron can be 
distinguished: heme and non-heme. A normal individual ingests approximately 10-20 mg of 
iron per day, that is mostly in heme iron form due to its higher absorption efficiency 
compared to the non-heme iron form.11,17 However, only approximately 10% (~1-2 mg) of 
iron is absorbed daily.2,7 The iron absorption is regulated mainly by the amount of storage 
iron, hypoxia and the rate of erythropoiesis. Thereby, an increase of the iron stores will lead 
to a decreased dietary iron absorption.11,15 The basic mechanism of iron absorption is shown 
in Fig. 1-2. 
At the luminal side of the enterocyte, the ferric iron (Fe3+) of non-heme iron requires to be 
reduced to ferrous iron (Fe2+) by the duodenal ferrireductase enzyme (Dcytb). The ferrous 
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iron is then transported into the enterocytes by the divalent metal ion transporter-1 (DMT-1). 
The dietary heme iron is transported across the enterocyte by heme carrier protein 1 (HCP1). 
 
Fig. 1-2 Mechanism of intestinal (enterocyte) iron absorption (adapted from Rizvi and Schoen, 2011).15 
Inside the enterocyte, ferrous iron Fe2+ is released from the protoporphyrin of heme iron by 
the heme oxygenase to enter in the same labile iron pool (LIP) as the dietary non-heme iron.18 
Depending on the cellular requirements, there are two possible pathways for the ferrous iron 
inside the cell: i) a part of the ferrous iron is incorporated into ferritin inside the enterocyte 
(this iron is probably never absorbed and is lost when the enterocytes senescence and are 
sloughed off into the gut lumen11) and ii) another part is transported across the basolateral 
membrane of the enterocyte by ferroportin. The transported Fe2+ is oxidized to the Fe3+ form 
by the ferroxidase (hephaestin) and then, it is incorporated into transferrin in the blood and 
transported to sites of use and storage,2,11,15 except when this transporter is saturated. In this 
case, the ferric iron will bind to other ligands, such as citrate, constituting the non-transferrin 
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bound iron (NTBI) pool.2 In a healthy organism, most of the iron will be transported to be 
involved in the erythroid iron metabolism or will be trapped in available ferritin 
molecules.2,19,20 
 
1.1.2 Erythroid iron metabolism 
Erythropoiesis in humans results in the average daily production of about 2 × 1011 
erythrocytes (red blood cells, RBCs). In adult humans, erythropoiesis occurs in the bone 
marrow21 and involves the entire process by which hematopoietic stem cells (HSCs) 
differentiate in the bone marrow through several stages into RBCs.22 The new cells enter into 
the circulation as reticulocytes where, within about 24 h, they develop into mature 
erythrocytes that circulate in the blood for about 120 days.4 Under normal conditions, 
approximately 1% of the RBCs are synthesized on a daily basis. The rate of erythropoiesis 
can increase significantly from this baseline level in response to hypoxic stress (hypoxia), 
which occurs when the body is deprived of adequate oxygen supply at the tissue level. It was 
observed that erythropoiesis is mainly regulated by the kidney-derived cytokine 
erythropoietin (EPO).23 The production of EPO in the kidneys is directly regulated by the 
tissue oxygen tension (Fig. 1-3, red arrows). In response to a low oxygen level, EPO is 
released from the kidneys and stimulates the bone marrow to produce more RBCs, which, in 
turn, increase the oxygen-carrying capacity of the blood. 
At the end of the RBC life span, senescent and/or damaged erythrocytes are phagocytosed by 
macrophages (mainly in the spleen, liver or bone marrow) to recycle the iron (Fig. 1-3). In 
this process, the heme-groups from hemoglobin are split into ferrous iron and the pigment 
bilirubin. The released ferrous iron is exported by the transmembrane transporter ferroportin, 
further oxidized to its ferric form in order to bind to circulating transferrin in the plasma and 
be exported, to be recycled for various functions.14,24 The bilirubin, inversely, is secreted into 
the blood and carried to the liver where it is bound to (conjugated with) glucuronic acid, a 
derivative of glucose. Some of the conjugated bilirubin is secreted into the blood and the rest 
is excreted into the bile as bile pigment that passes into the small intestine. The blood 
normally contains a small amount of free and conjugated bilirubin.4,24 
Because most of the body’s iron is used by the bone marrow for hemoglobinization of the 
RBCs, it is not surprising that erythropoietic regulation has a dominant function in the control 
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of iron homeostasis.12 Moreover, in disorders with ineffective erythropoiesis, the iron 
absorption is increased independently of the body iron (even when the iron stores are replete). 
 
Fig. 1-3 Iron balance in human body. The red arrows indicate the stimulation of RBC production: 1) Detection of 
a reduced O2-carrying capability of blood; 2) The kidneys respond by secreting EPO into the blood stream that 
stimulates erythropoiesis in the bone marrow; 3) Release of RBCs, increasing the O2-carrying capability that 
inhibits further EPO secretion. 
 
1.1.3 Iron homeostasis in the liver 
Iron enters into the plasma via intestinal absorption and macrophage iron recycling in 
response to various physiological needs. The excess of circulating iron in both transferrin-
bound and non-transferrin-bound forms (NTBI) is stored as ferritin and hemosiderin in the 
liver hepatocytes, which is the major storage location for body iron.25 The hemosiderin is the 
product of ferritin breakdown within the lysosomes. It represents a very small fraction of the 
normal body iron stores but it can increase dramatically under iron overload conditions.11 An 
additional fraction of free iron is present in the form of the LIP within cells. The LIP is 
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biologically active in the intracellular metabolism via oxidation–reduction reactions, cell 
proliferation, and cell signaling, but toxic when present in excess. 
 
Fig. 1-4 The main pathways for iron uptake by a hepatocyte.  
Ferritin is the main form of stored iron in hepatocytes under physiological circumstances. 
Hepatocytes have essentially two pathways for iron uptake from the circulation: uptake of Tf-
bound iron (Fe2-Tf) under healthy conditions, and of NTBI in case of iron overload, however 
the mechanism of the iron uptake by the hepatocytes is not fully understood yet.14 The 
principle of Fe uptake by the hepatocytes is shown in Fig. 1-4. Transferrin receptor 1 (TfR1) 
is a classical functional receptor, which bounds Tf-bound iron from the plasma and forms 
internalized Fe2Tf-TfR1 complexes. This complex releases iron within the endosome at acidic 
pH. The resulting apotransferrin-TfR1 complex is then recycled back to the cell surface for 
reutilization. In an iron overload situation, TfR1 is downregulated in the hepatocytes. 
Transferrin receptor 2 (TfR2), is highly present on hepatocyte surfaces and has a similar 
mechanism of recycling. This mechanism is not well known, but likely plays an important 
role in iron overload states. In normal and iron-loaded conditions, the expression of TfR2 
exceeds that of TfR1, which suggests that TfR2 plays an important role in hepatic iron 
loading in hemochromatosis (e.g., a mutation in TfR2 is responsible for type 3 
hemochromatosis). Based on murine studies, there is another Tf-bound iron uptake 
mechanism in the hepatocytes that is independent of TfR recycling. In iron-overloaded 
conditions, NTBI appears in the circulation and is taken up through two molecules, DMT1 
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and ZIP14, in hepatocytes.11,25 In contrast to iron uptake, likely there is only one mechanism 
to transport iron out of the hepatocytes by ferroportin: the exported iron is then oxidized by 
the ceruloplasmin and bound to transferrin.11 
Another important function of the liver in the systemic iron homeostasis is the production of 
the hormone hepcidin. In recent years, hepcidin has emerged as a primary regulator of iron 
homeostasis and it controls iron transport by binding to ferroportin and promoting its 
internalization and degradation. The loss of ferroportin from the cell membrane leads to 
cellular iron retention and represses absorption of dietary iron in the intestine, recycling of 
iron by macrophages, and mobilization of stored iron from hepatocytes. Consequently, the 
transferrin saturation decreases, resulting in the reduction of the amount of iron available.26 
 
Fig. 1-5 Regulation of circulating iron by hepcidin. (+) is stimulatory effect, (-) is inhibitory effect. 
A schematic diagram presenting the regulation of circulating iron by hepcidin is shown as 
Fig. 1-5. Hepcidin constantly regulates iron uptake to maintain sufficient iron stores for 
erythropoiesis, while preventing iron overload. Dysregulation of hepcidin production, whether 
genetic or acquired, causes an iron disorder. In healthy individuals, an increase in body iron 
would lead to an increased hepcidin expression and therefore to a decreased iron absorption. 
The level of hepcidin elevates during inflammation, which is the main reason of anemia of 
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chronic disease (ACD). In patients with hemochromatosis, iron absorption continues leading 
to iron overload due to an inadequate or ineffective down-regulation of ferroportin by 
hepcidin. In contrast, the level of hepcidin decreases in conditions of hypoxia, iron 
deficiency/anemia, and increased erythropoiesis, resulting in an increased iron export into the 
blood plasma.2 The nature of the suppressive signal is unknown but there is evidence that it 
could be a circulating factor produced by the erythroid signal in the bone marrow.14,16,19,25,27–29 
Defective erythropoiesis results in an increased iron export from enterocytes regardless of the 
liver iron stores status. Consequently, patients with defective erythropoiesis can be anemic 
and suffer simultaneously from tissue iron-overload.16,26,29,30 Although the conditions that 
regulate hepcidin expression are known, its molecular regulation and interactions form an 
active area of investigation.26 
 
1.1.4 Disorders of iron metabolism 
Iron plays a vital role in the hemoglobin synthesis and erythrocyte production but its excess 
can damage human cells. At the same time, iron is also an essential nutrient for germs and 
microbes that further can cause diseases in the host. Iron metabolism is very complex and 
strictly controlled by many different genes and proteins. Disturbance of iron homeostasis 
principally leads to either iron deficiency (ID) or iron overload diseases.1 In recent years, the 
identification of hepcidin was a major step forward in the understanding of the iron 
metabolism. However, early diagnosis and effective treatment of iron metabolism disorders 
remain a challenge. Disorders of iron homeostasis are invariably chronic, not acute diseases.31 
Iron metabolism disorders in humans can be classified based on four major categories: (i) 
diseases associated with defective regulation of iron absorption, (ii) diseases caused by the 
erroneous tissue and/or cellular compartmentalization of iron, (iii) secondary disorders caused 
by an altered iron content in cells and/or tissues, and (iv) genetic defects which lead to 
disturbance of iron metabolism.1 
Generally speaking, iron-overload disease occurs when the amount of absorbed plasma iron 
exceeds the binding capacity of transferrin, and it arises from the inability to down-regulate 
the iron absorption appropriately in response to increased iron stores. Iron-overload diseases 
owing to genetic misregulation of iron acquisition are referred to as primary iron-overload 
disease or hereditary hemochromatosis (HH).16 Secondary iron overload is developed as a 
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result of repeated blood transfusions, which are frequently applied for the treatment of various 
anemias.8 
ID is the most common nutrition problem globally, characterized by insufficient iron to 
maintain the normal physiological function of tissue (blood, brain, and muscles).32 In 
developed countries, approximately 10% of the toddlers (due to their rapid growth) and 
premenopausal women (due to menstrual blood loss) are iron-deficient. In the great majority 
of cases, the ID is acquired, but it can also come from hereditary etiologies, poorly understood 
to date.33 ID can be caused by either inadequate dietary iron absorption (including low dietary 
availability, high gastric pH, loss or dysfunction of enterocytes, hepcidin fluctuations) or 
increased iron losses (mainly blood losses) associated with hemodialysis, frequent blood 
sampling, gastrointestinal bleeding, multiple vascular access surgeries, etc.1,34 At a first step, 
ID leads to a depletion of iron stores with preservation of erythroid iron, which is reflected in 
low serum ferritin levels and transferrin saturation (TSAT). The cut-off level of serum ferritin 
for the diagnosis of ID varies between 12-15 µg L-1.32 However, due to the association of the 
ferritin concentration with the inflammatory status (the level of ferritin is elevated in the 
presence of inflammation), a cut-off value of ≥ 50 µg L-1 is used. As a result, the ferritin 
concentration is not widely used in clinical practice to assess ID. TSAT is another common 
clinical parameter that indicates the percentage of iron bound to transferrin. In the case of ID, 
either absolute or functional, this parameter is decreased (typically < 20%). The TSAT is a 




∙ 100 (1-1) 
where TIBC is total iron-binding capacity that indicates the maximum amount of iron needed 
to saturate plasma or serum transferrin and is calculated from serum transferrin 
concentration.35 
According to Wish34 and Hörl36, also the TSAT has some acute-phase response because the 
transferrin level may be elevated in the setting of inflammation, consequently leading to a 
lowered TSAT. Transferrin may also be low because of decreased transferrin synthesis in the 
setting of malnutrition and chronic disease, which would raise TSAT if circulating iron is 
constant. Moreover, TSAT fluctuates widely as a result of diurnal variation in serum iron, and 
transferrin is affected by the nutritional status. Therefore, due to these sources of variability, 
many other biochemical indexes are currently explored to evaluate the iron status, such as the 
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soluble transferrin receptor concentration, the reticulocyte hemoglobin concentration, the 
percentage of hypochromic red cells, the concentration of erythropoietin (and its relation to 
the expected values), and the concentration of hepcidin. The soluble transferrin receptor 
(sTfR) level is one of the most useful, as it is the least influenced by the presence of 
inflammation, and it correlates well with the concentration of transferrin receptor in the cell 
plasma membrane. However, in particular groups of patients with increased erythropoiesis 
due to a variety of disorders, its utility in the clinical setting remains to be proven. The 
combination of the sTfR and ferritin measurements, as the sTfR/log serum ferritin ratio, 
provides an increased specificity, but not sensitivity for the diagnosis of ID in such 
populations.34,37–42 
Iron deficiency anemia (IDA) is an advanced form of ID caused by a number of factors 
ranging from dietary deficiency, blood loss, and metabolic lesions and it is characterized by 
reduced erythropoiesis. The World Health Organization (WHO) estimates that about one third 
of the world population is anemic, defined as the presence of an insufficient mass of RBCs 
circulating in the blood. IDA is reflected in hemoglobin concentrations below the 
recommended thresholds.32,40 The most common symptoms of anemia conditions result from 
reduced oxygen transportation by hemoglobin. These symptoms include pallor, fatigue, 
faintness, shortness of breath, muscle weakness, angina pain, and elevated cardiac output (as 
compensation for reduced O2-carrying capacity).
31 The common diagnostic criterion for 
anemia is based on the hemoglobin concentration although different criteria can be found in 
the literature. According to the WHO and the Kidney Disease: Improving Global Outcomes 
(KDIGO) organization developed (2002), the diagnosis of anemia is based on a hemoglobin 
(Hb) level below 13 g dL-1 in men over 15 years, below 12 g dL-1 in non-pregnant women 
over 15 years, and below 11 g dL-1 in pregnant women.32,43,44 The European Renal Best 
Practice (ERBP) Position Paper uses a Hb value lower than 13.5 g dL-1 for male individuals 
(with a correction to Hb < 13.2 g dL-1 for males older than 70 yrs), and lower than 12 g dL-1 
for female individuals.44 In 2015, the National Institute for Health and Clinical Excellence 
(NICE) suggested to diagnose anemia based on a Hb level below 12 g dL-1 in men and below 
10 g dL-1 in premenopausal women.45 
ID and anemia can occur in absence of each other. ID can exist in absence of IDA if it has not 
lasted long enough or it has not been severe enough to cause depletion of erythroid iron. 
However, both ID and anemia have important consequences for human health and child 
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development: iron deficient and/or anemic women and their infants show a higher risk of 
dying during the perinatal period; the child’s mental and physical development is delayed or 
impaired by iron deficiency; and the physical work capacity and productivity of manual 
workers may be reduced. Besides ID, anemia can be also caused by (i) inflammation and 
infectious diseases such as malaria, hookworm infections and schistosomiasis; (ii) reduced 
erythropoietin (EPO) production in kidney; (iii) deficiencies of other key micronutrients 
including folate, vitamin B12, and vitamin A; or (iv) hereditary conditions that affect the 
RBCs, such as thalassaemia.32 
The condition termed functional iron deficiency (FID, relative iron deficiency) occurs in the 
situation of inadequate iron supply to the bone marrow. The physiological rate of RBC 
production exceeds the ability of transferrin-bound circulating iron to provide adequate 
substrate for Hb synthesis, which results in low TSAT. At the same time, the serum ferritin, 
which reflects iron stores, can remain normal or elevated.34,41,46 The iron balance is 
fundamentally regulated by the rate of erythropoiesis and the size of iron stores. In IDA, the 
iron supply depends on the quantity of the body’s stored iron, whereas in FID, the iron supply 
depends on the rate of iron mobilization.47 
An extreme case of FID is known as reticuloendothelial (RE) blockade and usually occurs in 
the setting of acute or chronic inflammation/infection. This often correlates with a high C-
reactive protein (CRP) level and/or a high erythrocyte sedimentation rate. Due to the 
inflammatory state and likely mediated hepcidin production (see section 1.1.3), the iron gets 
“locked up” in RE storage and therefore, it cannot bind to transferrin. Thus, transferrin-bound 
iron (reflected in the TSAT) is low, despite of a normal or elevated ferritin level. This 
condition is aggravated by the fact that ferritin is an acute-phase reactant and it increases in 
the setting of inflammation. Consequently, in such conditions, elevated serum ferritin levels 
can be due to high iron stores or due to the inflammatory state and therefore, patients have to 
be treated in different ways.34 FID is one of the forms of ACD which occurs in response to 
systemic illness and/or chronic inflammatory diseases, such as autoimmune conditions 
(rheumatoid arthritis and inflammatory bowel disease), cancer, and end-stage renal 
failure.41,47,48 ACD is the second most common form of anemia worldwide, which can mimic 
or co-exist with other types of anemia.  
The anemia can be caused by a variety of physiological conditions, such as an impaired 
production of EPO, reduced marrow erythroid response to EPO, iron-restricted erythropoiesis, 
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diminished pool of EPO-responsive cells, and reduced RBCs survival.48 Many efforts to fight 
iron deficiency and anemia have been made over the past two decades but, despite these 
efforts, ID and anemia are still common clinical conditions.32 
As has been mentioned above, in IDA, the iron supply depends on the quantity of iron storage 
in the body, while in FID (and consequently ACD) the supply depends on the rate of 
mobilization of iron from the stores. The diagnosis of both conditions is particularly 
challenging in patients with acute or chronic inflammatory conditions because most of the 
biochemical markers for iron metabolism are affected by the acute phase reaction. This is also 
the case of anemia associated to chronic kidney disease (CKD), where anemia of different 
types typically occurs.46 
ID and/or anemia is a common complication of CKD that can be derived from multiple 
causes. The main factors that contribute to iron deficiency in patients with end-stage renal 
disease (ESRD) are reduced intake and impaired intestinal absorption of dietary iron, blood 
losses, chronic inflammation associated with ESRD and/or increased iron requirements during 
therapy with erythropoiesis-stimulating agents (ESA).36 The anemia, in turn, can be the result 
of (i) ID (IDA), (ii) reduced production of EPO due to kidney damage (EPO-related anemia), 
and (iii) inflammatory conditions (FID and ACD). As has been shown in Fig. 1-3 (section 
1.1.2), EPO is produced by the kidney in response to a low tissue oxygen level and stimulates 
the bone marrow to produce new RBCs.45 Therefore, an altered EPO production has a 
significant effect on erythropoiesis. The management of ID and anemia is an important issue 
for patients with renal insufficiency. However, determining the real cause of anemia and 
consequently, making adequate decisions concerning the patient’s treatment is still a 
challenge. 
 
1.2 PRINCIPLES OF ICP-MASS SPECTROMETRY 
1.2.1 Principle design of ICP-MS  
Inductively coupled plasma-mass spectrometry (ICP-MS) is a powerful analytical technique 
for the determination of trace and ultra-trace concentrations of elements and their isotope 
ratios in a large variety of applications. An ICP-mass spectrometer consists of the 
combination of an inductively coupled argon plasma (ICP) as an ion source and a mass 
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spectrometer for subsequent separation and detection of the ions. This coupling was firstly 
proposed by Houk et al. in 1980.49 After the commercial introduction of this technique in 
1983, ICP-MS rapidly occupied a leading position among the analytical techniques. 
Nowadays, ICP-MS competes with and displaces other techniques commonly used for 
elemental determinations, such as atomic absorption spectrometry (AAS) and inductively 
coupled plasma-optical emission spectrometry (ICP-OES), and isotopic analysis, such as 
thermal ionization mass spectrometry (TIMS). The main advantages of ICP-MS are the high 
ionization efficiency of the ICP ion source, the high sensitivity, and low detection limits 
(down to pg L-1), wide linear dynamic range (up to 12 orders of magnitude), high speed data 
acquisition in multi-elemental determinations, flexibility of sample introduction (liquid 
samples via pneumatic nebulization and solid samples via laser ablation (LA) or 
electrothermal vaporization (ETV)50), and high sample throughput. Moreover, ICP-MS is also 
used in speciation by coupling it with different separation techniques, e.g.,  high-performance 
liquid chromatography or gas chromatography.51 In spite of the numerous advantages of the 
ICP-MS, it is not free from drawbacks. The occurrence of interferences is probably the 
strongest limitation of this technique, although several strategies can be used to overcome 
them. In general, ICP-MS is relatively expensive and requires reagents of high purity, slightly 
acidified measurement solutions (typically < 5%), and a total amount of dissolved solids        
< 0.2%.52–54  
 
Fig.1-6 Schematic representation of a typical ICP-MS instrument (adapted from Houk 1986).55  
An ICP-mass spectrometer consists of three principal components: (i) an ionization source 
(for atomization and ionization); (ii) a mass analyzer (for separation of the ions based on their 
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mass-to-charge ratios), and (iii) a detector (for converting the ions into a measurable signal). 
A schematic representation of an ICP-MS instrument is shown in Fig. 1-6. 
Nowadays, a number of different ICP-MS designs are available, which can differ from one 
another in the design of the interface, ion focusing system, and mass separation device.52 In 
this PhD, double-focusing sector-field inductively coupled plasma-mass spectrometry (SF-
ICP-MS) and multi-collector inductively coupled plasma-mass spectrometry (MC-ICP-MS) 
were employed. Conventional introduction of a liquid sample is accomplished via pneumatic 
nebulization, where an aerosol is formed through interaction of an accelerated argon flow on 
the liquid sample surface in the nebulizer (typically of concentric design). The nebulizer is 
mounted onto a spray chamber (typically of double-pass Scott-type or of cyclonic design) that 
prevents the large droplets to enter the plasma by gravitational and centrifugal forces, thereby 
providing stable atomization and ionization in the ICP. The fine aerosol is then transported to 
the plasma torch, consisting of three concentric tubes, each of which with argon gas flows 
(Fig. 1-7). 
 
Fig. 1-7 Torch and ICP. 
The argon ICP is a plasma ionization source, which can be defined as a gas mixture at high 
temperature that contains molecules, atoms, ions, and electrons. The plasma torch is 
surrounded at its top by a water- (or gas-) cooled load coil (usually made of copper) 
connected to a radio frequency generator (27.12 or 40.68 MHz). When RF power (ranging 
between 750-2000 W) is applied to the load coil, an alternating current oscillates within the 
coil at a rate corresponding to the frequency of the generator, thereby creating an intense 
electromagnetic field at the top of the torch. A high-voltage spark is applied to induce free 
electrons in the gas stream. These electrons are accelerated in the magnetic field, leading to 
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the formation of more electrons by collision with argon atoms (electron impact ionization, 
equation 1-2). The process of ionization of the argon continues in a chain reaction, leading to 
the formation of more electrons and a self-sustaining plasma.52,54,56 
Ar + e- →Ar+ + 2e- (1-2) 
At the same time, excited argon atoms are formed (equation 1-3): 
Ar+ +e- →Ar*  (1-3) 
The ICP is mainly operated in hot plasma conditions, with an RF power of about             
1200-1300 W and a plasma temperature (ionization temperature Tion) of about 8000 K (in the 
center of plasma). At such a temperature, sample aerosol, introduced with the carrier gas 
stream, is first desolvated and vaporized, and the molecules thus formed subsequently 
atomized. Analyte atoms M are then ionized by means of (i) electron impact ionization 
(equation 1-4), caused by collision with accelerated electrons; (ii) charge transfer reactions 
(equation 1-5), caused by collisions between ions and atoms; and (ii) Penning ionization 
(equation 1-6), caused by collisions between atoms and excited Ar atoms.54 
Electron impact ionization M + e- → M + + 2e- (1-4) 
Charge transfer ionization M + Ar+ → M + + Ar (1-5) 
Penning ionization M + Ar* → M + + Ar + e- (1-6) 
Simultaneously, also excited atoms are formed due to electron excitation of atoms (equation 
1-7) and ion–electron radiative recombination (equation 1-8)54: 
M + e- → M* + e- (1-7) 
M+ + e- → M* (1-8) 
Under such conditions, most of the chemical compounds present in the sample aerosol are 
decomposed into their atomic constituents and the atoms thus formed are further ionized to a 
high degree in the plasma. The ionization efficiency α depends on the first ionization energy 
Ei of the element (the higher Ei, the lower α). The elements with Ei < 8 eV are ionized with 
nearly 100% yield (α ≥ 0.9), the metalloids (α ≈ 0.3-0.8) and nonmetals (α ≈ 0.01-0.3) can be 
ionized with a reasonable ionization efficiency.56 
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Simultaneously with singly charged elemental M+ ions of the sample and the Ar plasma gas, 
also a variety of other species are formed, such as doubly charged ions and polyatomic ions, 
which can interfere with the determination of the target elements at a similar mass-to-charge 
ratio (m/z) in the mass spectrum. Several approaches can be used to avoid/minimize the 
occurrence or influence of these species, such as a chemical pre-treatment of the sample prior 
to ICP-MS measurement, higher mass resolution, the use of a collision/reaction cell, cool 
plasma conditions and/or mathematical corrections. 
The ionization in the ICP, operated at atmospheric pressure, is followed by extraction of 
analyte ions into the mass spectrometer, which operates under high vacuum conditions     
(Fig. 1-6). The interface plays a critical role and needs to transport the ions efficiently and 
with electrical integrity from the plasma into the mass spectrometer.52 The interface consists 
of two water-cooled metal cones (typically from Ni or Pt, rarely Al) with a small orifice, 
sampler and skimmer, which are mounted one after another with an intermediate vacuum 
(~102 Pa) accomplished using a rotary (or fore-vacuum) pump in-between. The ions generated 
in the plasma pass through the sampler cone first (0.8-1.2 mm orifice) then, travel a short 
distance to the skimmer cone (0.4-0.8 mm orifice) and subsequently enter the ion optics. The 
main function of the ion optics is focusing of the ion beam, selecting of positive ions and 
preventing photons and neutral species from impinging on the detector.53 
The ion beam, focused through the ion optics, is guided into the mass spectrometer, where the 
positive ions are separated from one another according to their m/z ratio. Quadrupole and 
sector-field analyzers are the typically used mass separation devices in commercial ICP-MS 
instrumentation. Resolution, abundance sensitivity, and scan speed are important 
characteristics of an ICP-MS instrument. 
The capability of the mass spectrometer to separate ions with masses m and m+Δm is 
characterized by the mass resolution R (or resolving power), defined as follows: 
𝑅 =  
𝑚
∆𝑚
 ≈  
(




Two approaches are used to calculate mass resolution (Fig. 1-8). The 10% valley definition 
(Fig. 1-8 a) considers two peaks of equal height in a mass spectrum (masses m1 and m2). The 
peaks are considered as resolved if the valley between the peak maxima does not exceed 10% 
34 
of the peak heights. The other definition is based on experimentally observed mass width of a 
single spectral peak at 5% of its maximum (Fig. 1-8 b).54,56 
 
Fig. 1-8 Mass resolution. (a) 10% valley definition: calculation of the resolution required to resolve two adjacent 
spectral peaks showing a mass difference of m2 – m1; (b) calculation of the resolution offered by a mass 
spectrometer on the basis of the width of a spectral peak at 5% peak height (Δm) at mass m (adapted from 
Vanhaecke and Degryse, 2012 and Becker, 2007).54,56 
The abundance sensitivity (Fig. 1-9) is a quantitative measure for the contribution of the tail 
of a neighboring peak to the signal intensity of the target element. This aspect is especially 
important when a low intensity signal has to be measured next to a high intensity signal peak 
(large difference between the relative isotopic abundances). The abundance sensitivity is 
defined by IUPAC as “the ratio of the maximum ion current recorded at a mass m to the ion 
current arising from the same species recorded at an adjacent mass (m ± 1)”.53,57 
 
Fig. 1-9 Abundance sensitivity: Influence of peak tailing (β) from the abundant ion peak A+ at mass m on 
neighboring ion peak B+ at mass m+1 with low intensity IB (adapted from Becker, 2007).54 
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The scan speed is an important characteristic in the context of isotope ratio measurements and 
is the speed with which the mass spectrometer can scan the mass spectrum or switch from one 
mass to another.56 
Three types of mass spectrometers are commercially employed in ICP-MS: (i) the quadrupole 
mass filter (Q-MS), (ii) the double-focusing sector field mass spectrometer (SF-MS), and (iii) 
the time-of-flight mass spectrometer (TOF-MS). 
The quadrupole filter consists of four parallel cylindrical or hyperbolic rods with a direct 
current (DC) and an alternating current (AC) voltage component applied to them. The 
diagonally opposed rods are electrically connected, forming two electrode pairs. The voltages 
applied on both pairs, have the same magnitude but show an opposite charge.56,58 A schematic 
representation of the quadrupole is given in Fig. 1-10.  
 
Fig. 1-10 Operation principle of a quadrupole mass filter. (adapted from School of Chemistry, University of 
Bristol).59  
The focused ion beam coming from the ion optics is directed into the central channel between 
the four rods. The positive DC component (+U) forces the ions to move towards the axis of 
the rod and the AC component (Vsinωt) focuses the ions to the center during the first half a 
period and defocuses the ions from the center in the direction of the rods during the second 
half period. Heavy ions are focused on the central axis and lighter ions are sufficiently 
accelerated towards the quadrupole rods and removed from the ion beam. The average 
potential is positive and this pair of the electrodes acts as a high-mass filter. The voltage 
applied to the other pair of electrodes shows the same magnitude, but the opposite sign. In this 
case, the pair of electrodes consist of a DC component (-U) and an AC component, which 
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shows a phase difference of 180 (Vsin(ωt + )). The average potential is negative and thus, 
this pair of electrodes acts as a low-mass filter. In this way, the heavier ions are defocused and 
removed from the ion beam, while the lighter ions are focused on the central axis. Thus, the 
combination of the two electrode pairs results in a bandpass filter (Fig. 1-11). The DC and AC 
voltages are selected in such a way that only the ions within a selected narrow mass-to-charge 
ratio range can pass through the quadrupole filter, and the heavier and lighter ions collide with 
the rods and/or are removed. The dynamic selection of masses passing the filter is 
accomplished by changing the DC and AC voltages in such a way that the ratio of their 
magnitudes remains constant.54,56,58 The most notable advantages of the quadrupole mass 
analyzer are its technical simplicity with rapid scanning, larger tolerance towards the spread 
of the kinetic energies of ions entering the filter, possibility to operate at higher pressure and, 
consequently, relatively low cost. The major disadvantage of the quadrupole mass 
spectrometer is the low mass resolution (m/Δm ≈ 300). 
 
Fig. 1-11 The combination the high-mass (a) and low-mass (b) filters resulting in bandpass filter (c). (adapted 
from Miller and Denton, 1986).60 
The sector-field mass spectrometer consists of a combination of a magnetic and an 
electrostatic sector (Fig. 1-12). Modern mass spectrometers contain the magnetic and 
electrostatic sectors located one after the other in a double-focusing setup. The ion beam is 
first accelerated in the ion optics, providing the ions with a high kinetic energy. Subsequently, 
ions (with mass m and charge z) are introduced into a magnetic field B (Fig 1-12 a). When 
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ions with velocity v are introduced into a magnetic field, they move according to a circular 




= 𝑧𝑣𝐵 (1-10) 
The resulting radius of the circular path r of the ion depends on its mass-to-charge ratio (m/z) 
at a constant acceleration voltage V and constant magnetic field B: 




The radius of the trajectory of the nuclide of interest need to be altered to allow it to reach the 
detector. When a single detector is used, the mass-to-charge ratio of the ion can be selected by 
either adapting the magnetic field strength B (magnetic scanning or B-scanning) or the 
acceleration voltage V (electric scanning or E-scanning).56  
 
Fig. 1-12 Operation principle of (a) magnetic and (b) electrostatic sectors. (adapted from Vanhaecke and 
Degryse, 2012).56  
The electrostatic sector (Fig. 1-12 b) provides energy focusing to improve the mass 
resolution. An electrostatic sector with strength E consists of two bent electrode plates, to 
which potentials equal in magnitude but opposite in charge are applied. The ions, moving 
between the positively charged and a negatively charged bent plate, are forced to move along 
a circular path. The centrifugal force (mv2/r) required to move ions along a circular path, is 
provided by the electrostatic force, equal to zE56: 
𝐹 =  
𝑚𝑣2
𝑟
= 𝑧𝐸 (1-12) 
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As a result, the radius of the circular path of an ion depends on its kinetic energy: 







The combination of magnetic and electrostatic sectors radically improves the mass resolution, 
but lowers the transmission efficiency as less ions eventually reach the detector.54,56,58 In a 
double-focusing setup, the electrostatic and magnetic sectors are combined in such a way that 
the dispersions of the ion beam in both sectors eliminate each other. Thus, ions with a 
different kinetic energy or direction and the same m/z will still be focused at the same point. 
In Fig. 1-13, three different double-focusing geometries (Mattauch-Herzog, Nier-Johnson and 
reversed Nier-Johnson geometry) are shown. In the Mattauch-Herzog geometry (Fig. 1-13 a), 
the electrostatic sector with a specific angle of 30°50´ is followed by an anti-directionally 
curved magnetic sector of 90°. This arrangement permits the simultaneous monitoring of a 
relatively large mass spectrum. In the Nier-Johnson geometry (Fig. 1-13 b), the electrostatic 
sector is followed by the magnetic sector (both at 90°) and in the reversed Nier-Johnson 
geometry (Fig. 1-13 c) the magnetic sector is followed by the electrostatic sector (both at 
90°). In this geometry, only one mass can be focused at the detector at any given time, and the 
spectrum needs to be measured dynamically, in scanning or peak hopping mode. For single-
collector instruments, such as SF-ICP-MS, scanning or peak hopping is accomplished by 
adapting the magnetic field strength B or the acceleration voltage V. Sector-field mass 
analyzers are characterized by a higher mass resolution (up to 10000), low abundance 
sensitivity, high ion transmission efficiency, and flat-topped peaks with a trapezoidal 
shape.54,56 
In a time-of-flight mass spectrometer (TOF), ions are accelerated over an electrical potential 
V and subsequently introduced into a field-free flight tube and thus, all ions acquire the same 
kinetic energy: 
𝐸𝑘𝑖𝑛 =  
1
2
𝑚𝑣2 = 𝑧𝑉 (1-14) 
A time t is required to travel the distance to the detector, placed at the end of flight tube with 
length L56 and velocity , determined from equation 1-15: 









Fig. 1-13 Double-focusing setups: (a) Mattauch-Herzog, (b) Nier-Johnson, and (c) reversed Nier-Johnson 
geometries (adapted from Wiedenbeck et al., 2012).61 
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The ions are continuously registered at the end of the flight tube and therefore a TOF analyzer 
provides a complete mass spectrum for each package of ions that is introduced. The 
combination of a TOF analyzer with an ICP as ion source requires beam modulation, which is 
typically accomplished by orthogonal acceleration. The high spread in kinetic energy of the 
introduced ions can be remedied to some extent using an ion mirror to reflect the ions, such 
that they pass the flight tube twice and the path length is increased. The use of an ion mirror 
also corrects for differences in kinetic energy, as ions with higher energy are forced to travel a 
longer distance. TOF currently demonstrates the fastest acquisition rate among the mass 
analyzers (~ 0.033 ms for full mass spectrum).56 
The final part of an ICP-MS unit is the ion detection system. The ions that passed the mass 
analyzer are detected and transformed into a suitable signal, proportional to the abundance of 
nuclides. Nowadays, two types of detectors are commonly used: the electron multiplier and 
Faraday cup. The operating principle of an electron multiplier is based on avalanche 
multiplication of electrons formed due to an ion striking the conversion electrode of a discrete 
dynode electrode. The electrons thus formed are accelerated towards the back end of the 
detector due to the potential difference over the detector (negatively charged front end and 
grounded back end of detector, each subsequent dynode is at a higher potential). This 
acceleration leads to multiple collisions with subsequent dynodes and whenever an electron 
collides with a dynode’s surface, more electrons are set free. As a result of this multiplication 
effect, one ion arriving at the detector finally leads to approximately 107–108 electrons. Each 
ion is individually detected in pulse counting mode.56,62 
In a Faraday cup, the ion beam coming from the mass analyzer is directed into a metallic cup, 
when the ions reach the wall of the cup, they are neutralized by accepting electrons. This 
leads to a current through the resistor, which is further amplified and detected. This type of 
detector consists of a thin and deep bucket (cup). In a multi-collector setup, several Faraday 
cups are fitted onto movable stages. The large depth of the cup helps to ensure that any 
secondary electrons produced by energetic incident ions cannot escape the detector. The cups 
are connected to current amplifiers with high-ohmic feedback resistors (modern systems have 
amplifiers of 1010, 1011,1012, and 1013 Ω). Faraday cup detection is the most robust, linear, and 
accurate technology for the measurement of ion currents. However, the main disadvantages of 
this detector are the low sensitivity, which is limited by the noise of the amplifiers, and a 
slower response time.  
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1.2.2 Multi-collector ICP-MS 
High-precision isotopic analysis via multi-collector inductively coupled plasma-mass 
spectrometry (MC-ICP-MS) is providing relevant information in the context of geological, 
cosmochemical, environmental, forensic, and biomedical applications. For such purposes, 
TIMS was traditionally used. However, nowadays multi-collector ICP-mass spectrometry is 
preferable for the high-precision isotopic analysis of metals and metalloids from a practical 
point of view. In TIMS, the element of interest, previously isolated chemically from the 
sample, is loaded onto a metal filament. Subsequently, the element is ionized under resistive 
heating in vacuum and thereafter, the ions are separated according to their mass to-charge 
ratio in the mass analyzer for further detection. Modern MC-ICP-MS provides comparable 
precision (~0.002% RSD, under ideal circumstances),63,64 but higher sample throughput. 
Moreover, the ICP ion source is capable of ionizing elements with high ionization energies   
(> 7 eV) such as Cu (7.7 eV), Fe (7.9 eV), W (8.0 eV), B (8.3 eV), Sb (8.6 eV), and even the 
volatile Hg (10.4 eV)65 at atmospheric pressure. The use of a detector array with multiple 
Faraday cups permits the simultaneous collection of the separated ion beams thereby ensuring 
high isotope ratio precision. The simultaneous detection of the isotopes of interest also allows 
the measurement of transient signals generated by devices, such as gas or liquid 
chromatographs, laser ablation systems, and on-line chemical reactors, coupled to the MC-
ICP-MS unit.56,66 
MC-ICP-MS instruments are based on a double-focusing sector-field mass analyzer to 
provide flat-topped peaks, which are necessary for high-precision isotope ratio measurements 
at low and “pseudo” high mass resolution67 and static separation of ion beams. The unit in 
operation at UGhent is equipped with movable faraday cups connected to 1010 - 1012 Ω 
amplifiers.66 The use of “jet” sample cones in combination with a large interface pump allows 
an improvement in sensitivity by a factor between 4 and 50 compared to the standard 
interface.68,69  
In comparison to MC-ICP-MS, the precision of the isotope ratios obtained via a quadrupole-
based instrumentation or SF-ICP-MS is ≤ 0.05% RSD.70–72 By increasing the mass resolution 
(which is necessary for elements as Fe due to the presence of Ar-based interferences) in SF-
ICP-MS, the peak shape changes from trapezoidal to almost triangular and therefore, the 
internal isotope ratio precision is deteriorated (~0.1% RSD under ideal conditions).73 
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Although the precision attainable with this instrumentation is significantly poorer than that 
obtained via MC-ICP-MS or TIMS, it can be sufficient for some applications. 
 
1.2.3 Correction for instrumental mass discrimination  
Isotope ratio measurements by MC-ICP-MS are affected by instrumental mass discrimination, 
principally due to a more efficient transport of the ions of the heavier isotopes of the target 
analyte. This phenomenon is mainly associated with the supersonic expansion of the ion beam 
in the interface and space-charge effects (in principle, heavier ions have higher kinetic energy 
and push the lighter ions away from the center of the ion beam due to electrostatic 
repulsion).66,74–77 However, to date, there is still no complete understanding of this 
phenomenon.78 The bias between true and measured values for light-mass elements, such as 
B, is more pronounced in MC-ICP-MS than in TIMS, where the origin of mass fractionation 
effects (time-dependent mass bias as a result of the finite amount of sample on the filament 
source and the more efficient thermal ionization of the lighter isotope) is better 
understood.56,76 Regardless of the exact origin of the mass discrimination in ICP-MS, this 
effect has to be carefully corrected for in isotope ratio measurements, in order to obtain 
precise and accurate results. 
Several approaches have been proposed for mass bias correction, typically mathematically 
based on external correction using a certified isotopic reference material with known isotopic 
composition, an internal correction using an internal standard (intra- or inter-elemental) or a 
combination of both. The simplest method is external correction, typically in a sample-
standard bracketing (SSB) approach, where the isotope ratio data obtained for a sample is 
referenced to the ratio obtained for an isotopic standard measured before and after the sample. 
The SSB approach has two major assumptions: (i) the mass discrimination is supposed to be 
relatively stable as a function of time and (ii) the external standard and samples show an equal 
mass discrimination behavior. Therefore, matrix matching of the samples and standard plays a 
critical role, which in practice is not always possible.56 Internal standardization using a second 
isotope pair of the analyte (invariant in nature) can be used to correct the target isotope ratio, 
containing a radiogenic isotope, for instrumental mass discrimination (intra-element internal 
standardization).63,79 This model not only corrects for instrumental mass discrimination, but 
also for any natural mass-dependent isotope fractionation of the target isotope ratio. However, 
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the main limitation of intra-elemental internal standardization is the number of isotopes 
required and the limited applicability. Another approach is based on using the another 
element, admixed to the sample as an internal standard (IS), for correction of the target 
element isotope ratios for instrumental mass discrimination (inter-element internal 
standardization).  
Different models for correction of instrumental mass discrimination have been proposed over 
the years.63,71,78,80,81 The difference between the measured (Rexp) and the true (Rtrue) isotope 
ratios is usually expressed by the mass bias correction coefficient, Kij (also termed ‘mass-bias 
factor’): 
𝑅𝑡𝑟𝑢𝑒 = 𝑅𝑒𝑥𝑝  ∙ 𝐾𝑖𝑗  (1-16) 
The mass-bias correction model, firstly described by Russell et al. (equation 1-17)82 remains 








   (1-17) 
where mi and mj are the nuclide masses, and fx is fractionation function. 
In general, mass-bias correction models express the mass-bias relation between the various 
isotope pairs of the same (intra-elemental internal standard) or differing (inter-elemental 
internal standard) elements. Thus, the two mass-bias correction factors are assumed to be 











Woodhead suggested to use the best-fitting straight line through data for the target isotope 
ratio (fsample) plotted against those for an IS (fIS), calculated according to equation 1-18, to 
deduce the correction factor.80 This model was further revised by Baxter et al.83 using a linear 
regression line between ln(Rsample) and ln(RIS) to establish the correlation between the 
correction factors for the analyte and the internal standard: 
𝑙𝑛𝑅𝑠𝑎𝑚𝑝𝑙𝑒 = 𝑎 + 𝑏 ∙ 𝑙𝑛𝑅𝐼𝑆 (1-19) 
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Both approaches (Woodhead and Baxter) provide equivalent results. Particularly for Fe 
isotope ratio data, SSB combined with internal correction (using Ni as an IS) by means of the 
Russell law, using a regression line to establish the correlation between the correction factors 
(fFe is plotted against those for an IS fNi) or revised Russell law, using a regression line to 
establish the correlation between the logarithm of uncorrected isotope ratio for Fe plotted 
versus that of Ni, were used in this PhD. 
Instrumental mass discrimination can also be corrected for by using the double spike 
approach, where a spike enriched in two isotopes and with known isotopic composition of the 
target element is added to the sample.56,84,85 Therefore, the target element needs to have at 
least four isotopes. This method provides accurate and precise isotope ratio data and allows to 
correct for sample loss in any sample preparation step, which can lead to artificial isotope 
fractionation. However, next to the number of isotopes required, the double spike technique 
also has other disadvantages such as the high cost of high-purity isotopically enriched 
materials, potential memory effects and lower sample throughput. 
 
1.2.4 Overcoming spectral interferences  
Spectral interferences are generally classified into three major groups depending on the type 
of ion at the origin of the problem: an isobaric atomic ion, a multiply charged ion (mostly 
doubly charged ion), or a polyatomic (molecular) ion. Isobaric interferences occur when 
nuclides from different elements have the same nominal mass, e.g., 58Fe and 58Ni. However, 
each element of the periodic table, except indium, has at least one isotope free from isobaric 
interference, although these nuclides are not always the most abundant. Doubly charged ions 
are formed when an ion is generated with a double positive charge and produces a spectral 
peak at half its mass. The level of doubly charged species is related to the ionization 
conditions of the plasma and can be minimized by optimization of the nebulizer gas flow, RF 
power, and torch position.52 Polyatomic or molecular ions consist of two or more atoms and 
typically contain Ar, and/or elements from the sample matrix, the solvent and/or the 
surrounding air. Moreover, the signals of neighboring ions with very high intensity, for 
instance derived from the matrix elements, can alter the analytical signal of the target element 
with lower intensity as a result of the signal "tails" of the neighboring peaks when the 
abundance sensitivity is not sufficient. 
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A variety of strategies can be used to overcome spectral interferences, such as high mass 
resolution in sector-field instruments, chemical or energy resolution using a reaction/collision 
cell, cold plasma conditions, mathematical corrections, and chemical separation of the target 
analyte from the sample matrix.100 A compilation of the isobaric and polyatomic interferences 
affecting iron isotopes and common strategies to overcome them are presented in the       
Table 1-1. 





Interfering Species Strategies 
54Fe 5.82 
54Cr+, 38Ar16O+, 36Ar18O+, 40Ar14N+, 
40Ar18O+, 38Ar18O+, 40Ar14N+, 39K15N+, 
24Mg16O14N+, 38Ar15N1H+, 37Cl16O1H+, 
35Cl18O1H+, 36Ar17O1H+, 37Cl17O+, 
36S18O+ 
Desolvating nebulizer system to 
eliminate influence of polyatomic 
interferences such as ArN+, ArO+ or 
ArOH+.87–89 
Use of reactive gases (e.g., NH3, CO, 
H2 and N2) in a collision/reaction cell 
in Q-ICP-MS and triple-quadrupole 
ICP-MS.90–94 
Use of a non-reactive gas (e.g., He) 
in a collision cell combined with 
kinetic energy discrimination.95 
Chemical separation of isobaric 
interferences.87,88,96 
High mass resolution.92,97 
Cold plasma conditions to suppress 
polyatomic ions such as 40Ar14N+ 
and 40Ar16O+.89,98,99 
56Fe 91.66 
40Ar16O+, 40Ca16O+, 40Ar15N1H+, 
38Ar18O+, 38Ar17O1H+, 37Cl18O1H+ 
57Fe 2.19 
40Ar16O1H+, 40Ca16O1H+, 40Ar17O+, 
38Ar18O1H+, 38Ar19F+, 40Ar18O+, 
40Ar17O1H+, 41K16O+, 39K18O+, 
43Ca14N+ 
58Fe 0.33 58Ni+, 40Ar18O+, 40Ar17O1H+, 44Ca14N+  
The measurement of iron signal intensities or isotope ratios in ICP-MS is usually performed at 
medium or high mass resolution due to the presence of spectral interferences, as a result of the 
presence of ArN+, ArO+, and ArOH+ species, which interfere with the signals of the iron 
nuclides at masses 54, 56, 57 and 58.86 Quantification of iron, for instance, can be performed 
successfully via SF-ICP-MS using “full” medium or high resolution (Fig. 1-14 b). In case of 
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Fe isotope ratio measurement via MC-ICP-MS, “pseudo” mass resolution is used, according 
to which the peaks from the analyte and the interferent are not entirely resolved, but there is a 
significantly wide window, wherein only the analyte ion contributes to the signal intensity and 
where the signal is flat (Fig. 1-14 c). An improved isotope ratio precision is obtained under 
these conditions compared to that obtained at “full” high mass resolution.64,67 
The collision/reaction cell is a universal and flexible strategy to reduce spectral interferences 
in ICP-MS equipped with a quadrupole mass spectrometer. The cell, containing a multipole 
under a radio frequency potential, is positioned between the interface and the mass analyzer 
and filled with a selected gas. The analyte ion can be separated via selective ion-chemical 
reactions of the interfering ion with the reaction gas in the cell with subsequent neutralization 
or change in its m/z ratio and therefore, reducing its contribution to the spectrum. Newly 
formed species, as a result of the reactions, can be eliminated by kinetic energy discrimination 
using a deceleration voltage. Alternatively, the target ion can be involved in a selective 
reaction and measured under a form of reaction product ion. Another approach is based on 
using an inert collision gas (He or H2) in combination with energy discrimination. As a result, 
a decelerating voltage may be applied to discriminate selectively against the polyatomic 
ions.56,101 Triple-quadrupole ICP-MS (ICP-QQQ) is a recently introduced type of instrument, 
equipped with an octopole or quadrupole collision cell located between two quadrupole mass 
filters and it offers the potential to improve the removal of spectral interferences compared to 
conventional quadrupole ICP-MS with a collision/reaction cell. The tandem mass 
spectrometer configuration provides two separate mass selection steps, which provides full 
control over the ion/molecule chemistry that occurs in the cell.102 Particularly for Fe, the 
precision obtained via QQQ-ICP-MS is in the order of 0.1% RSD for 56/54Fe, 0.15 % RSD for 
57/54Fe  and 0.5 % RSD for 58/54Fe. Self-evidently, the precision is worse than that achieved 
with MC-ICP-MS, but it is equal to or better than that of SF-ICP-MS. This confirms that 
QQQ-ICP-MS can be considered as a suitable technique for the routine determination of 
induced changes in the isotopic composition of Fe as encountered in studies on human iron 
absorption and the evaluation of the efficacy of Fe supplementation, but of course, it cannot 
replace MC-ICP-MS for the measurement of natural Fe isotope ratio variations due to its 
significantly lower isotope ratio precision. 
Cool plasma conditions are obtained by reducing the RF power of the ICP and increasing the 








Fig. 1-14 Appearance of mass spectral peak subject to overlap at (a) low mass resolution, (b) (full) high mass 
resolution, and (c) pseudo high resolution with multi-collector ICPMS (adapted from Vanhaecke and Moens, 
2004).67 
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completely atomized and charge transfer from Ar-containing ions to these species is then 
significantly lowering the signal intensity of interfering ions (such as 40Ar16O+ and 
40Ar14N+).56,89,103 
Another way to eliminate spectral interferences is via chemical separation of the target 
element from sample matrix prior to ICP-MS measurement. Ion exchange chromatography is 
typically used for such purpose. Ion exchange chromatography can induce mass-dependent 
isotope fractionation (artificial fractionation), but the effect of on-column isotope 
fractionation on the final results is avoided when the recovery of the target element is 
quantitative.104 In case of a non-quantitative recovery, the double spike approach is 
recommended. Another possible disadvantage is the presence of organic material stripped 
from the resin in the pure fraction of the analyte. Pietruszka and Reznik105 observed a 
significant effect on Mo isotope ratio measurement results due to the organic material 
released from the resin. 
 
1.3 IRON ISOTOPIC VARIABILITY IN A BIOMEDICAL CONTEXT 
Natural variations in the isotopic composition of elements with two or more isotopes can 
occur due to the isotope fractionation that is accompanying (bio)chemical reactions and/or 
physical processes. Isotopes of the same element may take part in such reactions or processes 
to slightly different extents. The lighter of two isotopes reacts slightly faster (kinetic effect) 
and the heavier one shows a slight preference for the strongest bond (thermodynamic or 
equilibrium effect).106,107  
Light elements, such as H, C, N, O or S, have been analyzed for their isotope ratios because 
of their large isotopic variations in nature, due to the large relative mass difference between 
the isotopes. In a biomedical context, for instance, the 13C-urea breath test is used in 
gastroenterology practice to measure small-bowel bacterial overgrowth and for the diagnosis 
of Helicobacter pylori infection of the stomach in an indirect way via gas source isotope ratio 
mass spectrometry of the 13C/12C ratio in exhaled breath.108 The 13C-glucose breath 
methodology relies on measuring the 13CO2/
12CO2 isotope ratio with high-precision via laser-
based high-resolution cavity-enhanced absorption spectroscopy and can also be used for the 
accurate real-time monitoring of individuals with small intestinal bacterial overgrowth.109  
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Recently, considerable effort has been made to obtain precise and accurate isotope ratio data 
for heavier elements, such as Fe, Cu, Zn, and Ca, in this context in order to extend the 
applicability of stable isotopic analysis.110 For such purpose, MC-ICP-MS is nowadays the 
preferred technique for tracing down isotope fractionation processes occurring during 
biological processes. As has been described before, the combination of a highly efficient ion 
source with simultaneous detection of all isotope signals allows the typically unstable signal 
intensities to be counteracted, thus realizing high isotope ratio precision.87,110,111 
A variety of studies have already demonstrated that iron shows natural variations in its 
isotopic composition as a result of isotope fractionation accompanying physical processes 
and/or biochemical reactions.56,112 As a result of the small variations, the isotopic composition 
is typically expressed in delta notation (i.e. as the relative difference between the isotope ratio 






− 1) (1-20) 
where x is 56 or 57. 
Beard et al.113 demonstrated that the Fe isotopic composition of ferrous iron produced by 
iron-reducing bacteria was lighter than that of the ferrihydrite substrate and pointed out as a 
first time that natural isotopic fractionation can occur due to biological effects. Over the last 
decade, iron isotopic analysis of human fluids and tissues gained increasing attention. 
Walczyk and von Blanckenburg114 were the first who showed that human whole blood and 
muscle tissue have a similar iron isotopic composition, while that of liver is heavier. The 
authors hypothesized that natural iron isotope variations in human blood are primarily related 
to the dietary iron absorption. They also demonstrated that gender is as an important source of 
variability in the Fe isotopic composition. Men show a greater proportion of the lighter iron 
isotopes in whole blood than women.114,115 The same result was later observed by Van Heghe 
et al.116,117 in whole blood, Ohno et al.87, and Jaouen and Balter118 in RBCs and Albarede et 
al.119 in whole blood, RBCs and serum. Later on, the menstruation and the associated iron 
loss and the body’s reaction to replenish the iron store were identified as the underlying 
reason of gender-related Fe isotope ratio variations.118,120 For post-menopausal women and 
those with a Mirena® (an intra-uterine contraceptive device), a significant shift to lighter Fe 
isotopic signatures (overlapping with those for the male reference population) was observed 
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compared to menstruating women. Between post-menopausal women and women with a 
Mirena®, no differences were observed in the whole blood Fe isotopic composition.120 At the 
same time, Jaouen and Balter came to the same conclusion, indicating that Fe isotopic 
composition of RBC from newly post-menopausal women is similar to pre-menopausal 
individuals and an isotopic shift becomes visible 5 years after the menopause.118  
Walczyk and von Blanckenburg observed that (i) the iron in the biosphere (including plants, 
animals and humans) shows an 56Fe/54Fe ratio lower by 2-3‰ than the iron in the geosphere 
and (ii) the Fe isotopic composition changes along the human food chain.115 Further,  in a 
study on isotope fractionation along mammal trophic chains, Jaouen et al., this observation 
was confirmed by demonstration that the second trophic step (as documented by the 
difference in the isotopic composition of Fe between bones of herbivores and bones of 
carnivores) is characterized by a 56Fe-depletion of about 0.6‰.121 Thus, Fe becomes enriched 
in the lighter isotope along the human food chain.115,121 
 
Fig. 1-15 Fe isotope ratio variations in the human body and different food samples covering the most relevant 
dietary Fe sources. Data are plotted relative to an isotopic reference material (IRMM-014, δ = 0). (adapted from 
Walczyk and von Blanckenburg).114 
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By using a pig model, Hotz et al. identified the preferential uptake of light iron isotopes in the 
intestine and the extent of dietary iron absorption efficiency as key factors governing the 
whole blood Fe isotopic composition.122,123 Comparison of the isotopic composition of Fe in 
whole blood and tissues from humans,114 as well as in animal models122,124 demonstrated that 
Fe is systematically isotopically lighter in all organs and biofluids than in the diet (Fig. 1-15). 
Walczyk and von Blanckenburg114,115 reported a difference of 1.7‰ between the whole blood 
and diet Fe isotopic composition. Isotopic analysis of different food products showed that 
animal products show a δ56Fe value of around -2‰, while plant products are characterized by 
a value of around -0.7 ‰ to 0 ‰.125 Van Heghe et al.,116 however, demonstrated that whole 
blood from supposedly healthy subjects following different diets, i.e. omnivores and 
vegetarians of the same gender, do not show a significant difference in Fe isotopic 
composition. This finding supported the conclusion of Walczyk and von Blanckenburg,114 
who stated that the isotopic composition of Fe in blood is not primarily determined by the 
diet, but by the favoured uptake of the lighter isotopes in the intestine. Von Blanckenburg et 
al. 125 hypothesized that heme-bound Fe passes through the intestinal mucosa without ligand 
exchange and therefore without fractionation, while Fe originating from vegetables (mostly in 
ferric form) is reduced in the intestine and is fractionated in the process.  
The heavier Fe isotopic composition of liver and spleen, as main Fe store sites, and the higher 
fraction of lighter iron isotopes in whole blood were demonstrated first by Walczyk and von 
Blanckenburg.114,115 Later, Balter et al.124 observed the same trend in organs and body fluids 
of mice and sheep. 
Current researches are focused on the study of diseases related with iron metabolism to reveal 
the possible occurrence of a significant effect on the isotopic composition. In first studies, in 
patients with hereditary hemochromatosis (HH), which leads to ironoverload, the whole blood 
56Fe was shown to be shifted to higher values.126,127 Krayenbuehl et al. found an altered Fe 
isotopic composition of whole blood of patients with HH compared to assumed healthy 
individuals. The heavier whole blood Fe isotopic composition of HH patients was explained 
by the upregulated intestinal iron absorption and therefore, the preferential transfer of lighter 
isotopes was less emphasized.127 Later on, in HH patients under phlebotomy treatment, it was 
observed that this effect is further enhanced by remobilization of iron from the storage tissues, 
which is characterized by a heavier isotopic composition than iron in the blood.117,128 In 
contrast, ACD had a contrary effect on the Fe isotopic composition as a consequence of a 
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downregulated iron uptake, transfer of a larger amount of iron to the storage sites and no 
mobilization of storage iron to the circulation.117 Fig. 1-16 provides a general indication of 
how the Fe status affects the whole blood and serum delta Fe values. At low iron status, the 
production of hepcidin is downregulated to increase intestinal iron absorption, and only a 
small portion (if any) of the iron taken up is deposited in hepatocytes. The iron store and the 
macrophages recycling iron from senescent red blood cells are activated thus stimulating 
hemoglobin synthesis. At high iron status, in contrast, the iron absorption is downregulated 
due to increased production of hepcidin as a result of inflammation or genetic predisposition, 
or low bioavailability of dietary iron 
 
Fig.1-16 General indication of effect of iron status on whole blood and serum delta Fe values. 
Von Blanckenburg et al.129 compared the isotopic composition of human erythrocytes and 
plasma. The Fe isotopic composition in blood plasma is more variable than in erythrocytes 
and shows a higher fraction of the heavier iron isotopes. Ferritin was indicated as a key player 
that can induce isotope fractionation by release and uptake of iron involving redox processes.  
Since there is a clear association between the whole blood Fe isotopic composition and an 
individual’s iron status,117,123 high-precision Fe isotopic analysis turns out to be a potentially 
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interesting approach for assessing iron depletion or overload in clinical practice. However, the 
main carrier of iron in whole blood is hemoglobin in erythrocytes with a lifespan of 110 - 120 
days, and thus are not an ideal measure of immediate iron stores. In turn, serum, with 
transferrin as a main carrier of iron with highest turnover (the protein undergoes cycling 
between holo- and apo-states more than 10 times per day, thus cycling around 30 mg of iron), 
can provide more accurate information on current iron status. 
The precision attainable in isotopic analysis is the decisive factor when it comes to the 
question of which instrument type to be employed in studies of element metabolism. In 
comparison to MC-ICP-MS (~0.002% RSD, under ideal circumstances), the precision of Fe 
isotope ratios obtained via quadrupole-based or SF-ICP-MS instrumentation is about 0.05% 
RSD under ideal circumstances. Thus, these instruments cannot be recommended for tracing 
down the small changes and quantifying the resulting small differences in isotopic 
composition accompanying physical processes and/or (bio)chemical reactions, however, they 
can be considered as a suitable technique for the routine determination of iron absorption in 
human iron supplementation studies with stable isotopic tracers. 
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CHAPTER 2  
I R O N  I S O T O P I C  A N A L Y S I S  O F  H U M A N  W H O L E  
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T R A C E R  
 
Parts of this chapter will be included in a publication in collaboration with the MRC Human 
Nutrition Research group from the University of Cambridge, UK. The manuscript is in 





2.1 INTRODUCTION  
Iron deficiency (ID) is the most common nutritional disorder worldwide and it accounts for 
approximately half of the cases of anemia.1–4 ID can occur due to malnutrition, decreased 
intestinal iron absorption, hemodialysis, frequent blood sampling, gastrointestinal bleeding, 
multiple vascular access surgeries, hepcidin fluctuations, etc.5 Iron deficiency refers to the 
reduction of iron stores, under the form of ferritin, and transferrin saturation (TSAT) with the 
hemoglobin level remaining normal until the iron stores get exhausted.6,7 Iron deficiency can 
exist in the absence of anemia if it has not lasted long enough or if it has not been severe 
enough to cause the hemoglobin concentration to fall below the threshold for the specific sex 
and age group.8 The highest prevalence of ID is among women and young children and it 
entails important consequences for human health and child development. According to 
Umbreit,9 the occurrence of ID in women aged 16–19 years old is 19% and in 1-2 year old 
children of both sexes, the prevalence is 7%. Among pregnant women, ID and/or iron 
deficiency anemia (IDA) can occur during all three trimesters (9%, 14%, and 37% prevalence, 
respectively). ID and IDA in pregnancy is typically associated with an increased risk of poor 
pregnancy outcomes, including intra-uterine growth retardation, stillbirth, preterm delivery, 
low birth weight and delayed or impaired mental and physical development.10  
Many efforts have been done to avoid ID and IDA over the past two decades but, to date, 
these conditions are still common.8 In practice, the treatment of ID is based on iron 
supplementation, however optimum iron administration is still a challenge due to the low 
intestinal absorption of the iron supplements. The most common oral iron supplements are in 
the form of ferrous salts, such as ferrous sulfate (included in the WHO list of essential 
medicines11), ferrous gluconate and ferrous fumarate. The estimated absorption efficiency of 
the ferrous salts is between 5 and 15% only.12 Alternatively, ferric iron supplementations 
(e.g., succinylate protein or polymaltose complex) may be used, but ferric ion compounds are 
either poorly absorbed (3-4 times less than ferrous forms) or expensive.13 Due to the low 
absorption efficiency of iron, a high dosing of iron supplements is typically used to counteract 
ID. However, high doses of iron supplements may give rise to side effects such as abdominal 
discomfort, nausea, vomiting, diarrhea and constipation.14–16  
In nutritional or clinical studies assessing the suitability of iron supplements or food 
fortificants, an ‘absorption and utilization test’ is performed. Absorption is considered as a 
systemic uptake across the gut and utilization refers to the incorporation of iron into 
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hemoglobin. The gold standard test in humans requires the incorporation of isotopically 
labelled iron in the supplements followed by the measurement of the isotopic enrichment in 
the hemoglobin 14 days after supplementation relative to the baseline (i.e. before the 
supplementation).17 Stable isotopes, such as 58Fe and 57Fe, are typically used to avoid any 
radio-isotopic exposure for the subjects. For a long time, the reference technique used for 
tracing isotopic changes has been thermal ionization mass spectrometry (TIMS), which 
provides a high isotope ratio precision (0.001 % relative standard deviation18,19), but requires 
exhaustive sample pre-treatment, resulting in a very low throughput and, consequently, high 
costs.20 For iron in particular, the ionization efficiency (conversion into Fe+) in TIMS is lower 
than that in ICP-MS.21,22 Moreover, instrumental mass fractionation has to be appropriately 
corrected for (e.g., by using the double-spike approach).21 A precision of 0.07% RSD was 
obtained for the 54/56Fe ratio using a negative ion TIMS approach, in which FeF4
- ions were 
measured. The precision thus realized was better than the 0.3% RSD reported for the 54/56Fe 
ratio using positive ion TIMS.23 Multi-collector inductively coupled plasma mass-
spectrometry (MC-ICP-MS) is nowadays preferred for high-precision isotope ratio 
measurements in clinical samples.24–28 Like in TIMS, in MC-ICP-MS, an array of Faraday 
cups is used for ion detection. Faraday cups are robust and stable detectors and their use in an 
array constellation for simultaneous monitoring of the various ion beams provides an isotope 
ratio precision equivalent to that of TIMS.29,30 MC-ICP-MS also requires sample preparation, 
including the chemical separation of the target element form the matrix, but the sample 
throughput is still higher than for TIMS.31 However, both TIMS and MC-ICP-MS are not 
analytical techniques adapted for routine clinical and nutritional studies.22 Quadrupole ICP-
MS equipped with a collision/reaction cell and sector-field ICP-MS (SF-ICP-MS) techniques 
have therefore often been preferred in human iron absorption studies.17,22,32,33 These single-
collector instruments are also more robust, such that often blood samples are analyzed without 
prior chromatographic isolation of iron. Both quadrupole-based and sector-field ICP-MS 
instruments are equipped with a single secondary electron multiplier (SEM) for detection of 
positively charged ions.29,30 A modern SEM can be used in a dual detector mode, whereby a 
high speed amplifier operates in the pulse counting mode for lower ion currents and in the 
analogue mode for higher ion currents. For isotope ratio measurement, however, a SEM needs 
to be deployed in one mode only. When used in pulse counting mode, a SEM requires a dead 
time correction (particularly if extreme isotope ratios are measured) and typically the 
precision attainable in the isotope ratio measurements is deteriorated compared to that 
obtained with MC-ICP-MS, in which the ion beams are monitored simultaneously.20,29,30,34 
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In this study, the potential use of SF-ICP-MS was evaluated for tracing changes in the 
isotopic composition of Fe in whole blood of individuals participating to a human nutritional 
study. The whole blood Fe isotopic composition obtained via SF-ICP-MS (with and without 
prior chromatographic Fe isolation) was compared to that obtained via high-precision MC-
ICP-MS. This work was performed in collaboration with the MRC Human Nutrition Research 
group of the University of Cambridge (UK). 
 
2.2 EXPERIMENTAL 
2.2.1 Materials and reagents 
Ultrapure water (resistivity ≥18.2 MΩ cm) was obtained from a Milli-Q Element water 
purification system (Millipore, France). Pro analysis purity level nitric acid (HNO3, 14 M) 
used for the digestion and the isolation procedure was purified by sub-boiling distillation in a 
PFA equipment. Optima grade hydrochloric acid (HCl, 12 M) was obtained from Fisher 
Chemicals (UK) and used as such. Ultrapure hydrogen peroxide (H2O2, 9.8 M) was acquired 
from Sigma-Aldrich (Belgium). Sample preparation was performed in a class-10 clean lab. 
The Fe isotopic reference material IRMM-014 (Institute for Reference Materials and 
Measurements, Belgium) was used for external correction for instrumental mass 
discrimination in a standard-sample bracketing approach. An elemental iron standard solution 
(Inorganic Ventures, The Netherlands; lot D2-FE03110) was used as in-house isotopic 
standard solution (further referred to as A&MS-Fe) for checking the quality of isotope ratio 
measurements. Single-element standard stock solutions (Inorganic Ventures, the Netherlands) 
were used for quantification purposes after the isolation procedure. Ga, used as internal 
standard correcting for instrument instability and matrix effects in SF-ICP-MS elemental 
determination measurements, was coming from a commercially available 1 g L-1 stock 
solution. 
AG MP-1 strong anion exchange resin (100-200 mesh, chloride form) and polypropylene 




2.2.2 Samples and sample preparation 
12 whole blood samples originating from 4 Gambian women were obtained from the MRC 
Human Nutrition Research group. In this study, two different oral iron supplements 
containing either 57Fe (60 mg Fe + 14 mg 57Fe) or 58Fe (60 mg Fe + 2 mg 58Fe) were given to 
the individuals during 2 visits 14 days apart. The samples were collected immediately before 
the administration of the supplement (time point zero) and at two time points after supplement 
administration, i.e. after 14 and after 28 days.  
EDTA vacutainer tubes, suitable for trace element analysis, were used to collect whole blood 
samples. Samples were stored at -20 ºC until sample preparation. Ethical approval was 
obtained for using these samples by an independent commission of the Gambian Government 
/ MRC Joint Ethics Committee. The individuals signed an informed consent. 
About 1 mL of blood was digested in a closed Teflon Savillex beaker using a mixture of 3 mL 
of 14 M HNO3 and 0.75 mL of 9.8 M H2O2 at 110 ºC overnight (~16 h). The digest thus 
obtained was evaporated to dryness and re-dissolved in 5 mL of 8 M HCl + 0.001% H2O2 for 
chromatographic Fe isolation. 
The Fe isolation from whole blood matrixes was based on the procedure described by Van 
Heghe et al.31 In brief, the Bio-Rad Poly-Prep columns were filled with 1 mL of AG MP-1 
(100-200 mesh) strong anion exchange resin. A frit was placed as a bed support and a piece of 
cotton was placed on the top of the resin as a stopper. Prior to Fe isolation from the whole 
blood matrix, the resin was cleaned with 3 mL of 7 M HNO3, 10 mL of MQ water and 
conditioned with 5 mL of 8 M HCl + 0.001% H2O2. After sample loading, the matrix was 
eluted with 3 mL of 8 M HCl + 0.001% H2O2. Next, Cu was eluted with 9 mL of 5 M HCl + 
0.001% H2O2. Finally, Fe was eluted with 7 mL of 0.6 M HCl. The purified Fe fraction was 
collected in 15 mL Teflon Savillex beakers and evaporated to dryness at 95 ºC to remove 
residual chlorides and re-dissolved in 14 M HNO3. This procedure was repeated twice. The 
final residue was re-dissolved in 0.42 M HNO3. Procedure blank and A&MS-Fe in-house 
standard, treated in the same way as the samples, were included in each samples batch. The 
efficiency of isolation procedure and the recovery of the target element was tested by 
elemental analysis of the pure fraction via SF-ICP-MS.  
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2.2.3 Instrumentation and measurements  
A Thermo Scientific Element XR sector-field ICP-MS instrument (Bremen, Germany) was 
used for quantification purposes after the isolation procedure and for Fe isotopic analysis
Table 2-1. Instrument settings and data acquisition parameters used for elemental determination (A) and for 
isotope ratio measurements (B) via the SF-ICP-MS Element XR. 
Setting/parameter  Value/Description 
(A)  Elemental determination  
RF power (W) 1200 
Guard electrode Connected 
Sample and skimmer cones Ni, 1.1 mm and 0.8 mm orifice diameter 
Lens settings Optimized for maximum Fe+ signal intensity 
Ar flow-rates (L min-1):  
plasma gas 15 
auxiliary gas 0.8-0.9 
nebulizer gas 1.0-1.1 
Sample uptake rate (μ.L min-1) 200 
Resolution mode Low, medium, high 
Nuclides monitored 23Na (LR), 44Ca (MR), 54,56,57,58Fe (MR), 52Cr (MR), 39K (HR), 
63,65Cu (MR), 64,66Zn (MR), 60Ni (MR), 69Ga (LR, MR, HR)  
Acquisition mode E-scan 
Dwell time per point (ms) 10 
Samples per peak 20 
Number of runs 5 
Number of passes 5 
(B)  Isotope ratios  
RF power (W) 1200 
Guard electrode Connected 
Sample and skimmer cones Ni, 1.1 mm and 0.8 mm orifice diameter 
Lens settings Optimized for maximum signal intensity 
Ar flow-rates (L min-1):  
plasma gas 15 
auxiliary gas 0.8-0.9 
nebulizer gas 1.0-1.1 
Sample uptake rate (μL min-1) 200 
Resolution mode Medium 
Nuclides monitored 54Fe, 56Fe, 57Fe, 58Fe 
Detector mode Pulse counting 
Dead time (ns) 7  
Dwell time (ms) 10 
Mass window (%) 5  
Integration window (%) 5  
Samples per peak 125 
Number of runs 5 
Number of passes 150 
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(after Fe isolation and without prior Fe isolation). For the introduction of solutions into the 
plasma, a 200 μl min-1 quartz concentric nebulizer mounted onto a cyclonic spray chamber 
was used. For the elemental determinations, external calibration (calibration curve) combined 
with an internal standard (Ga) to correct for matrix effects and instrument instability was 
used. In Fe isotopic analysis, the Fe isotopic reference material IRMM-014 was used for 
external mass bias correction in a standard-sample bracketing approach. The instrument 
settings and data acquisition parameters used for elemental determination (A) and for isotope 
ratio measurements (B) are summarized in Table 2-1. 
A Thermo Scientific Neptune MC-ICP-MS instrument (Germany) was used for reference Fe 
isotope ratio measurements. A (100 μL min-1) PFA concentric nebulizer and a double spray 
chamber with cyclonic and Scott-type sub-units were used for the introduction of solution into 
the plasma. Measurements were performed at medium resolution (pseudo mass resolution35), 
in static collection mode, using four Faraday collectors connected to 1011 Ω amplifiers. 
Instrument settings and data acquisition parameters are shown in Table 2-2. 
Table 2-2. Instrument settings and data acquisition parameters for the MC-ICP-MS Neptune.  
Setting/parameter  Value/Description 
RF power (W) 1275 
Guard electrode Connected 
Sample and skimmer cones Jet sampler and X-type skimmer, Ni, 1.1 and 0.8 mm 
orifice diameter, respectively  
Lens settings Optimized for maximum Fe+ signal intensity 
Ar flow-rates (L min-1):  
plasma gas 15 
auxiliary gas 0.75 
nebulizer gas 0.9-1.0 
Sample uptake rate (μL min-1) 100 
Resolution mode Medium 
Acquisition mode Static; multi-collection 
Number of blocks 9 
Number of cycles 5 
Integration time (s) 4.194 
Cup configuration L4: 54Fe; L2: 56Fe; L1: 57Fe; C: 58Fe 
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In this study, mass bias correction relied only on external correction in a sample-standard 
bracketing approach (SSB). Mass bias correction using admixed Ni was not used to avoid the 
isobaric interference on 58Fe. 
For both measurements, with SF- and MC-ICP-MS, procedural blanks were measured at the 
beginning of the measurement session to evaluate their contribution to the Fe+ signal 
intensities. An A&MS-Fe in-house standard solution, previously characterized isotopically,31 
was measured every 5 samples to monitor the quality of the isotopic measurements.  
 
2.3 RESULTS AND DISCUSSION 
2.3.1  Iron isotope ratios via SF-ICP-MS 
Dead time of the detector 
A critical issue in isotope ratio measurements via SF-ICP-MS is related with the dead time of 
the detector. A certain dead time τ of the detector and its associated electronics has to be taken 
into account when the electron multiplier is used in pulse counting mode. Depending on the 
type of electron multiplier used, the detection and electronic handling of every pulse typically 
takes 5-100 ns and another ion arriving at the detector within a shorter time frame after the 
first one will not be detected.32 Consequently, this will lead to a signal loss. This effect is 
more pronounced when the rate of ions arriving at the detector increases. As a result, isotope 
ratios data show a bias relative to the corresponding true value.32 A number of approaches for 
determining dead time in ICP-MS systems can be found in the literature.36–40  
In general, appropriate correction for dead time losses of the measured signal intensities 
should result in a sensitivity which is independent of the signal intensity and therefore, 
independent of the analyte concentration.32 In the dead time determination method according 
to Russ,41 a series of standard solutions with different concentrations of the target element is 
measured for a given isotope ratio. Different assumed dead time values are subsequently used 
for correction. The normalized isotope ratios (56/54Feexperimental / 
56/54Fetrue) thus obtained are 
plotted as a function of the τ value applied for the correction.37 The values obtained for each 
concentration level, lay on a line, and the intercept of the lines will provide the experimental 
detector dead time (x-value). The bias of the corresponding y-value from 1 reflects the extent 
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of mass discrimination.32 Fig. 2-1 shows the plot of the normalized isotope ratios versus the 
assumed detector dead time. The experimental dead time obtained was ≈ 7 ns. 
 
Fig. 2-1 Normalized 56/54Fe isotope ratio plotted as a function of the dead time value applied for correction.  
 
Iron isotope ratio precision  
As a result of isobaric and polyatomic interferences,42 isotope ratio measurements of Fe via 
SF-ICP-MS requires higher mass resolution. However, at medium and high resolution          
(~4000 and 10000, respectively43,44) the precision on the isotope ratios is compromised due to 
the absence of a flat top peak and the significant loss in signal intensity (sensitivity).45 The 
selection of the optimum Fe concentration is a critical step for isotope ratio measurements via 
SF-ICP-MS in order to obtain accurate and precise isotope ratio data taking into account the 
automatic switch of the detector mode. This automatic switch between modes of the EM 
detector of SF-ICP-MS has to be avoided.46 As a result, a relatively low concentration of Fe is 
required. Thus, the concentration of Fe in the final solutions was adjusted in order to be able 
to monitor the signal intensities of all of the nuclides monitored (54Fe, 56Fe, 57Fe, 58Fe) in the 
pulse counting detector mode. The Fe concentration used was 25 μg L-1. 
73 
The precision of the Fe isotope ratios was evaluated as repeatability (the precision of within-
run replicates) and reproducibility (the precision of between-run replicates). The repeatability, 
expressed as relative standard deviation (RSD, %), of the A&MS-Fe in-house standard 
solution obtained within one measurement session after external mass bias correction using 
the IRMM-014 reference material was 0.2% for the 56/54Fe ratio, 0.4% for the 57/54Fe ratio, and 
1.3% for the 58/54Fe ratio (n = 10). The results obtained in this study agreed with previously 
reported data (0.2, 0.4 and > 1% for 54/56Fe, 57/56Fe and 58/56Fe, respectively, via SF-ICP-MS 
and ≤ 0.2% for 54/56Fe, 57/56Fe and 0.2-0.4% for 58/56Fe via collision/reaction ICP-QMS).47  
When the concentration of the target element was increased to 150 μg L-1, the RSD obtained 
for the 57/54Fe and 58/54Fe ratios was 0.07% and 1%, respectively. However, when using this 
concentration, the signal of 56Fe could not be monitored in the pulse counting detector mode. 
The reproducibility obtained for a period of 1 month is presented in Fig. 2-2. The RSD 
obtained was 0.3% for 56/54Fe, 0.5% for 57/54Fe and 1.5% for 58/54Fe.  
 
2.3.2 Iron isotope ratios via MC-ICP-MS 
The relative standard deviations for the Fe isotope ratios obtained for the A&MS-Fe in-house 
isotopic standard solution at an iron concentration of 500 μg L-1 via MC-ICP-MS (after 
correction of mass discrimination) were 0.003% RSD for 56/54Fe, 0.008% RSD for 57/54Fe and 
0.08% RSD for 58/54Fe (n = 7). The repeatability obtained in one measurement session is 
presented in Fig. 2-3. This improved precision is the result of simultaneous measurement of 
the signal intensities for the 54Fe, 56Fe, 57Fe and 58Fe isotopes and the fact that a flat-topped 
peak shape is preserved at medium mass resolution.  
The low natural abundance and consequently low intensity signal for 58Fe (~ 0.05 V) explains 
the higher relative standard deviation for the 58/54Fe ratio. Increasing the concentration of Fe 
up to 2 mg L-1, and therefore the signal intensity for 58Fe (~ 0.3 V), allowed the RSD for the 
58/54Fe ratio to be improved to 0.02% (n = 5). However, under these conditions the signal for 
56Fe would give rise to detector saturation and thus, it was not monitored. 
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Fig. 2-2 Reproducibility for Fe isotope ratios measured via SF-ICP-MS during a period of 1 month using the 
A&MS-Fe in-house standard. The solid line represents the average ratio and the dashed lines represent 2 times 
the standard deviation. 
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Fig. 2-3 Repeatability obtained over one measurement session for the A&MS-Fe in-house standard with MC-
ICP-MS. The solid line represents the average ratio and the dashed lines represent 2 times the standard deviation.  
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A series of isotope ratio measurements of the A&MS-Fe in-house standard solution was 
performed over a longer period to evaluate the reproducibility of Fe isotope ratios. The 
graphical visualization of the 56/54Fe ratios obtained is presented in Fig. 2-4. The relative 
standard deviation over 3 years of measurements with MC-ICP-MS was 0.004% RSD for 
56/54Fe and 0.008 % RSD for 57/54Fe (n = 238). The RSD for 58/54Fe based on measurements 
spread over 1 year was 0.09 % (n = 45). 
 
Fig. 2-4 56/54Fe isotope ratio of the A&MS-Fe in-house standard solution obtained over a 3 years period via MC-
ICP-MS. The solid line indicates the average value and the dashed lines 2 times the standard deviation (15.70581 
± 0.00104). 
 
2.3.3 Study of the iron absorption via SF-ICP-MS 
In order to evaluate the possibility of using SF-ICP-MS for iron absorption studies, the iron 
isotope ratios were measured in 12 whole blood samples from individuals under 
supplementation labeled with stable 57Fe or 58Fe isotopes by SF-ICP-MS and MC-ICP-MS. 
Prior the Fe isotope ratio measurements by both techniques, elemental concentrations were 
determined by SF-ICP-MS before and after the chromatographic separation of the target 
element from the sample matrix to verify that on-column fractionation effects that can occur 
during the chromatographic separation did not affect the final isotope ratio results.48 The 
recoveries of Fe were quantitative in all cases (100 ± 4%, n = 13), thus avoiding any influence 
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from on-column isotope fractionation. The presence of matrix elements, which can potentially 
give rise to interfering ions or affect the isotope ratio measurements49 (such as Cr, Ca, Na and 
K), were monitored in the purified Fe fraction. After isolation, the presence of matrix 
elements was negligible. In addition, the level of Fe in the procedural blanks, treated in the 
same way as the samples, was 0.1% and therefore no blank correction of the isotope data was 
needed. 
Table 2-3 compiles the Fe isotope ratios obtained using SF-ICP-MS and MC-ICP-MS for the 
whole blood samples from the supplemented individuals. As can be seen in Table 2-3, the 
results obtained using both techniques were in good agreement. In human absorption studies 
by using supplements labeled with stable iron isotopes, the high precision attainable with MC-
ICP-MS is not required due to the relatively large induced changes in the target element’s 
isotopic composition and thus, SF-ICP-MS could be useful for this purpose.  
The Bland-Altman plots50 (Fig. 2-5) show that the iron isotope ratios obtained by SF-ICP-MS, 
expressed as enrichment, i.e. the change in the ratio from the baseline (time point zero) at day 
14 or day 28, were in good agreement with the corresponding MC-ICP-MS results. All data 
were within a narrow range of 1% for 57Fe and 1.7% for 58Fe enrichment difference and no 
significant bias throughout the entire data range in the Bland-Altman analysis was evidenced. 
 
Fig. 2-5 Bland-Altman plots showing the differences between the SF-ICP-MS and MC-ICP-MS results as a 
function of the average 57Fe (a) and 58Fe (b) enrichment. The solid line represents the average differences 
between techniques and the dashed lines correspond to the 95% confidence intervals. 
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Table 2-3. Iron isotope ratios in whole blood samples obtained via SF-ICP-MS and MC-ICP-MS (both after chromatographic isolation of Fe). The data have been corrected 
for instrumental mass discrimination using external correction in a sample-standard bracketing approach. The absolute deviation between two SF-ICP-MS measurement 
values was ≤ 0.0007 for 56/54Fe, ≤ 0.0003 for 57/54Fe and ≤ 0.0010 for 58/54Fe. The absolute deviation between two MC-ICP-MS measurement values was ≤ 0.00005 for 56/54Fe, 
≤ 0.00004 for 57/54Fe and ≤ 0.00002 for 58/54Fe.  
Subject 
Sample collection time, 
 days 
SF-ICP-MS  MC-ICP-MS 
56/54Fe 57/54Fe 58/54Fe  56/54Fe 57/54Fe 58/54Fe 
1 
0 15.71396 0.36184 0.04896  15.66871 0.36160 0.04803 
14 15.66397 0.39650 0.04918  15.66843 0.39745 0.04852 
28 15.73055 0.39885 0.05082  15.66910 0.39835 0.05020 
2 
0 15.70888 0.36269 0.04842  15.66521 0.36144 0.04800 
14 15.66802 0.36276 0.04997  15.66527 0.36146 0.04960 
28 15.71049 0.39732 0.05044  15.66601 0.39774 0.05013 
3 
0 15.71062 0.36182 0.04883  15.66539 0.36148 0.04801 
14 15.63921 0.38897 0.04868  15.66556 0.38982 0.04840 
28 15.62071 0.38813 0.05145  15.66535 0.39022 0.05140 
4 
0 15.69772 0.36262 0.04787  15.66699 0.36156 0.04802 
14 15.68860 0.38609 0.04886  15.66719 0.38584 0.04835 




The difference between the 57Fe and 58Fe enrichments as obtained by SF-ICP-MS and MC-
ICP-MS was 0.3% and 0.6%, respectively. Fig. 2-6 shows the linear correlation between the 
iron enrichment obtained using both techniques (R2 = 0.9950, p < 0.0001 and 0.9502,             
p < 0.0001 for 57Fe and 58Fe, respectively). Thus, results obtained using SF-ICP-MS are 
consistent with those obtained using MC-ICP-MS. 
 
Fig. 2-6 Enrichment of 57Fe (a) and 58Fe (b) in whole blood samples as obtained by SF-ICP-MS and MC-ICP-
MS (both after chromatographic isolation of Fe). The dashed lines correspond to the 95% confidence intervals. 
Analysis of the whole blood samples after digestion and dilution only were performed to 
verify whether acceptable results would also be obtained under these conditions, which would 
increase the overall sample throughput considerably. As can be seen in Table 2-4, the results 
obtained in digested whole blood via SF-ICP-MS are in good agreement with data obtained 
via SF-ICP-MS in the pure iron fractions obtained upon chromatographic isolation. Fig. 2-7 
illustrates the linear correlation between the iron enrichments obtained via SF-ICP-MS 
without prior isolation of Fe and that obtained via high-precision MC-ICP-MS after Fe 
isolation from blood matrix (R2 = 0.9927, p < 0.0001 and 0.9749, p < 0.0001 for 57Fe and 
58Fe, respectively). Thus, Fe isotopic analysis of human whole blood by SF-ICP-MS for Fe 
absorption studies without prior Fe isolation from the blood matrix is also providing reliable 
results, while significantly improving sample throughput compare to MC-ICP-MS. 
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Table 2-4. Iron isotope ratios in whole blood samples obtained via SF-ICP-MS after digestion and dilution and 
via SF-ICP-MS after isolation of Fe from blood matrix. The data have been corrected for instrumental mass 
discrimination using external correction in a sample-standard bracketing approach. The absolute deviation 
between two SF-ICP-MS measurement values was ≤ 0.0008 for 57/54Fe and ≤ 0.0009 for 58/54Fe. The absolute 










0 0.36111 0.04870  0.36184 0.04896 
14 0.39713 0.04883  0.39650 0.04918 
28 0.39809 0.05046  0.39885 0.05082 
2 
0 0.36110 0.04758  0.36269 0.04842 
14 0.36045 0.04934  0.36276 0.04997 
28 0.39692 0.04994  0.39732 0.05044 
3 
0 0.36087 0.04812  0.36182 0.04883 
14 0.38972 0.04840  0.38897 0.04868 
28 0.38759 0.05189  0.38813 0.05145 
4 
0 0.36154 0.04830  0.36262 0.04787 
14 0.38418 0.04860  0.38609 0.04886 
28 0.38595 0.05151  0.38604 0.05093 
 
 
Fig. 2-7 Enrichment of 57Fe (a) and 58Fe (b) in whole blood samples as obtained by SF-ICP-MS after digestion 




2.4 CONCLUSIONS  
Although MC-ICP-MS provides a superior precision for isotope ratio measurements, the 
results evidenced that SF-ICP-MS can be used to determine the 57/54Fe and 58/54Fe ratios in 
whole blood samples of supplemented individuals sufficiently accurately and precise and also 
to detect the ratio of increase in 57Fe and 58Fe for absorption studies. It has been demonstrated 
that SF-ICP-MS can track 57Fe and 58Fe enrichments down to 0.3% and 0.6%, respectively. 
The changes observed via SF-ICP-MS were in good agreement with those obtained via MC-
ICP-MS. Since a minimum 5% oral iron absorption is expected for any worthwhile 
supplementation strategy, SF-ICP-MS can be considered as a suitable technique for the 
routine determination of iron absorption in human iron supplementation studies. Moreover, 
isotopic analysis of digested and diluted whole blood samples without prior Fe isolation from 
whole blood matrix results in an increased sample throughput and decreased cost compared to 
MC-ICP-MS. 
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3.1 ABSTRACT 
Recently, it has been documented that Fe isotopic analysis of whole blood and serum by 
means of multi-collector ICP-mass spectrometry (MC-ICP-MS) is providing promising 
results in a biomedical context and thus, there is a demand for simple, fast and reliable 
methodologies, providing high sample throughput. In this work, the possibility of Fe isotopic 
analysis by MC-ICP-MS directly in acid-digested whole blood and thus, without prior Fe 
isolation was evaluated. The influence of the main mineral matrix elements and the effect of 
potentially remaining organic compounds were first systematically evaluated using synthetic 
solutions. The Fe isotopic composition was biased low in the presence of matrix elements 
such as Na and K, while it was biased high for glucose concentrations ≥ 1% (w/v). 
Nevertheless, after dilution of the whole blood sample digest to 0.75-1.5 mg L-1 of Fe, 
followed by adequate correction for instrumental mass discrimination using a combination of 
internal (with admixed Ni) and external correction, MC-ICP-MS isotope ratio measurements 
provided accurate and precise results. For actual samples, the Fe isotopic data obtained agree 
well with those using the reference procedure, based on prior chromatographic isolation of Fe 




Recently, several research groups have demonstrated that isotopic analysis of iron (Fe) in 
whole blood or serum might reveal potentially very useful clinical information. Van Heghe et 
al. have established a clear link between an individual’s whole blood Fe isotopic composition 
and his/her iron status.1 Hotz et al. have identified the extent of mobilization of storage iron 
(liver) and the dietary iron absorption efficiency as governing factors.2,3 It was also 
demonstrated that patients suffering from hereditary hemochromatosis (HH)1,4 or anemia of 
chronic disease (ACD)1 show an altered Fe isotopic composition in whole blood compared to 
healthy subjects. The HH and ACD populations investigated by Van Heghe et al. show a 
difference in 56Fe/54Fe isotope ratio in whole blood of +0.5‰ and -0.3‰ compared to the 
reference population, respectively.1,5–7 The number of patient samples was too low to assess 
gender-based differences. For tracing down and quantifying such small differences, a high 
isotope ratio precision is mandatory, making multi-collector ICP-mass spectrometry (MC-
ICP-MS) the preferable technique. However, Fe isotope ratio data with MC-ICP-MS can be 
compromised by instrumental mass discrimination and spectral interference, mainly from 
54Cr+, 58Ni+ and Ar- and Ca-based molecular ions.8,9 
To overcome spectral overlap, medium or high mass resolution, potentially in combination 
with aerosol desolvation, can be used with MC-ICP-MS.10–15 With the standard sample 
introduction system, relatively high concentrations of the target analyte, i.e. ≥ 1 mg L-1 are 
typically preferred to minimize the effect of spectral interference.16 
Correction for instrumental mass discrimination can be accomplished via external correction 
in a sample-standard bracketing (SSB) approach, or a combination of such external correction 
with internal correction using Ni or Cu as an admixed internal standard. Both methods have 
been proven suitable for high-purity iron solutions.10,17 The double spike 57Fe-58Fe approach, 
combined with SSB, was also used, mainly in the context of environmental and geological 
studies.18–20 However, it needs to be stressed that both the matrix composition and the target 
element concentration affect the extent of mass discrimination. Such effects can obscure the 
small, natural isotope ratio differences that need to be revealed.21 The origin of mass 
discrimination is still poorly understood, although several contributions, such as a shift in the 
ionization equilibrium, collisional scatter, energy consumption for matrix decomposition, 
space-charge effects and ambipolar diffusion, have been suggested.9,22–27  
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As a result, the sample preparation procedure preceding isotopic analysis of whole blood iron 
is a critical issue. Typically, whole blood is first digested with HNO3 or a mixture of HNO3 
and H2O2 to set the iron free (predominantly from hemoglobin) in ionic form, followed by the 
chemical isolation of the target element from the concomitant matrix and residual organic 
components that potentially affect the extent of mass discrimination. Anion exchange 
chromatographic methods, based on the high affinity (and thus, partition coefficients) of Fe-
chloride complexes towards an anion exchange resin, such as AG MP-1, are the most 
frequently used for the isolation of Fe from biological samples.7,10,13,28 Since on-column 
fractionation effects occur due to the slightly different elution behavior of the different Fe-
isotopes on the column, the recovery of iron needs to be quantitative.28 Chromatographic 
isolation of Fe is effective and provides better recoveries and a more effective target element / 
matrix separation than the more conventional iron precipitation methodology. However, the 
chromatographic approach is labor-intensive and time-consuming, thus reducing the sample 
throughput. Relatively large amounts of highly pure acid (about 20 mL of concentrated HCl 
per sample) and additional evaporation / re-dissolution steps are required to make the final 
matrix suited for isotope ratio measurements with MC-ICP-MS. 
Stenberg et al.14 have compared different sample preparation procedures for the isotopic 
analysis of Fe in Seronorm whole blood reference material by MC-ICP-MS, including 
microwave-assisted acid digestion with and without Fe isolation via anion exchange 
chromatography and via selective iron precipitation with different reagents. Although no 
differences in the Fe isotopic composition were found following the approaches mentioned, 
the authors recommended precipitation of iron with NH3 based on practical considerations, 
e.g., high sample throughput. Based on the high concentration of iron in whole blood samples 
(~ 350 mg L-1, healthy subjects) we decided to perform and evaluate the Fe isotopic analysis 
of whole blood by MC-ICP-MS without matrix separation, i.e. directly after acid digestion 
and dilution of the sample digest. Synthetic solutions were used to systematically investigate 
the effect of concomitant matrix components on the Fe isotope ratio results. The MC-ICP-MS 
instrument settings were optimized using an actual whole blood sample. Eleven whole blood 
samples were analyzed directly (digestion & dilution) and after chromatographic Fe isolation, 






3.3.1 Reagents and standards 
Ultrapure water (resistivity > 18.2 MΩ cm) was obtained from a Milli-Q Element water 
purification system (Millipore, France). Pro analysis purity level nitric acid (14 M) was used 
after sub-boiling distillation. Optima grade hydrochloric acid (12 M) was obtained from 
Fisher Chemical (UK) and used as such. Ultrapure hydrogen peroxide 9.8 M was acquired 
from Sigma-Aldrich (Belgium). All sample manipulations were carried out in a class-10 clean 
laboratory. 
The Fe isotopic reference material IRMM-014 from the Institute for Reference Materials and 
Measurements (IRMM, Belgium) was used for external correction in a sample-standard 
bracketing approach. A single-element Fe standard solution acquired from Inorganic Ventures 
(The Netherlands; lot D2-FE03110) was used as in-house isotopic standard solution (further 
referred to as A&MS-Fe) for preliminary experiments and for validating the isotope ratio 
measurements. Single-element standard stock solutions (1 g L-1) acquired from Inorganic 
Ventures were used for the preparation of synthetic solutions, for mass discrimination 
correction using an internal standard (Ni) and for quantification of the target element. Also 
glucose (Merck, Germany) was used for the preparation of synthetic solutions. 
AG MP-1 strong anion exchange resin (100-200 mesh, chloride form) and polypropylene 
chromatographic columns (Bio-Rad, Belgium) were used for the Fe isolation procedure. 
 
3.3.2 Instrumentation and measurements  
A Thermo Scientific Neptune MC-ICP-MS instrument (Germany) was used for the Fe isotope 
ratio measurements. A PFA concentric nebulizer (100 μL min-1) and double spray chamber, 
with a cyclonic and a Scott-type sub-unit, were used for the introduction of the solutions into 
the plasma. Measurements were performed in medium resolution, in static collection mode 
and using six Faraday collectors connected to 1011 Ω amplifiers. Instrument settings and data 
acquisition parameters are shown in Table 3-1.  
Ni was used as an internal standard at the same concentration as the target element Fe. The Fe 
isotope ratios were calculated off-line after removal of outliers using a 2s-test. Mass bias 
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correction was performed by means of (i) external correction in a sample-standard bracketing 
approach (SSB) and (ii) a combination of internal correction (with Ni) by means of the 
revised Russell’s law (using a regression line to establish the correlation between the 
correction factors for Fe and Ni) and SSB.29 The isotopic composition is expressed in delta 
notation (56Fe, 57Fe, ‰ ), calculated against the isotopic reference material IRMM-014 























Fe  (3-1) 
Table 3-1. Instrument settings and data acquisition parameters for the Neptune MC-ICP-MS. 
RF power (W) 1275 
Guard electrode Connected 
Sampling cone and skimmer 
Ni standard sampling cone 1.1 mm aperture diameter 
Ni H-type skimmer, 0.8 mm orifice diameter 
Lens settings Optimized for maximum signal intensity 
Ar flow-rates (L min-1)  
plasma gas 15 
auxiliary gas 0.75 
nebulizer gas 0.9-1.0 
Sample uptake rate (µL min-1) 100 
Resolution mode Medium  
Acquisition mode Static; multi-collection 
Number of blocks 9  
Number of cycles 5 
Integration time (s) 4.194 
Cup configuration L4: 54Fe; L2: 56Fe; L1: 57Fe; C: 58(Fe + Ni); H1: 60Ni; H3: 62Ni 
Elemental concentrations were determined using an Element XR single-collector sector-field 
ICP-MS instrument (Thermo Scientific). For the introduction of solutions into the ICP, a 
combination of a 200 μL min-1 quartz concentric nebulizer and a cyclonic spray chamber was 




A Shimadzu UVmini-1240 UV-Vis spectrophotometer was used to assess the presence of 
organic matter in the sample. 
 
3.3.3 Samples and sample preparation 
Whole blood samples of 11 individuals, provided by the Ghent University Hospital 
(Belgium), were analyzed. One of these samples (from a hemochromatosis patient and 
available in a large quantity) was used to optimize the analytical protocol and to evaluate its 
analytical performance. Synthetic samples were also analyzed to evaluate matrix effects. 
These were prepared using the A&MS-Fe standard and major, minor and trace elements (Cu, 
Zn, Mn, Mg, Ni, Ca, Br, P, S, Na and K), mixtures of these elements and/or glucose as an 
organic compound. 
About 3 mL of blood was digested in a closed Teflon Savillex beaker using a mixture of 7 mL 
of HNO3 and 1.5 mL of H2O2. The digestion was carried out at 110 ºC overnight (~16 h). The 
digest thus obtained was evaporated to dryness and re-dissolved in 2 mL of concentrated 
HNO3. Then, two aliquots of 1 mL were separated for a second evaporation step. After that, 
one aliquot was re-dissolved in 0.42 M HNO3 for direct Fe isotope ratio measurement and the 
other one was re-dissolved in 5 mL of 8 M HCl + 0.001% H2O2 for chromatographic Fe 
isolation. 
Chromatographic isolation of Fe was carried out according to Van Heghe et al.7 For this 
purpose, 5 mL of the sample aliquot were loaded onto the column containing 2 mL of 
previously cleaned AG MP-1 anion exchange resin. The matrix was eluted with 8 mL of 8 M 
HCl + 0.001% H2O2, followed by Cu, eluted with 12 mL of 5 M HCl + 0.001% H2O2. Finally, 
Fe was eluted with 10 mL of 0.6 M HCl. The purified Fe solution was evaporated to dryness 
at 95 ºC twice to remove residual chloride. The final residue was re-dissolved in 0.42 M 
HNO3 for the isotope ratio measurements. Procedural blanks, treated in the same way as the 
samples, were also included. 
Ethical approval was obtained for using these samples by an independent commission 
connected to the Ghent University Hospital. Patients and individuals forming the reference 
population signed an informed consent. 
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3.4 RESULTS AND DISCUSSION 
3.4.1 Evaluation of the effect of concomitants using synthetic 
solutions 
Fe isotope ratio measurements via MC-ICP-MS are potentially adversely affected by the 
presence of matrix components, as these might affect the ion transmission efficiencies of the 
target nuclides.9,16 Even after chemical isolation, residual matrix may alter the extent of mass 
bias.11 To evaluate the effect of blood matrix components, synthetic solutions containing the 
A&MS-Fe standard (500 g L-1), individual matrix elements (Cu, Zn, Mn, Mg, Ni, Ca, Br, P, 
S, Na and K) and combinations of these were used. The average Fe isotopic composition of 
the pure A&MS-Fe standard obtained during a period of 1 year is: 0.46 ± 0.07 ‰ for δ56Fe 
and 0.69 ± 0.10 ‰ for δ57Fe (n = 25). The 56Fe values in the synthetic solutions after 
correction for mass discrimination using the combined internal & external correction 
approach are presented in Fig. 3-1. As can be seen, among the elements studied, Na and K 
showed the highest influence on the Fe isotope ratio results. The presence of these easily 
ionizable elements alters the plasma conditions, i.e. temperature and electron density, which 
might explain the effect on the extent of mass discrimination. Shifts of -0.11, -0.17 and -
0.13 ‰ were observed in the presence of 1 mg L-1 of Na, of K and of a mixture of Na, K, S, P 
and Br (at 1 mg L-1 each), respectively. Levels higher than 2 mg L-1 of S (characterized by a 
high ionization energy and thus, low ionization efficiency) also led to significantly deviating 
δFe values, but in this case towards higher values. 
In contrast, the presence of the other elements studied, whether assessed individually or 
together, did not generate any deviation of the 56Fe value outside of the 0.07‰ experimental 
uncertainty. It had also been previously pointed out that matrix elements should not affect the 
accuracy of Fe isotope ratio data for an element/Fe ratio  2.10,30 However, a deterioration in 
the precision was reported for increasing concentrations of the matrix elements due to 
instability of the instrumental mass bias.30 This effect can be alleviated via correction for 
mass discrimination using the combined approach of internal & external correction for mass 
discrimination. 
A synthetic solution simulating the mineral composition of whole blood after the acid 
digestion was prepared by addition of the following components to A&MS-Fe standard 




Fig. 3-1 Influence of concomitant elements present in whole blood on the δ56Fe measurement results studied 
using synthetic solutions. The solid line indicates the average value and the dashed lines 2 times the standard 
deviation for the A&MS-Fe in-house standard. Error bars indicate the standard deviation for 3 measurements. 
and 20 μg L-1 of Cu, Zn, Br, Mg, Mn, Ca and Ni. For this mixture, the 56Fe value was 0.12  
0.06 ‰ after SSB correction and 0.53  0.04 ‰ after the combined correction approach with 
62Ni/60Ni and SSB (n = 4). This synthetic solution was also admixed with different amounts of 
glucose to assess the effect of potentially remaining organic components. The 56Fe values 
obtained for the synthetic blood solutions with different amounts of glucose are shown in   
Fig. 3-2. An increasing concentration in organic C concentration led to an increasing bias in 
the Fe values. The influence of organic substance shifted the isotope ratio results in the 
opposite direction than did Na and K, i.e. the δ56Fe value was shifted by 0.15‰ after the SSB 
correction, and by 0.08‰ after the combined internal & SSB correction in the presence of 1% 
(w/v) of glucose. The experimental 56Fe value for the synthetic solution containing all 
expected matrix components and 1 % (w/v) of glucose was 0.31‰. This value corresponds 
well with that expected based on the individual extents of bias observed, i.e. 0.27‰ 
(compensation of effects). 
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Fig. 3-2 Influence of the glucose content on the δ56Fe measurement results for a synthetic solution also 
containing the whole blood matrix elements. The solid line indicates the average value and the dashed lines 2 
times the standard deviation for the A&MS-Fe standard. Open symbols indicate the data obtained after SSB 
correction and filled symbols after the combined (internal & SSB) correction. Error bars indicate the standard 
deviation of 2 measurements. 
 
3.4.2 Optimization of experimental conditions using actual 
whole blood 
Fe isotope ratio measurements were performed in a whole blood sample (obtained from a 
hemochromatosis patient and available in a large quantity) after acid digestion. Instrument 
settings, such as gas flow rates, sampling depth and RF power, affect the properties of the 
plasma, especially the temperature, and consequently, the vaporization rate and atomization 
and ionization efficiencies.31–33 Thus, these settings were optimized using the acid-digested 
whole blood (Table 3-1). 
Different sample dilutions were performed. The results obtained after mass discrimination 
correction using the combination of internal correction & SSB are shown in Table 3-2. The 
isotopic composition of this sample, obtained following the reference procedure, i.e after 
sample digestion and chromatographic Fe isolation (n = 6), is also included in this table. Two-
way ANOVA at a 5% significance level was applied using JMP statistical software (version 
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12.1.0, SAS Institute Inc., Cary, NC, USA) for the evaluation of the effects of two 
parameters, i.e. the sample dilution and the method of mass discrimination correction, on the 
delta value. The outcome showed that both factors have a statistically significant effect on the 
response investigated. Moreover, an interaction between the two factors was also revealed by 
two-way ANOVA, meaning that the outcome of the methods for mass discrimination 
correction will be significantly different depending on the dilution of the sample. The 
reference values (i.e. after sample digestion and chromatographic Fe isolation) obtained using 
the two different approaches of mass discrimination correction were not found to be 
significantly different from each other. Only the results for a concentration range between 
0.75 and 1.5 mg L-1 Fe and corrected using the combined correction approach were not 
significantly different from the reference values obtained.  
For higher dilution, the results deviated by about -0.35 ‰ and -0.14 ‰ from the reference 
values when using SSB alone and the combined correction approach, respectively. This 
deviation can be tentatively explained by vaporization fractionation and analyte losses from 
the zone of efficient ion sampling from the ICP by diffusion.16 Thus, 1 mg L-1 of Fe was 
selected as the optimum concentration for isotopic analysis in acid-digested whole blood. As 
the concentration of the internal standard Ni used for the mass discrimination correction is 
also of importance, especially when matrix components are present, the effect of the Fe/Ni 
ratio was evaluated. A 1:1 ratio provided the most precise results and thus, 1 mg L-1 of Ni was 
further used for the mass discrimination correction. 
Table 3-2. Isotopic analysis of Fe in whole blood without Fe isolation at different dilution factors. 
[Fe], mg L-1 
SSB  SSB and exponential law 
δ56Fe δ57Fe  δ56Fe δ57Fe 
0.30 -2.83 ± 0.08 -4.12 ± 0.11  -2.62 ± 0.06 -3.78 ± 0.10 
0.50 -2.85 ± 0.04 -4.17 ± 0.07  -2.64 ± 0.04 -3.87 ± 0.07 
0.75 -2.96 ± 0.14 -4.29 ± 0.18  -2.47 ± 0.03 -3.57 ± 0.06 
1.00 -3.28 ± 0.06 -4.86 ± 0.21  -2.45 ± 0.03 -3.59 ± 0.05 
1.50 -3.35 ± 0.27 -4.93 ± 0.39  -2.44 ± 0.02 -3.58 ± 0.04 
Reference value -2.50 ± 0.05 -3.71 ± 0.09  -2.49 ± 0.05 -3.72 ± 0.11 
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The organic matter present in the measurement solutions, as estimated using the UV 
absorption at 254 nm, was a factor of 30 higher in the digested sample than in the 
chromatographically purified iron fractions. After SSB correction, the delta values deviated 
from the ‘true’ value, but correction with the combined approach provides accurate results up 
to a level of 1% of organic C. 
Solutions of isotopic reference material IRMM-014, used as external standard (external 
correction for mass discrimination) and as wash solution used in-between two measurements 
were also matrix-matched via addition of matrix elements (simulated blood concentrations) to 
minimize changes in the ICP conditions. Every sample was measured 10 times. Although a 
slight improvement was obtained using matrix-matched IRMM-014 when relying on SSB 
correction only, the results still deviated from the reference value by about 0.5‰. However, 
with the combined mass discrimination correction, accurate and precise results were obtained 
using either matrix-matched or non-matrix-matched IRMM-014 standard. For reasons of 
simplicity, the non-matrix-matched IRMM-014 standard was used in all further work for SSB 
correction. 
 
3.4.3 Application to human blood samples  
To prove the concept of the study, 10 samples of human whole blood were analyzed with and 
without Fe analyte isolation. The 56Fe values obtained for the digested samples and for the 
purified iron fractions are illustrated in Fig. 3-3. The samples were measured in duplicate. All 
sample results fall on the normal mass-dependent fractionation line, i.e. δ57Fe = 1.47 δ56Fe. 
No significant differences at a 95% confidence level were observed between the results 
obtained using both methods. In all cases, the experimental t values were < the critical 
value.  
The precision was evaluated as repeatability (internal and external precision) and 
reproducibility. The internal precision, expressed as the standard deviation within one 
measurement (45 subsequent cycles), was 0.04 ‰ for δ56Fe and 0.07 ‰ for δ57Fe. The 
external precision, expressed as standard deviation for 10 measurements of the whole blood 
sample measured in one measurement session (one day), was 0.02 ‰ for δ56Fe and 0.03 ‰ 
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for δ57Fe. This is similar to the external precision obtained for the samples after Fe isolation 
(0.02 ‰ for δ56Fe and 0.04 ‰ for δ57Fe). 
 
Fig. 3-3 Delta Fe results for actual whole blood samples with and without Fe isolation. Open circles indicate the 
results obtained after Fe isolation and filled diamonds those without Fe isolation. Error bars represent the 
external precision as 2 times the standard deviation (0.07‰ for 56Fe). 
The reproducibility obtained, as standard deviation of the sample measured 8 times on 
different days within 4 months, was 0.03 ‰ for δ56Fe and 0.06 ‰ for δ57Fe. In addition, no 
decrease in the sensitivity was observed after 3 measurement sessions (measurement days) in 
a row and the condition of the cones was still adequate. Thus, accurate and precise results 
were obtained for the Fe isotopic composition in whole blood after acid digestion followed by 
the adequate dilution of the sample under the conditions described and provided that 
instrumental mass discrimination was corrected for using a combination of internal correction 





It was shown that direct isotopic analysis of whole blood Fe is possible after acid digestion 
and adequate dilution (0.75-1.5 mg L-1 of Fe) provided that instrumental mass discrimination 
is corrected for using a combination of internal correction using 62Ni/60Ni and external 
correction versus IRMM-Fe isotopic reference material in a standard-sample bracketing 
approach. As a result, chromatographic Fe isolation preceding the MC-ICP-MS Fe isotope 
ratio measurement can be avoided. Similar results were obtained following this approach and 
following the reference procedure (including chromatographic Fe isolation) for actual whole 
blood samples. This simple methodology allows to increase the sample throughput and reduce 
the amount of acids, cost and time required. Further routine use of the method without Fe 
isolation will have to reveal long-term robustness and the burden on the instrument. At least, 
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4.1 ABSTRACT 
High-precision isotopic analysis of iron (Fe) in blood is currently assessed as a 
complementary approach to achieve a better understanding of human iron metabolism and for 
diagnosis of diseases. Volumetric absorptive microsampling (VAMS) is a recently introduced 
technique that allows the straightforward collection of a well-defined volume of blood by 
dipping an absorbent polymeric tip into it. In this work, the use of VAMS was evaluated for 
high-precision isotopic analysis of whole blood iron by multi-collector inductively coupled 
plasma mass spectrometry (MC-ICP-MS). Iron concentrations in whole blood sampled using 
VAMS were determined by single-collector sector-field ICP-MS. A variety of solvents were 
evaluated for extraction of iron from the VAMS-device (MitraTM). Iron was quantitatively 
extracted from the absorbent using 1 mL of Milli-Q water. The extracted material was 
subsequently subjected to acid digestion and to a miniaturized chromatographic procedure for 
isolation of iron from the blood matrix. The Fe isotopic compositions and concentrations of 
paired finger-prick and venous blood samples collected at the same time from six individuals 
were compared. No significant differences were found between the two blood types. The 
proposed methodology significantly increases the sample throughput and facilitates sample 





High-precision iron (Fe) isotopic analysis of biological fluids via multi-collector ICP-mass 
spectrometry (MC-ICP-MS) is nowadays assessed as a potential tool to achieve a better 
understanding of human iron metabolism and for the diagnosis of disorders.1 The Fe isotopic 
composition of serum and whole blood reflects an individual´s iron status.2–4 Patients 
suffering from hereditary hemochromatosis (HH) and anemia of chronic disease (ACD) show 
opposite alterations in their whole blood Fe isotopic composition.3,5 Walczyk and von 
Blanckenburg showed that blood and muscle tissue have a similar Fe isotopic composition, 
while that of liver iron is heavier.6,7 Hotz et al. identified the preferential uptake of light iron 
isotopes in the intestine and the fact that the extent of this fractionation depends on the dietary 
iron absorption efficiency as key factors governing the whole blood Fe isotopic 
composition.2,8 Chronic kidney disease (CKD) also affects the serum Fe isotopic 
composition.4 In patients with renal insufficiency, serum Fe isotopic analysis allows iron 
deficiency anemia (IDA) and erythropoietin-related (EPO-related) anemia to be distinguished 
from one another.4 
As the potential of exploiting natural Fe isotope ratio variations in whole blood / serum iron 
for clinical purposes has been evidenced, developing simple and reliable analytical methods, 
providing higher sample throughput and thus lower cost, are needed. Both sample acquisition 
and sample preparation preceding high-precision isotope ratio measurements by MC-ICP-MS 
take considerable time, especially the chromatographic isolation of the target analyte from the 
sample matrix that is typically required to ensure accurate correction for instrumental mass 
discrimination. In a previous work, it has been demonstrated that direct Fe isotopic analysis of 
acid-digested whole blood, i.e. without isolation of the target analyte, can be performed 
followed by an adequate dilution and correction for instrumental mass discrimination. This 
approach is very straightforward, but its routine use over longer periods of time might 
overburden the instrument.9 
Also blood collection and storage are critical issues for both elemental determination and 
isotopic analysis. Although in current clinical practice, whole blood sampling is typically 
carried out by venipuncture, ‘dry microsampling’ techniques, such as the collection of dried 
blood spots (DBS) on different support types (e.g., filter paper spotting cards or hydrophilic 
membranes), have become popular for regular clinical examination and in the context of other 
bioanalytical applications, e.g., neonatal screening,10 toxicokinetics,11 drug monitoring12 or 
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viral disease management.13 Dry microsampling facilitates sample acquisition, transport and 
bioanalysis on a large scale.14 It is inexpensive, minimally invasive and requires microliters of 
sample only, mostly finger- or heel-prick blood. DBS has been used for measurements of the 
ferritin and soluble transferrin receptor contents in blood plasma and blood serum with the 
aim of iron status assessment15,16 and for identifying IDA.17 However, the methods described 
require a multi-step sample preparation. Several papers report on the combination of DBS 
whole blood sample collection and ICP-MS for multi-element determination,18,19 although to 
the best of our knowledge, iron was not included in the list of elements studied, probably 
because in whole blood it is not a meaningful clinical parameter. Aramendía et al. developed 
a method for the simultaneous determination of trace element (Cd, Co, Cu and Pb) 
concentrations and Cu isotope ratios using DBS and split-flow laser ablation single-collector 
ICP-MS / multi-collector ICP-MS, but the precision attainable with this approach is not 
sufficient for clinical applications.20 
Successful analysis after dry microsampling via DBS is jeopardized by varying hematocrit 
levels (HCT %, volume fraction of red blood cells in blood), an inhomogeneous distribution 
of the sample material on the support and the risk of contamination.21–23 Blood with a low 
HCT level has a lower viscosity, thus giving rise to a larger spot size for a given volume of 
blood.21 Also between certified reference materials and real samples, different dispersion 
properties were observed.20  
An alternative technique for dry microsampling, termed volumetric absorptive microsampling 
(VAMS), has recently been proposed for quantitative bioanalysis.24–27 It is based on the 
absorption of liquid sample into a porous polymeric tip. This device, commercially available 
under the brand name MitraTM from Phenomenex (CA, US), overcomes the issues associated 
with the HCT level and sample inhomogeneity, while it is equally simple and can be 
integrated into an automated sample preparation procedure.24,27,28 VAMS has recently been 
applied to the accurate determination of (ultra)-trace concentrations of prosthesis-related 
metals (Al, Ti, V, Cr, Co, Ni, Sr and Zr) in whole blood.29 Moreover, the VAMS hydrophilic 
polymer with absorbed blood microsamples showed good stability at different storage times 
and temperature variations for caffeine and paraxanthine determinations,28 although the 
maximum storage time for an antibiotic was limited to 10 days.26 Verougstraete et al. 
observed a good agreement between the hemoglobin A1c level measured after VAMS and in 
capillary microsamples, but only when using a wet VAMS tip.30 
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The goal of this study was to investigate the potential of using VAMS for the Fe isotopic 
analysis by MC-ICP-MS of venous and finger-prick blood for further clinical applications. 
Prior to the Fe isotope ratio measurements, the Fe concentrations in blood sampled via VAMS 
were determined using single-collector sector-field ICP-MS. Extraction conditions and the 
stability of the sample-loaded VAMS tip were studied and a miniaturized chromatographic Fe 
isolation procedure was developed. The proposed methodology was optimized using the 
SeronormTM Trace Elements Whole Blood L-1 reference material and real venous blood 
samples. The Fe isotopic compositions of finger-prick and venous blood collected at the same 
time from 6 donors were compared. 
 
4.3 EXPERIMENTAL 
4.3.1 Materials and reagents 
Ultrapure water (resistivity ≥18.2 MΩ cm) was obtained from a Milli-Q Element water 
purification system (Millipore, France). Pro analysis grade 14 M nitric acid (Pro-Labo, 
Belgium) was further purified by sub-boiling distillation in PFA equipment (PicoTrace, 
Germany). Optima grade 12 M hydrochloric acid used in the chromatographic separation was 
obtained from Fisher Chemicals (UK). Ultrapure 9.8 M hydrogen peroxide used for sample 
preparation was acquired from Sigma-Aldrich (Belgium). Purissima grade acetone (≥ 99.5%) 
and trace select grade methanol (≥ 99.9%) were purchased from Sigma Aldrich. 
The Fe isotopic reference material IRMM-014 (Institute for Reference Materials and 
Measurements, IRMM, Belgium) was used for external correction in a standard-sample 
bracketing approach. The elemental Fe standard solution (Inorganic Ventures, The 
Netherlands; lot D2-FE03110), previously characterized isotopically3, was used as an in-
house reference to monitor the quality of the isotope ratio measurements. Single-element 
standard stock solutions (Inorganic Ventures) used for quantification purposes and Ni single-
element standard solution (Inorganic Ventures, lot G2-Nl02086), used as an internal standard 
for correction of instrumental mass discrimination, were prepared from commercially 
available 1 g L-1 stock solutions. SeronormTM Trace Elements Whole Blood L-1 (SERO AS, 
Norway, lot 1406263) was used for method optimization and validation. 
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The VAMS MitraTM (lot 41106A) devices used for blood microsampling were obtained from 
Phenomenex (CA, US). The VAMS device consists of a hydrophilic porous material fitted to 
a plastic holder. This material absorbs a fixed volume of blood when exposed to a liquid 
blood sample. The absorption volume (~ 10.6 μL) into the hydrophilic polymer tip and the 
corresponding reproducibility have been experimentally validated by Denniff et al.24 and 
Spooner et al.27  
AG MP-1 strong anion exchange resin (100-200 mesh) purchased from Bio-Rad (CA, USA) 
was used for Fe chromatographic isolation. 
 
4.3.2 Samples and sample preparation 
Whole blood samples of supposedly healthy individuals (2 females and 9 males, 23-35 years) 
were obtained from the Ghent University Hospital (Belgium). Ethical approval was obtained 
for this research from an independent commission connected to the Ghent University hospital 
and an informed consent was signed by the blood donors. Venous blood samples and the 
Seronorm reference material were used for method optimization and validation. For 6 
individuals, the venous and finger-prick blood samples were collected simultaneously in order 
to evaluate the possibility of relying on the finger-prick (capillary) blood Fe isotopic 
composition in the context of biomedical applications.  
Venous blood was sampled by venipuncture in EDTA vacutainer tubes suitable for trace 
element analysis and stored at -20 ºC until sample preparation. Finger-prick blood and also 
venous microsamples were collected via VAMS following the manufacturer’s instructions. 
The venous microsamples were obtained by immersing the VAMS tip into the blood collected 
in the vacutainer tube. For the finger-prick blood, the first and second blood droplets after the 
finger-prick were discarded to avoid contamination from sloughing skin, and the third and 
fourth droplets were separately loaded onto VAMS tips for further analysis.31 The hydrophilic 
polymer VAMS tip was dipped into the blood sample until it was fully colored 
(approximately 6 s). The VAMS device containing the blood microsample was subsequently 
dried under ambient conditions for about 2 hours and then stored as such for further analysis. 
Thereafter, two procedures were applied. First, the VAMS tip was placed in a Savillex® PFA 
beaker and 1 mL of Milli-Q water was added. After vortexing during 5 min, the tip was 
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removed and the mixture was acid digested at 110 ºC overnight (~16 h) using 2 mL of 14 M 
HNO3 and 500 µL of 9.8 M H2O2. As a reference procedure, 10.6 L of the corresponding 
venous blood samples were directly pipetted in a Savillex® PFA beaker and subsequently acid 
digested. The digests obtained after the two procedures were evaporated to dryness and then 
re-dissolved in 500 µL of 6 M HCl + 0.001% H2O2 for chromatographic isolation of Fe. 
The chromatographic separation was performed using 1 mL pipette tips filled with 0.5 mL of 
AG MP-1 (100-200 mesh) strong anion exchange resin. A piece of cotton was placed as bed 
support and as stopper. The resin was pre-cleaned with 500 μL of 7 M HNO3, 2 mL of    
Milli-Q water, 2 mL of 0.7 M HNO3 and 2 mL of Milli-Q water and conditioned with 4 mL of 
6 M HCl + 0.001% H2O2. After sample loading, the matrix components were eluted from the 
column in 2 two steps, firstly with 2 mL of 9 M HCl and secondly with 5 mL of 6 M HCl + 
0.001% H2O2. The Fe fraction was then eluted with 6 mL of 1 M HCl and collected in a       
15 mL Teflon Savillex® beaker. The purified Fe fraction was evaporated to dryness at 90 ºC 
to remove residual chlorides and re-dissolved in concentrated HNO3. This procedure was 
repeated twice. The final residue was re-dissolved in 500 μL of 0.42 M HNO3. A procedural 
blank, treated in the same way as the samples, was included in each batch of samples. All 
sample manipulations were carried out in a class-10 clean room. The Teflon Savillex® beakers 
were pre-cleaned in sequential steps with 7 M HNO3 and with 6 M HCl. 
 
4.3.3 Instrumentation and measurements 
A Thermo Scientific Neptune MC-ICP-MS instrument (Bremen, Germany) equipped with a 
large dry interface pump (130 m3 h-1 pumping speed) and high-transmission ‘jet’ Ni interface 
cones (‘jet’ sampling cone and X-type skimmer) was used for Fe isotope ratio measurements. 
A PFA concentric nebulizer (100 μL min-1) mounted onto a double spray chamber with 
cyclonic and Scott-type sub-units was used for sample introduction into the plasma. 
Measurements were performed at medium mass resolution (pseudo mass resolution32), in 
static collection mode, using six Faraday collectors connected to 1011 Ω amplifiers. 
Instrument settings and data acquisition parameters are shown in Table 4-1 (A). Ni was used 
as an internal standard at the same concentration level as the target element (300 μg L-1). The 
in-house isotopic standard solution was included in the sequence after each 5 samples to 
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check quality of the isotope ratio measurements. All solutions (in-house standards and 
samples) were measured in duplicate.  
Table 4-1. Instrument settings and acquisition parameters for (A) the Neptune MC-ICP-MS instrument and (B) 
the Element XR SF-ICP-MS instrument 
A. MC-ICP-MS Neptune   
RF power (W) 1275 
Guard electrode Connected 
Sample and skimmer cones Jet sampler and X-type skimmer, Ni, 1.1 and 0.8 mm orifice 
diameter, respectively 
Lens settings Optimized for maximum Fe+ signal intensity 
Ar flow rates (L min-1): plasma gas 15 
                                  auxiliary gas 0.75 
                                  nebulizer gas 0.9-1.0 
Sample uptake rate (μL min-1) 100 
Resolution mode Medium (pseudo) 
Acquisition mode Static; multi-collection 
Number of blocks 9 
Number of cycles 5 
Integration time (s) 4.194 
Cup configuration L4: 54Fe; L2: 56Fe; L1: 57Fe; C: 58(Fe + Ni); H1: 60Ni; H3: 62Ni 
B. SF-ICP-MS Element XR  
RF power (W) 1250 
Guard electrode Connected 
Sample and skimmer cones Ni, 1.1 mm and 0.8 mm orifice diameter 
Lens settings Optimized for maximum signal intensity 
Ar flow rates (L min-1):  
plasma gas 15 
auxiliary gas 0.8-0.9 
nebulizer gas 1.0-1.1 
Sample uptake rate (μL min-1) 200 
Resolution mode Low, medium, high  
Acquisition mode E-scan 
Dwell time per point (ms) 10 
Point per peak 20 
Number of runs 5 
Number of passes 5 
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The isotopic composition of the samples is expressed in delta notation (56Fe and 57Fe, ‰) 
relative to the reference material IRMM-014 and calculated as follows (eqn. 4-1), where x is 






− 1) (4-1) 
Mass bias correction was performed through the combination of internal correction with 
admixed Ni relying on the revised Russell’s law (using a regression line to establish the 
correlation between the correction factors for Fe and Ni) and external correction in a sample-
standard bracketing approach (SSB).33 2s-rejection of outliers was applied for the measured 
isotope ratios.  
A Thermo Scientific (Bremen, Germany) Element XR single-collector sector-field ICP-MS 
instrument was used for determination of element concentrations. For the introduction of 
sample into the plasma, a 200 μL min-1 quartz concentric nebulizer mounted onto a cyclonic 
spray chamber was used. The instrument settings and data acquisition parameters used are 
summarized in Table 4-1 (B). External calibration was performed and Ga was used as an 
internal standard to correct for matrix effects and instrument instability.  
 
4.4 RESULTS AND DISCUSSION 
4.4.1 Iron determination 
The use of VAMS was first evaluated for the quantitative determination of Fe using the 
Seronorm reference material and real venous whole blood. A variety of solutions, such as 
Milli-Q water, 0.7 M HNO3, 5% acetone, 5% methanol, and hot 7 M HNO3 (v/v) were tested 
as extraction solutions. Fig. 4-1 shows the VAMS tips after extraction using different 
extraction solutions. First, Fe was determined in the supernatant obtained after extraction of 
the blood microsample from the VAMS tip and centrifugation. As can be seen in Fig. 4-1 (a), 
quantitative recoveries of Fe were only obtained using hot 7 M HNO3. These recoveries were 
99 with 1% of absolute deviation between the two replicates for the reference material and 94 
with 4% of absolute deviation between the two replicates for real blood, both relative to the 
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Fig. 4-1 Recoveries for Fe obtained after VAMS tip extraction (a) in the resulting supernatant and (b) after 
digestion of the extracted mixture for Seronorm whole blood L-1 reference material and a real whole blood 
sample. Recoveries are expressed as the average of 2 measurement replicates. The absolute deviation between 
the two values was ≤ 10%.  
reference value (i.e. the result obtained using the reference procedure). The poor Fe recoveries 
obtained using the other extraction solutions tested can be related to precipitation of proteins 
and/or inadequate extraction conditions (Fig. 4-1 a). To evaluate this, the resulting mixture 
extracted from the VAMS tip was further digested. The results for the Seronorm reference 
material and for the real blood sample obtained after acid digestion of the extracted mixture 
from VAMS are shown in Fig. 4-1 (b). As can be seen, the recoveries obtained with Milli-Q 
water, 5% acetone, 5% methanol and 7 M HNO3 (hot) were all quantitative. However, a ca. 
two-fold longer extraction time was required for the real blood sample (5 min) compared to 
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the reference material (2 min) to reach similar recoveries from the VAMS tip for both 
matrixes. The different extraction efficiencies obtained for the reference material and the real 
blood are probably related to the viscosity of the sample. This dissimilarity has already been 
previously observed in the context of extraction of blood from a VAMS tip28 and also in the 
case of DBS sample collection on filter paper.20  
Based on the results obtained, the extraction of sample material from the VAMS tip 
containing the dry blood sample was accomplished with 1 mL of Milli-Q water and 5 min of 
agitation. The extract was subsequently subjected to acid digestion. This approach enables 
accurate determination of Fe in microsamples of blood using SF-ICP-MS and can therefore be 
applied in future routine applications. The efficiency and corresponding reproducibility of 
extraction of Fe from VAMS tips was 98 ± 5 % standard deviation (n = 4).  
The procedural blank of Fe was 0.5 µg L-1 using Milli-Q water, but was increased after acid 
digestion to 15 µg L-1; this value is still negligible compared to the Fe concentration in a 
whole blood sample (~ 350 mg L-1 in venous blood) and is thus acceptable for further high-
precision isotopic analysis.  
 
4.4.2 Iron isotopic analysis  
Isolation procedure 
It is well known that the presence of matrix components in the sample solution can cause 
spectral interference and affect the extent of instrumental mass discrimination in MC-ICP-MS 
and therefore, the target analyte is traditionally chromatographically isolated to guarantee 
accurate and precise results.34 This procedure is labour-intensive and time-consuming, thus 
reducing sample throughput. In order to perform the Fe isotopic analysis of blood 
microsamples using VAMS, a miniaturized chromatographic isolation approach, using a small 
amount of anion exchange resin AG-MP1 (0.5 mL), was developed. For studying the 
chromatographic separation in detail, the analyte element and concomitant matrix elements 
were determined using SF-ICP-MS in separately collected 1 mL eluent fractions. The elution 
profile of the target element and concomitant elements is presented in Fig. 4-2 for the 
Seronorm reference material. As can be seen, the matrix elements were successfully removed,  
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Fig. 4-2 Elution profile for Seronorm Trace Elements Whole Blood L-1 reference material. For fractions (frs) 1-
2 (matrix) 1 mL of 9 M HCl and for frs 3-7 (matrix) 1 mL of 6 M HCl + 0.001% H2O2 were used for matrix 
elution; for frs 8-13 (Fe) 1 mL of 1 M HCl is used for elution; for fr 14 (matrix) 5 mL of 0.7 M HNO3 is used to 
clean the resin for further use.  
while recoveries of Fe were quantitative (101 ± 8%, n = 48 over a period of one year). The 
average concentration of Fe after the isolation procedure was 349 ± 10 mg L-1 (n = 4), which 
is in excellent agreement with the certified value of 349 ± 7 mg L-1 (t-test, texp < tcrit,  < 0.05). 
For one batch of samples (~ 20 columns), Fe isolation is accomplished in 2 hours compared to 
9 hours for the standard procedure for whole blood matrixes,35 which reduces the total sample 
preparation time. Moreover, the use of the miniaturized chromatographic isolation approach 
results in a significant reduction in the consumption of the expensive ultrapure acids (a 2.3-
fold lower consumption of HNO3 and a 3.3-fold lower one of HCl). 
 
Iron isotopic analysis after VAMS 
The suitability of VAMS for high-precision isotopic analysis of Fe by MC-ICP-MS was 
evaluated using the Seronorm reference material and real venous whole blood. Incomplete 
extraction of Fe from a VAMS tip, due to non-optimized extraction conditions, induced 
isotope fractionation. A shift of -0.56‰ in δ56Fe was observed when the recovery of Fe was 
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less than 72%. This significantly lighter isotopic composition can be explained by the slightly 
faster elution of the lighter of two Fe isotopes.34,36,37 The Fe isotopic composition of blood 
microsamples extracted with Milli-Q water from VAMS devices, followed by acid digestion 
were in good agreement with the reference values obtained on the basis of the standard 
approach (for an aliquot of blood that was directly digested). The results obtained for 5 
venous blood microsamples and for the Seronorm reference material after VAMS and for the 
corresponding reference samples are plotted in Fig. 4-3. A paired t-test showed that no 
significant difference could be established between both methodologies at a 95% confidence 
level (texp = 1.659 < tcrit = 2.571). The individual data for Fe concentrations are shown in the 
Supplementary Information (Table 4-S1). The repeatability for the Fe isotope ratio 
measurements, expressed as the standard deviation for three sample replicates, was between 
0.03 and 0.08‰ in the case of VAMS. The reproducibility, expressed as the standard 
deviation, was between 0.05‰ and 0.18‰ for 56Fe and 57Fe, respectively (values obtained 
for 5 independent measurement sessions). 
The results for all of the samples fall on the normal mass-dependent fractionation line     
(57Fe = 1.47 56Fe). The differences between the results with and without blank correction 
were 0.05 and 0.07‰ for δ56Fe and δ57Fe, respectively and thus, no blank correction was 
required. 
 
Fig. 4-3 Isotopic composition of 5 venous whole blood samples (filled circles) and Seronorm Whole Blood 
reference material (open circle) obtained using VAMS and the reference approach. The dashed lines indicate the 
confidence interval ( < 0.05). 
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4.4.3 Stability of blood samples in the VAMS device  
The stability of blood samples loaded onto the VAMS device was evaluated according to De 
Kesel et al.28 For this evaluation, samples were extracted from a VAMS tip after 2 h of drying 
(considered as the zero time point), after 4 days of storage at 60 C, 4 C and -20 C and after 
long storage at room temperature (1-4 weeks). This experiment was carried out using one 
venous whole blood sample, analyzed in triplicate for each time point. The VAMS devices 
with the dried blood microsamples were placed in closed tips holders, thus avoiding contact 
between tips and stored as such until analysis. A blank tip was included in each set of samples 
to evaluate potential contamination originating from the VAMS device. The average Fe 
concentrations, isotopic compositions and procedural blanks are presented in Table 4-2. No 
significant differences were observed between the group means at a 5% significance level 
using one-way ANOVA (JMP statistical software, version 12.1.0, SAS Institute Inc., Cary, 
NC, USA). Thus, the Fe concentrations and isotopic compositions of dried microsamples 
were not affected during a period of at least 28 days when the VAMS tips are stored at room 
temperature. Thus, the VAMS device is suitable for high-precision Fe isotopic analysis and 
quantitative Fe assay until at least 1 month after sampling. Moreover, the samples were also 
stable for at least 4 days when they were stored under harsher conditions, such as storage 
temperatures of 60 C, 4 C and -20 C. These results indicate the potential for long term 
storage and shipping of VAMS-collected samples under different temperature conditions. 
 
4.4.4 Finger-prick versus  venous blood 
Finger-prick blood is generally considered as capillary blood,31 although it can actually be a 
mixture of arterial, venous and capillary blood. In previous works focused on clinical 
research, the Fe isotopic composition was established for venous whole blood, serum and/or 
plasma collected by venipuncture and no data are available for capillary blood and/or blood 
collected using dry microsampling techniques. In neonates, capillary blood shows higher 
levels of hemoglobin and HCT than venous blood38 and thus, the Fe isotopic composition 
could be different between finger-prick and venous blood.4 The difference in hemoglobin 
level between capillary and venous blood diminishes in adults.39–41 Discrepancies between 
finger-prick DBS and venous blood in adults are reported in the literature, e.g., for HCT, 
cholesterol and glucose levels,42 however, the lack of consensus for these differences between 
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Table 4-2. Fe isotopic compositions and concentrations in blood microsamples extracted from VAMS tips stored under different conditions. Fe concentrations and recoveries 
are expressed as the average of 3 sample replicates ± SD, %. Delta Fe values are expressed as the average  SD (n = 3). 
 Room temperature (21C)  60 C 4 C -20 C 
 2h 7 days 14 days 28 days  4 days 
[Fe], mg L-1 370 ± 1 340 ± 14 365 ± 27 354 ± 18  358 ± 22 358 ± 15 372 ± 4 
[Fe] blank, mg L-1 0.015 0.073 0.079 0.079  0.080 0.178 0.078 
Recovery, % 101 ± 1 101 ± 3 102 ± 3 105 ± 7  103 ± 1 92 ± 15 98 ± 3 
56Fe -2.35 ± 0.01 -2.34 ± 0.03 -2.39 ± 0.05 -2.42 ± 0.01  -2.36 ± 0.02 -2.40 ± 0.03 -2.40 ± 0.03 
57Fe -3.45 ± 0.05 -3.43 ± 0.05 -3.51 ± 0.07 -3.50 ± 0.02  -3.50 ± 0.04 -3.52 ± 0.04 -3.51 ± 0.05 
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capillary and venous blood could be related with the microsampling technique used and/or the 
representativeness of the microsample. 
To evaluate the suitability of the finger-prick blood Fe isotopic composition for further 
clinical research (e.g., assessment of an individual’s iron status), finger-prick and venous 
blood samples were collected simultaneously from 6 healthy individuals (1 female and 5 
males). The microsampling was performed in duplicate, i.e. the third and fourth blood droplet 
were sampled separately for each individual. Fe concentrations were determined before and 
after the isolation procedure and matrix elements that can potentially interfere with the 
determination of Fe isotope ratios, such as Cr, Ca and K, were monitored after the isolation 
procedure. The contribution of these elements was negligible in all cases. Table 4-3 compiles 
the Fe recoveries, average concentrations and Fe isotopic composition. No significant 
differences were established between the finger-prick and venous blood using a paired t-test at 
a level of confidence of 95% (texp = 0.125 < tcrit = 2.571). The use of dried finger-prick blood 
after VAMS combined with a miniaturized isolation procedure can thus be used for high-
precision isotopic analysis of Fe with the final aim of clinical research. 
 
4.5 CONCLUSIONS 
Volumetric absorptive microsampling (VAMS) using a commercially available device 
(MitraTM) was suitable for high-precision Fe isotopic analysis of whole blood using MC-ICP-
MS for clinical applications. Fe was recovered quantitatively after VAMS. Accurate and 
precise data were obtained using 1 mL of Milli-Q water as extraction solution followed by 
acid digestion and a miniaturized chromatographic approach for Fe isolation. The Fe isotopic 
composition and Fe concentrations are not affected during a period of at least 28 days when 
the VAMS device is stored at room temperature and during a period of at least 4 days when it 
is stored at 60 C, 4 C or -20 C. By using this methodology, no differences in the Fe 
isotopic composition or Fe concentration were observed between finger-prick and venous 
blood. The approach proposed greatly enhances the sample throughput, reduces the amount of 
reagents required and thus, is beneficial in terms of time and cost. The VAMS-collected 
finger-prick blood samples were adequate for Fe isotopic analysis and thus, the suitability of 
this approach for future applications was shown. 
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Table 4-3. Fe isotopic compositions and concentrations of finger-prick and venous blood from supposedly healthy individuals. Delta Fe values for 2 sample aliquots are 
shown. The absolute deviation between two value was ≤ 0.09 for 56Fe and ≤ 0.11 for 57Fe. 
Sample 
Finger-prick blood Venous blood 
[Fe], mg L-1  56Fe  57Fe [Fe], mg L-1  56Fe  57Fe 
f28 370  -2.41 -2.40  -3.49 -3.55 399  -2.35 -2.36  -3.41 -3.48 
m27 338  -2.63 -2.63  -3.91 -3.88 381  -2.61 -2.69  -3.82 -3.92 
m28 393  -2.97 -3.01  -4.38 -4.45 389  -3.04 -3.04  -4.59 -4.48 
m23 416  -2.89 -2.81  -4.28 -4.21 416  -2.91 -2.89  -4.32 -4.28 
m26 433  -2.81 -2.72  -4.15 -4.04 423  -2.79 -2.73  -4.11 -4.02 
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4.8 SUPPLEMENTARY INFORMATION  
 
Table 4-S1. Iron concentrations of venous whole blood samples after extraction from VAMS tips and using the 
reference procedure. Data are expressed in mg L-1 as average of 2 sample replicates. The absolute deviation 
between the two values ranged between 7 and 10 mg L-1 
 
Venous whole blood sample Seronorm whole blood L-1 
reference material 1 2 3 4 5 
Reference procedure 411 370 388 362 387 348 
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5.1 ABSTRACT 
In this work, Fe isotopic analysis of samples coming from an in vitro intestinal model was 
performed via multi-collector ICP-mass spectrometry (MC-ICP-MS) to evaluate the isotope 
fractionation accompanying the iron uptake and transport mechanisms at a cellular level. The 
Caco-2 cell line has been used, after cell differentiation, as enterocyte model and a bi-cameral 
experimental setup has been developed and optimized for stimulating intracellular iron fluxes. 
An Fe : ascorbic acid mixture with a molar ratio of 1:5 was used as a source of non-heme 
bioavailable iron. Good experimental repeatability and reproducibility were attained with low 
blank contribution levels, allowing precise and reliable Fe isotope ratio results. Both iron 
absorption and transport processes were accompanied by Fe isotope fractionation in favor of 
the lighter isotopes. After 3 hours of exposure, the isotopic composition of the apical solution 
and the cells did not significantly differ from the original solution added to the cells. After 24 
hours of exposure, the trend observed was towards a light Fe isotopic composition in the cells, 
whereas the apical solutions were enriched in the heavier isotopes. These results were in good 
agreement with previous in vivo and ex vivo findings. An overall increase in delta Fe values of 
the cell layers exposed to iron treatment relative to the corresponding values for the untreated 
cells also seems to support the assumption of a preferential accumulation of heavy isotopes in 
enterocyte ferritin. The consistency of the results obtained supports the usefulness of in vitro 
cell culture models as an interesting complementary tool for studying iron metabolic 




Iron is an essential micronutrient for almost all living organisms. Particularly, in the human 
body, iron is involved in oxygen transport and storage, acts as cofactor in some metallo-
enzymes, and takes part in many other fundamental processes.1 However, regulation of the 
iron metabolism is of capital importance, as iron may exert toxicity when present at high 
levels and iron deficiency may likewise give rise to metabolic disorders.2 With a lack of an 
active iron excretion route, iron homeostasis is mainly maintained through an interplay 
between iron absorption, recycling and loss (e.g., bleeding). From a mechanistic point of 
view, iron absorption from the diet takes place at the apical membrane of duodenal 
enterocytes. Part of this iron is then stored as ferritin (major iron storage protein) within the 
enterocyte and part is transferred to the basolateral site of the enterocytes through the 
membrane transporter protein ferroportin. In the blood, transferrin (Tf, a circulating iron 
transport protein) binds this exported iron and serves as a major vehicle to deliver iron to the 
periphery. Iron from transferrin is then internalized by cells expressing a transferrin receptor 
protein.1,3 
These biochemical mechanisms are accompanied by reduction/oxidation or by bonding 
reactions. Both may be accompanied by mass-dependent fractionation effects as different 
isotopes of the same element may engage in these biochemical reactions to a slightly different 
extent. Light isotopes react more readily owing to a slightly lower activation energy (kinetic 
effect), while heavier isotopes exhibit a slight preference for strong molecular binding 
environments (thermodynamic or equilibrium state).4,5 
It has been established that the Fe isotopic composition of an individual’s whole blood/serum 
provides reliable information on his/her iron status, and therefore, it appears to be a potential 
marker for diseases related to a dysfunction in the iron regulating axis.6–11 These impairments 
in iron regulation have a direct effect on the intestinal iron absorption efficiency and may 
eventually lead to iron deficiency or iron overload. This was pointed out in an early study by 
Walczyk and von Blanckenburg,12 in which they indicated a trend towards a lighter Fe 
isotopic signature in blood than in Fe-storage organs. This finding was later confirmed by 
Hotz et al. using a pig model.13 In the latter work, the Fe isotopic composition of the diet and 
the blood of a pig was compared to that of the intestinal mucosa at different sites. An 
enrichment in the light Fe isotopes was observed in the main intestinal absorptive points, 
stressing a preferential uptake of light Fe isotopes in the intestine. 
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However, the processes occurring at the cellular or molecular level leading to isotope 
fractionation are still unknown or poorly understood. In this context, in vitro studies are 
valuable for the identification of such biological processes and for studying the incorporation 
pathways of iron into the cells. Isotope fractionation during the incorporation of metals, such 
us Cu, Fe and Zn, into bacteria has been evidenced.14–16  Kappler et al.17 described different 
extents of Fe isotope fractionation produced by a variety of biological and abiological iron 
oxidation processes. Recently, Cu and U isotope fractionation has been evidenced in human 
cell lines, such as the HepG2 (hepatoma-like cells)18 and SH-SY5Y (neuroblastoma-like 
cells),19 respectively. The intracellular Cu was isotopically heavier under hypoxic conditions 
than under normoxic conditions, in concordance with the 65Cu enrichment found in 
hepatocellular tumorous tissues compared to the healthy surrounding tissue.18 The 
intracellular U in the neuroblastoma cells was enriched in the light 235U isotope relative to the 
exposure solutions. Different incorporation pathways of U into the cells have been 
suggested.19 
In the present work, Fe isotopic analysis of samples obtained from an in vitro model of 
enterocytes was performed via multi-collector inductively coupled plasma-mass spectrometry 
(MC-ICP-MS) to investigate the mechanisms responsible for Fe isotope fractionation at the 
cellular level of the intestinal enterocytes, as a first metabolic barrier where iron uptake from 
the intestinal lumen and subsequent incorporation of iron to the peripheral circulation takes 
place. The Caco-2 cell line is a well-established enterocyte model used for iron absorption 
studies. Caco-2 cells differentiate spontaneously into bipolar enterocyte-like cells, exhibiting 
tight intercellular junctions which allow also optimal conditions for transcellular transport 
studies. This cell line has been extensively used for iron bioavailability tests and manifests a 
behavior in good agreement with in vivo comparative uptake and transport studies.20–23 An 
experimental setup was developed to optimize iron fluxes through the epithelial cells and the 
analytical procedure was evaluated aiming at controlling any source of analytical bias for 








5.3.1 Reagents and standards 
14 M pro-analysis grade HNO3 (ProLabo, Belgium) was used throughout this work for 
sample digestion, chromatographic Fe isolation and sample/standard dilution after further 
purification by sub-boiling distillation in a PFA system. Optima grade 12 M HCl used for 
sample preparation was purchased from Fisher Chemical (UK). Ultrapure water used for all 
experiments (with a resistivity of 18.2 MΩ·cm at 25°C) was obtained from a Milli-Q Element 
water purification system (Merck Millipore, USA). TraceSELECT® Ultra H2O2 9.8 M 
(Fluka, Sigma-Aldrich, Belgium) was used for sample digestion. 
Analytical grade AG® MP-1 strong anion exchange resin (100-200 m dry mesh size, 
chloride anionic form, Bio-Rad, Belgium) packed in polypropylene chromatographic columns 
(Bio-Rad PolyPrep), was used for Fe isolation from the sample matrix. 
Single-element standard solutions of various elements (1 g L-1) purchased from Inorganic 
Ventures (The Netherlands) were used for quantification (Fe and Ga) and mass bias correction 
purposes (admixed Ni). 
An Fe isotopic reference material (IRMM-014, Institute for Reference Materials and 
Measurements, Belgium) was used for external mass bias correction through the sample-
standard bracketing approach. A single-element Fe standard solution in nitrate form (from 
now on referred to as A&MS-Fe) purchased from Inorganic Ventures (lot D2-FE03110) and 
previously characterized for its isotopic composition was used for Caco-2 cells uptake and 
transport experiments and also as an in-house isotopic standard for measurement quality 
control. All standards and samples were properly diluted with 0.42 M sub-boiled HNO3 prior 
to the measurements. 
BioXtra, 99.0% crystalline L-Ascorbic acid and human apo-transferrin (apo-Tf), cell culture 
tested, were purchased from Sigma-Aldrich in powder form.  
Iron (II) sulfate heptahydrate, an ACS reagent for analysis grade, was purchased from Carlo 
Erba Reagents (Italy). 
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5.3.2 Cell culture and sample harvesting  
The human colon adenocarcinoma Caco-2 cell line (HTB37) was obtained from the American 
Type Culture Collection (MD, USA). Cells were seeded (at a density of 100 000 cells per 
well) in 24 mm diameter polyester membrane filters of 0.4 µm pore size with a 4.52 cm2 cell 
growth area, fitted to 6-well Transwell® polystyrene plates (Costar, Corning, UK), creating a 
bicameral chamber. The cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with GlutaMAXTM (Gibco, Life Technologies, CA, USA), 10% heat-
inactivated fetal bovine serum (FBS, Greiner Bio One, Belgium), 1% non-essential amino 
acids (NEAA, Gibco, Life Technologies) and 1% penicillin-streptomycin (P/S, Gibco, Life 
Technologies). Cells were incubated in a humidified atmosphere with 5% CO2 and at 37°C 
(Memmert CO2 incubator, VWR, Belgium). The culture medium was replaced every 2-3 days 
and cells were allowed to grow and differentiate for 17 days. Cell confluence was regularly 
checked using a trinocular inverted phase-contrast microscope (AE31, Motic, VWR, 
Belgium) and the integrity of a tight monolayer was evaluated by monitoring the 
transepithelial electrical resistance (TEER) prior to the exposure with an automated tissue 
resistance measurement system (REMS, World Precision Instruments, UK), ensuring that in 
every bicameral chamber the measured TEER was > 300 Ω·cm2, indicative of an intact 
monolayer. 
 
5.3.3 Sample preparation  
After 17 post-seeding days, cells were washed twice with Iscove’s modified Dulbecco’s 
medium (IMDM, Sigma-Aldrich) and were incubated in IMDM without FBS during 24 hours 
for iron and serum protein depletion. After this period, the cell monolayer was washed twice 
with IMDM and an exposure medium with 120 µM of Fe, prepared from the isotopically 
characterized Fe in-house standard A&MS-Fe in IMDM, was added to the apical surface, 
together with 600 µM of ascorbic acid (1 : 5, Fe : AA molar ratio). The basal compartment 
was filled either with IMDM or with a 50 µM apo-Tf solution prepared in IMDM. This setup 
was used in four of the six wells per plate in every experiment, while the remaining two were 
used for procedural blanks, with the same basal composition, but with an apical solution 
containing 600 µM ascorbic acid in IMDM only (no Fe). The first batch of samples in every 
experiment was collected after 3 hours of exposure (two exposure wells plus one blank well), 
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while the rest were incubated for 24 hours to allow ferritin production. Apical and basal 
compartment solutions were separately collected in Teflon Savillex® beakers (Savillex, MN, 
USA). Cells were washed twice with IMDM to remove any nonspecifically bound iron. Then, 
the fine polyester membrane containing the cell monolayer was detached from the well insert 
and also placed in Teflon Savillex® beakers for further acid digestion. 
All samples (cells, apical and basal solutions) were digested in the Teflon Savillex® beakers 
with a mixture of 4 mL of 14 M HNO3 and 1 mL of 9.8 M H2O2. As this mixture was highly 
reactive, the digestion was first performed at room temperature and with the beakers not 
completely closed to avoid overpressure, and subsequently, after tightly closing the beakers, 
on a hotplate at 110°C for 18 hours. The digests thus obtained were evaporated to dryness at 
95°C and re-dissolved in 5 mL of 8 M HCl (with the addition of 0.001% H2O2 to ensure that 
Fe is in its higher oxidation state) for subsequent Fe chromatographic isolation. 
Iron was isolated from the samples by anion exchange chromatography, based on the 
procedure described by Van Heghe et al.24 In short, 1 mL of AG MP-1 resin is packed in the 
polypropylene chromatographic column, supported by a microporous polyethylene frit. A 
piece of cotton is placed as stopper on top of the resin bed. After the resin has been 
thoroughly cleaned and conditioned with 8 M of HCl, the sample is loaded into the column. 
Matrix compounds are eluted with 3 mL of 8 M HCl + 0.001% H2O2 and 9 mL of 5 M HCl + 
0.001% H2O2. Fe is then quantitatively collected in pre-cleaned Teflon Savillex® beakers by 
passing through 7 mL of 0.6 M HCl. This purified Fe fraction is evaporated to dryness at 
95°C and subsequently re-dissolved in 1 mL of 14 M HNO3. This drying/re-dissolving step is 
repeated twice to get rid of the chlorine. After that, the final residue was re-dissolved in       
0.5 mL of 0.42 M HNO3. 
Cell seeding and exposure, as well as sample collection, were carried out under aseptic 
conditions inside a class II biological safety cabinet (MSC-Advantage, Thermo Scientific, 
VWR, Belgium). All solutions used for cell exposure were previously filter-sterilized with 
0.22 µm pore membrane filters units (Millex-GP, Merck Millipore). After sample collection, 
all manipulations were carried out inside a class 10 clean lab. The Teflon Savillex® beakers 
were previously cleaned with 7 M HNO3 and 6 M HCl in several steps and further rinsed with 
Milli-Q water and all the polyethylene metal-free material with 1.4 M HNO3 followed by 
Milli-Q water. 
130 
5.3.4 Instruments and measurements  
For total Fe quantification before and after chromatographic isolation, an Element XR single-
collector sector field ICP-MS instrument (Thermo Scientific, Germany) operated at medium 
mass resolution was used. The sample introduction system consisted of a quartz concentric 
nebulizer (200 µL min-1) and a cyclonic spray chamber. Samples and calibration standards 
were properly diluted with 0.42 M sub-boiled HNO3 and Ga added as internal standard (10 g 
L-1) to correct for non-spectral interferences and instrument instability. The instrument 
settings and data acquisition parameters are summarized in Table 5-1.  
Table 5-1. Instrument settings and data acquisition parameters for Fe quantification using a Thermo Scientific 
Element XR single collector sector field ICP-MS instrument. 
Instrument settings  
RF power (W) 1230 
Guard electrode Connected 
Sampler cone Ni; Standard; 1.1 mm aperture diameter 
Skimmer cone Ni; H-type; 0.8 mm aperture diameter 
Lens settings Optimized for maximum analyte signal intensity 
Plasma gas flow rate (L min-1) 15 
Auxiliary gas flow rate (L min-1) 0.84 
Nebulizer gas flow rate (L min-1) 1.015 
Sample uptake rate (µL min-1) 200 
Resolution Medium (~ 4000 resolving power) 
Data acquisition parameters  
Scan mode E-Scan 
Segment duration (s) 0.2 
Sample time (s) 0.01 
Runs 5 
Passes 5 
Samples per peak 20 
Nuclides monitored 54Fe, 56Fe; 57Fe; 69Ga 
Isotopic analysis was performed using a Thermo Scientific Neptune multi-collector ICP-MS 
instrument. The sample introduction system comprised a low-flow PFA concentric nebulizer 
(100 µL min-1) and a tandem quartz spray chamber consisting of a cyclonic and a Scott-type 
sub-unit. The instrument was equipped with a large dry interface pump and an X-type Ni 
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skimmer and Jet-type Ni sampling cones were used to improve the sensitivity. Measurements 
were performed at medium mass resolution and in static multi-collection mode, making use of 
six Faraday cups connected to 1011 Ω current amplifiers. The instrument settings and data 
acquisition parameters are given in Table 5-2. 
Table 5-2. Instrument settings and data acquisition parameters for Fe isotopic analysis using a Thermo Scientific 
Neptune MC-ICP-MS. 
Instrument settings  
RF power (W) 1275 
Guard electrode Connected 
Sampler cone Ni; Jet-type; 1.1. mm aperture diameter 
Skimmer cone Ni; X-type; 0.8 mm aperture diameter 
Large dry interface pump (m3 h-1) 130  
Lens settings Optimized for maximum analyte signal intensity 
Plasma gas flow rate (L min-1) 15 
Auxiliary gas flow rate (L min-1) 0.80 
Nebulizer gas flow rate (L min-1) 1.003 
Sample uptake rate (µL min-1) 100 
Resolution Medium 
Data acquisition parameters  
Acquisition mode Static; multi-collection 
Number of blocks 9 
Number of cycles/block 5 
Integration time (s) 4.194 
Cup configuration L4: 54Fe, L2: 56Fe, L1: 57Fe, C: (58Fe+58Ni), H1: 60Ni, H3: 62Ni 
The sample-standard bracketing (SSB) approach was applied by alternating the measurement 
of every sample/A&MS-Fe in-house standard with a measurement of the isotopic standard 
(IRMM-014) for applying external mass bias correction. The Fe concentration in samples and 
standards was carefully matched (within ± 5%) to avoid variation in the extent of instrumental 
mass bias due to differences in the target element concentration. Whenever possible, Fe 
concentration was adjusted to 300 µg L-1. For those cases where the Fe concentration in the 
samples was not sufficiently high, samples and standards were adjusted to 200 µg L-1. Ni was 
added to all samples and isotopic standards at the same concentration and was used as the 
internal standard for mass bias correction. The A&MS-Fe in-house standard was measured 
every 5 samples to ensure correct instrument performance.  
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Off-line mass bias correction was performed by combining internal correction (using the 
admixed Ni as internal standard) by applying the revised Russell’s model for calculating the 
mass bias factors as described by Baxter et al. and the SSB external correction approach.25 
The isotopic composition is expressed in delta notation (δ56Fe and δ57Fe, ‰) relative to the 
IRMM-014 Fe isotopic reference material, as described elsewhere.11,26 
 
5.4 RESULTS AND DISCUSSION 
5.4.1 Optimization of the in vitro enterocyte model  
Cell viability assays 
Caco-2 cells were seeded in 96-microwell plates (104 cells per well density) to perform 
several cell viability assays towards the iron species intended for the exposure to find a 
suitable concentration, offering a good compromise between cell viability and a sufficient iron 
content for reliable isotopic analysis. The cells were incubated in DMEM with 10% FBS, 1% 
NEAA and 1% P/S (200 µL per well) and allow to differentiate for 18 days prior to the 
experiments. The culture medium was changed every 2-3 days. Established protocols for the 
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) test for mitochondrial 
activity27 and the sulforhodamine B (SRB) assay for protein content determination28 were 
applied to cells exposed for 24 hours to solutions with different Fe concentration (0, 1, 5, 10, 
15, 20, 30, 40 and 50 mg L-1) prepared by the appropriate dilution of the A&MS-Fe in-house 
isotopic standard with IMDM, in the presence of 600 µM of ascorbic acid. Results of the SRB 
assay show no significant differences in protein content and thus, no evidence of immediate 
toxicity leading towards protein loss of the cells for any of the concentrations tested after 24 
hours. MTT assay results show somewhat more variability, and some decrease in 
mitochondrial activity was observed for the higher concentrations (30-50 mg L-1), but the 
decrease was always < 20%. The results for these viability assays can be found in Tables 5-S1 






Enhancement of non-heme iron bioavailability  
It is already known that several compounds may inhibit iron absorption, for instance by 
promoting insoluble iron aggregates, or enhance it, by stabilizing its reduced and more 
soluble form Fe2+. The soluble species Fe2+ is the most suitable for the non-heme iron 
absorption by brush-border membrane transport proteins of the intestinal enterocytes and, 
therefore, the most bioavailable form.1 Ascorbic acid exerts a very pronounced enhancing 
effect on non-heme iron absorption29 and it has been frequently used in studies of iron 
availability involving Caco-2 cells.30–32 The effectiveness of the ascorbic acid relies on its 
ability to reduce Fe from ferric to ferrous form and the chelating properties of ascorbate at 
nearly neutral pH environment to preferentially form Fe2+ soluble complexes.  
The enhancement of the iron absorption by Caco-2 cells was not evaluated in detail in this 
work; however, it was tested for further study of the Fe isotope fractionation accompanying 
the processes involved. For this, the conditions recommended in the literature32 were applied 
in the present setup to obtain the Fe in the bioavailable form for the cells, and thus to ensure 
sufficient intracellular Fe for isotope ratio measurements. Ascorbic acid needs to be added in 
a sufficient excess to Fe. As no strong inhibitors are expected to be present in the exposure 
media, an Fe : AA molar ratio of 1 : 5 was appropriate. Under these conditions, the iron 
uptake increased up to 5-fold, in concordance with previous studies.32,33 
 
Control of blank levels 
The setup conditions and manipulation of the cell cultures were optimized, not only for 
assuring a sufficient Fe concentration in the samples, but also to achieve the maximum 
possible control over the Fe blank levels, which is crucial for the correct interpretation of the 
isotope ratio data obtained. During cell growth to confluency and differentiation, cells were 
maintained under normal Fe conditions in DMEM culture medium (originally containing    
0.1 mg L-1 of Fe, added as Fe(NO3)3·9H2O) supplemented with 10% FBS, which provides the 
cells with a total constant Fe dose of approximately 400 µg L-1. Prior to the exposure 
experiment, the cell layers were carefully rinsed twice with fresh IMDM culture medium 
(with no Fe inorganic salts added, having an Fe concentration of < 5 µg L-1) and incubated 
during 24 hours in IMDM to allow Fe depletion. After this depletion time, the medium was 
discarded and substituted by the corresponding apical and basal exposure media, both 
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properly prepared in IMDM. The Fe contents in procedural apical and basal blank solutions 
were monitored after every experiment and were always < 10 µg L-1. Samples were collected 
in due course in pre-cleaned Teflon beakers for acid digestion. Under these conditions, the 
average amount of Fe in each compartment of 9 setup blanks seeded on 5 different days was 
0.04 ± 0.02 µg Fe (per 1.5 mL of apical solution), 0.06 ± 0.02 µg Fe (per 2 mL of basal 
solution) and 0.10 ± 0.04 µg Fe (per cell monolayer), expressed as average and standard 
deviation of 9 replicates measured in different sessions. 
 
Evaluation of the experimental and measurement precision 
Under the optimized conditions described above, experimental repeatability and 
reproducibility were assessed. Repeatability is expressed as the standard deviation of the Fe 
isotopic composition of the cell monolayer obtained from four different exposure replicates in 
a single experimental setup, which was between 0.01-0.08‰ for δ56Fe and 0.01-0.15‰ for 
δ57Fe. The reproducibility values, expressed as the standard deviation of the isotopic 
composition of the cell monolayer of four exposure replicates determined in two different 
experimental setups (within 3 months), were 0.03‰ for δ56Fe and 0.06‰ for δ57Fe. 
Regarding the measurement precision, the internal precision expressed as the standard 
deviation for 45 cycles within a single measurement was 0.04‰ for δ56Fe and 0.06‰ for 
δ57Fe. The external precision, expressed as the standard deviation of 10 measurements of the 
A&MS-Fe in-house standard during a 16-hours measurement session, was 0.03‰ for δ56Fe 
and 0.05‰ for δ57Fe. The isotopic composition of the A&MS-Fe in-house standard was 
measured a total of 45 times during 6 different measurement sessions (on 6 different days) 
within 5 months. The reproducibility of the measurements thus obtained, expressed as the 
standard deviation for those 45 measurements, was 0.02‰ for δ56Fe and 0.05‰ for δ57Fe. An 
average isotopic composition for the A&MS-Fe in-house standard of 0.46 ± 0.02‰ for δ56Fe 





5.4.2 Natural iron isotope fractionation accompanying iron 
fluxes through the cells  
Non-heme extracellular iron is taken up by the intestinal cells as Fe2+ (after the action of a 
membrane protein with ferric reductase activity) through a pathway involving a divalent metal 
ion transporter protein (DMT1) located in the brush-border at the apical pole of the 
enterocyte. Once inside the cell, the iron is gathered in the cytosol, where it is forming a pool 
of exchangeable intracellular transit iron associated with low molecular weight ligands, 
commonly known as labile iron pool (LIP). Ferritin production is stimulated within the cell in 
response to intracellular iron enrichment, and thus the iron from the LIP will either be 
sequestered as ferritin-bounded (after oxidation) within the enterocyte for eventual discarding 
by cell shedding into the intestinal lumen or transported across the basolateral membrane 
through the membrane divalent iron exporter protein ferroportin1 into the systemic 
circulation. Iron release across the basolateral membrane involves the oxidation of iron to its 
Fe3+ form by the membrane-bound ferroxidase hephaestin, to be incorporated into circulating 
apo-Tf.1,3,35,36 
In the current in vitro enterocyte model, non-heme iron is already offered to the cells in a 
highly bioavailable stabilized Fe2+ form by the addition of ascorbic acid in the apical solution 
to facilitate the uptake process. Apo-Tf was added to the basal solution in order to stimulate 
iron transport to the basal chamber. A final concentration of 50 µM of apo-Tf was selected, 
which would be considered a normal value for human serum and will offer enough iron 
binding sites (each apo-Tf molecule presents two high-affinity iron binding sites). 
The optimized setup for the isotopic analysis of the different culture compartments consisted 
of a 6-well Transwell® plate with filter inserts creating a two-chamber system. Caco-2 cells 
were seeded over the surface of the inserts and maintained immersed in DMEM culture 
medium for 17 days to allow cell differentiation prior to the exposure experiment. After a 
subsequent 24 hours of iron and serum protein depletion in iron- and serum-free IMDM 
medium and appropriate assessment of monolayer integrity by TEER measurements, the cell 
layers were carefully rinsed twice with fresh IMDM medium and a 1.5 mL solution 
containing 120 µM of Fe as Fe-ascorbate (prepared as described above) was offered to the 
apical chamber of four of the six wells. The remaining two wells were kept as procedural 
blanks, and thus, each apical compartment consisted of 1.5 mL of an ascorbic acid solution of 
600 µM prepared in IMDM culture medium. 2 mL of a 50 µM solution of apo-Tf in IMDM 
136 
medium were added to each basal chamber, and the cells were kept at 37°C in an incubator, in 
a humidified atmosphere with 5% CO2. A scheme of the experimental setup is represented in 
Fig. 5-1. 
 
Fig. 5-1 Scheme of the in vitro experimental setup relying on the intestinal Caco-2 cell line model for studying 
Fe isotope fractionation accompanying intestinal Fe uptake. 
Samples (apical and basal media and the cell monolayer) were collected after 3 and after 24 
hours of iron exposure. These time points have been selected in order to isolate as much as 
possible the mechanisms potentially involved in inducing mass-dependent fractionation in the 
Fe isotopic composition, i.e. iron uptake from the apical compartment into the cytosolic iron 
pool, iron incorporation into ferritin within the cells, and iron transport across the basolateral 
membrane to the basal compartment. After sample collection, iron was quantified in each 
compartment, before and after chromatographic analyte isolation, to assure complete 
recovery. The Fe transport efficiency (expressed in percent) was calculated based on the 
original Fe concentration in the exposure medium at the start of the experiment and the final 
Fe concentrations in the apical, cell and basal compartments. At the 3 hours’ time point, an 
uptake of around 30% was observed, while very little transport was recorded. After 24 hours, 
enough time to allow ferritin production in the cells, the intracellular iron accounted for 
around 45% of the initially fed iron, while approx. 1% of this iron was found in the basal 
compartment. This increase in absorbed iron with a very low transport rate could maybe be 
explained by a cellular response towards changes in the LIP, which is an indicator of the iron 
status of the cell. The cells on their own have a regulatory mechanism by which, in response 
to their metabolic requirements, they can modulate the expression of the proteins required for 
import, storage and export of iron.37,38 Similar low magnitude percentages of iron transported 
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Table 5-3. Isotopic composition of Fe (‰) in the three compartments of the setup - samples collected at two different time points (after 3 and after24 hours); each experiment 
was performed in duplicate (ER1 and ER2). Uncertainties represent the internal precision of the measurements expressed as the standard deviation of all the measurement 
cycles. The δ56Fe value of the original exposure medium is 0.53 ± 0.04 ‰. 
* Values of δ56Fe for the basal compartments are the result of the analysis of the combined solution from both experimental setups at each time point 
 
 
 3 hours Fe exposure  24 hours Fe exposure 
 ER1 ER2  ER1 ER2 
 δ56Fe δ57Fe δ56Fe δ57Fe  δ56Fe δ57Fe δ56Fe δ57Fe 
Apical 0.51 ± 0.04 0.75 ± 0.06 0.46 ± 0.03 0.68 ± 0.07  0.73 ± 0.04 1.11 ± 0.06 0.77 ± 0.04 1.08 ± 0.07 
Caco-2 cells 0.33 ± 0.04 0.50 ± 0.05 0.39 ± 0.03 0.49 ± 0.06  0.15 ± 0.04 0.26 ± 0.06 0.27 ± 0.04 0.39 ± 0.06 
Basal* -0.33 ± 0.06 ---------- -0.33 ± 0.06 ----------  -1.52 ± 0.06 ---------- -1.52 ± 0.06 ---------- 
Untreated Caco-2 cells -0.55 ± 0.05 ---------- ---------- ----------  -0.86 ± 0.05 ---------- ----------- ---------- 
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Fig. 5-2 (a) Variations in δ56Fe values of the apical, basal and cell compartments after exposure to Fe (as 
Fe(NO3)2 in the presence of ascorbic acid) and sample collection at different time points (after 3 and after 24 
hours). (b) Differences in δ56Fe values between each culture compartment and its corresponding “time zero”. 
Increments in apical δ56Fe values are expressed relative to the value of the exposure medium, and cell and basal 
values are expressed for procedural blank cells and basal solution, respectively. The external precision, 
expressed as the standard deviation of five replicates of A&MS-Fe in-house standard subjected to sample 
preparation, was 0.03 ‰ for δ56Fe. The absolute deviation obtained for culture replicates wells ranged between 
0.01 and 0.08 ‰. 
in Caco-2 cells cultured under normal iron conditions were reported previously for in vitro 
studies of intestinal iron transport across Caco-2 cells.39,40 
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For each time point, two individual experimental setups were used and cells and apical 
solutions were analyzed separately for their Fe isotopic composition. The basal solutions for 
both experimental replicates were combined in order to have sufficient Fe concentration for 
obtaining reliable isotope ratio data. Results for the isotopic analysis are gathered in Table 5-3 
and represented in Fig. 5-2a for ease of interpretation. A trend towards a heavier isotopic 
composition with time is observed in the apical compartment, evidencing a preferential uptake 
of the lighter isotopes. Both the cells and the solution of the basal compartment exhibit an 
enrichment in light Fe isotopes. This trend is particularly pronounced in the basal solution, 
which indicates also a strong preferential transfer of the lighter isotopes across the epithelial 
cells. These in vitro results are in good agreement with previously reported conclusions from 
in vivo and ex vivo studies.13,41 In Fig. 5-2b, the differences in δ56Fe value between the 
solution of each setup compartment and its corresponding “time zero” are represented,        
i.e. apical solution minus exposure medium, exposure cells minus procedural blank cells and 
basal solution minus basal blank. The most noteworthy behavior is probably an overall 
increase in the intracellular Fe isotopic composition relative to the corresponding value for the 
control setup (Δ56Fe = (δ56Fe)t - (δ
56Fe)0 > 0), which together with the fact of a less 
pronounced enrichment in light isotopes than in the basal solution, seems to support the 
statement presented by Hotz et al.13 of a preferential accumulation of heavy Fe isotopes in the 
form of ferritin within the enterocytes. 
 
5.4.3 Presence/absence of apo-Tf in the basal compartment 
Alvarez-Hernandez et al.40 studied iron transport through Caco-2 cells using 59Fe radioisotope 
as tracer. They demonstrated that, while Caco-2 cells show a constitutive rate of iron transport 
in the absence of any chelating ligand or serum protein, the presence of apo-Tf as iron 
“sequestering” protein is needed to stimulate transepithelial iron transfer to the basal 
compartment. In their study, several chelators with higher affinity for iron than that of the 
apo-Tf were tested, as well as some other Tf forms. In all those cases, iron transport to the 
basal compartment was poorly stimulated or no effect was observed compared to the transport 
in the presence of apo-Tf, suggesting a unique mechanism of interaction of this protein with 
the basal surface of the Caco-2 cells. 
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Fig. 5-3 Comparative study of Fe isotopic composition trends after 3 and after 24 hours of exposure to the Fe / 
ascorbic acid mixture in the presence and absence of apo-Tf for stimulating iron transport to the basal 
compartment. The standard deviation is 0.03 ‰ for five replicates of in-house standard subjected to sample 
preparation and measured in the same session. 
A similar experiment to that described in the previous section was performed by only 
eliminating the presence of apo-Tf in the basal solution to block the iron transfer process and 
evaluate only the isotopic effects accompanying iron uptake. Fig. 5-3 shows a comparative 
representation of the trend in Fe isotopic composition obtained for each compartment at 3 and 
at 24 hours in absence and in presence of apo-Tf as stimulating factor for iron transport to the 
basal compartment. Without apo-Tf in the basal compartment, the Fe concentration observed 
after 3 h and 24 h in the basal compartment was not high enough for reliable measurement of 
the Fe isotopic composition via MC-ICP-MS. After 3 hours exposure, the isotopic 
composition of the apical solution and the cells does not significantly differ from that of the 
A&MS-Fe in-house standard (value indicated in the figure with a solid line). After 24 hours 
exposure, the trend towards a lighter Fe isotopic composition in the cells and a heavier 
isotopic composition of the apical solutions was observed in both cases. A possible 
explanation may rely on the fact that the iron absorption efficiency of the cells is maximal 
after cell depletion and, after 3 hours exposure, the cells had already incorporated almost 70% 
of the total iron uptake observed at the end of the experiment. The approximately remaining 
30% is absorbed over the subsequent 21 hours of exposure, indicating that the uptake 
efficiency gradually decays, probably due to the increased iron status of the cells, resulting in 
a more pronounced isotope fractionation. 
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5.4.4 Natural iron isotope fractionation of the specific non-
heme iron uptake pathway  
Ferrous sulfate is traditionally the inorganic iron source of choice for all in vitro iron 
uptake/transport experiments through Caco-2 cells21,42 as well as in vivo iron absorption 
studies.43,44 This salt is widely employed as Fe fortificant in many kinds of dried meals as a 
highly bioavailable iron source due to its high solubility in water. In the development of the 
enterocyte model used in the current work, the A&MS-Fe in-house standard in nitrate form 
was used to facilitate the isotopic data interpretation. However, a study offering iron to the 
Caco-2 cells as FeSO4 at different time points under the optimized conditions was carried out 
to compare the trend in the isotopic variation occurring across the epithelial cells. The results 
obtained are represented in Fig. 5-4. As expected, the apical solution tends towards a heavier 
Fe isotopic composition with time, while the cells and the basal solution are characterized by 
a lighter isotopic composition, supporting the hypothesis that both uptake and transport 
processes are accompanied by an Fe isotope fractionation in favor of the light isotopes. From 
a metabolic point of view, a similar behavior should be expected due to the fact that all iron 
offered to the cells in an inorganic salt form seems to be transported through the apical 
membrane by the same specific uptake pathway for non-heme iron. Once it is incorporated 
into the LIP, the origin or initial form of an iron ion is no longer of relevance. 
 
Fig. 5-4 Trend in the δ56Fe values of the apical, basal and cell compartments upon exposure to Fe as FeSO4 in the 
presence of ascorbic acid and sample collection at different time points (after 3, 6, 24 and 48 hours). The 
standard deviation is 0.03 ‰ for five replicates of in-house standard subjected to sample preparation and 
measured in the same session. 
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5.5 CONCLUSIONS 
In this pilot study, an in vitro intestinal model was developed and evaluated as a tool to study 
the isotope fractionation effects triggered by the iron metabolic uptake and transport 
mechanisms at a cellular level. The Caco-2 cell line has been used, after cell differentiation, 
as enterocyte model and a bi-cameral experimental setup has been developed and optimized 
for stimulating intracellular iron fluxes. Under the optimum conditions, good experimental 
repeatability and reproducibility were attained with low blank contribution levels, allowing 
precise and reliable results for Fe isotope ratios. Both iron absorption and transport processes 
are accompanied by Fe isotope fractionation in favor of the light isotopes. These results are in 
good agreement with previous conclusions from in vivo and ex vivo studies, in which the Fe 
isotopic composition of the blood or intestinal mucosa was lighter than that of the diet. 
Furthermore, the data generated in this work also support the assumption of a preferential 
accumulation of the heavier isotopes in enterocyte ferritin. The consistency of the results 
obtained supports the usefulness of in vitro cell culture models as an interesting 
complementary tool for studying iron metabolic pathways. 
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5.8 SUPPLEMENTARY INFORMATION 
Table 5-S1. Results of the MTT test for mitochondrial activity of cells exposed to different concentrations of the 
A&MS-Fe in-house standard, in the presence of 600 µM of ascorbic acid. 
Fe concentration Absorbance Average Blank corrected % 
1 mg L-1 0.512 0.722 0.812 0.682 0.613 104 
5 mg L-1 0.543 0.692 0.713 0.649 0.580 98 
10 mg L-1 0.639 0.524 0.638 0.600 0.531 90 
15 mg L-1 0.810 0.627 0.700 0.712 0.643 109 
20 mg L-1 0.668 0.629 0.624 0.640 0.571 97 
Blank 0.699 0.537 0.680 0.660 0.591 100 
Blank 0.729 0.650 0.663   
  
30 mg L-1 0.649 0.644 0.497 0.597 0.528 89 
40 mg L-1 0.501 0.536 0.579 0.539 0.470 80 
50 mg L-1 0.618 0.561 0.582 0.587 0.518 88 
plate blank 0.073 0.066 0.068 0.069 
  
 
Table 5-S2. Results for the sulforhodamine B (SRB) assay for protein content for cells exposed to different 
concentrations of the A&MS-Fe in-house standard, in the presence of 600 µM of ascorbic acid. 
Fe concentration Absorbance Average Blank corrected % 
1 mg L-1 2.742 2.725 2.920 2.796 2.745 110 
5 mg L-1 2.733 2.626 2.789 2.716 2.665 107 
10 mg L-1 2.818 2.915 2.710 2.814 2.763 111 
15 mg L-1 2.774 2.736 2.686 2.732 2.681 108 
20 mg L-1 2.847 2.617 2.549 2.671 2.620 105 
Blank 2.648 2.545 2.487 2.543 2.492 100 
Blank 2.569 2.493 2.518   
  
30 mg L-1 2.725 2.763 2.764 2.751 2.700 108 
40 mg L-1 2.782 2.693 2.677 2.717 2.666 107 
50 mg L-1 2.787 2.518 2.694 2.666 2.615 105 






CHAPTER 6  
I R O N  I S O T O P I C  C O M P O S I T I O N  O F  A G E -








Iron is an essential micronutrient with a unique pathway within the human body. On the one 
hand, iron is a component of the heme-group in hemoglobin and of iron-sulfur proteins which 
are required for numerous biological processes.1 On the other hand, iron is able to catalyze 
redox reactions generating toxic radicals that are harmful to human cells. Dietary iron is not 
readily absorbed due to its insolubility at intestinal pH and by its precipitation and/or 
chelation by many food compounds (e.g., phytates). There are no specific mechanisms for 
iron excretion from the body. Loss of iron typically occurs through bleeding and normal 
sloughing of intestinal epithelial cells, where it is retained under the form of ferritin when 
body iron stores are elevated.  
The greatest need for iron mobilization in the body is the erythropoiesis. About 70% of the 
iron in an adult human body is found under the form of heme in hemoglobin in the red blood 
cells (RBCs). Although ~25 mg of iron is required per day for hemoglobin production and 
erythropoiesis, only 1 to 2 mg is absorbed in the gut per day. Therefore, the majority of iron 
used for the RBC formation comes from iron recycled from the senescent red blood cells by 
macrophages.1,2 
Erythropoiesis is a continuous process of proliferation and differentiation which begins from 
the hematopoietic stem cell and ends with the erythrocyte (red blood cell).3 Human RBCs, 
after differentiating from erythroblasts produced in the bone marrow, are released into the 
blood circulation. A normal RBC progresses through several stages in the circulation, 
including a short period as a reticulocyte, a long period as a mature RBC, and most probably, 
a short period at a senescent state4, after which it is phagocytized by macrophages.5 On 
average, in a healthy subject, erythrocytes have a life span of about 120 ± 15 days (~ 117 days 
in men and ~106 days in women), however, this value may vary between 70 and 140 days.6 
The limited lifespan of RBCs may be due to a variety of age-dependent changes, including 
biochemical, physical and immunological alterations.7 However, the molecular mechanism, as 
well as the signaling pathways of regulation involved into lifespan of RBCs are still unknown. 
During their life, erythrocytes undergo multiple changes, which affect the properties of the 
cell directly, such as an increase in the hemoglobin concentration, a moderate elevation in the 
Na+ concentration and a decrease in the levels of K+ and sialic acid, and a decrease in 
diameter and corpuscular volume due to the release of membrane proteins, all of which result 
in a gradually increasing cellular density of erytrocytes.7–10  
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Many methods have been reported for the separation of erythrocytes based on age-dependent 
density changes.8,11 The separation of RBC according to their density can be achieved by 
simple centrifugation of RBCs with an angle-head rotor12 or by using a mixture of water-
insoluble compounds with well-defined density ranges.11,13 The isolated erythrocyte fractions 
correspond to age ranges.8,11,14 The separation of the RBCs by centrifugation alone does not 
provide the resolution achieved using a mixture of phthalate esters, however the latter method 
provides only two fractions per centrifugation.8 The methodologies using Stractan 
(arabinogalactan) and/or Percoll (colloidal silica particles coated with polyvinylpyrrolidone) 
gradients provide an improved migration of the RBC according to their actual density.15–18 
Besides density separation, aging RBCs can be also separated by size, using counterflow 
centrifugation (elutriation).19 
While transferrin-bound iron represents the iron transport compartment, erythrocyte iron 
represents the Hb-bound iron, which provides information on the functional iron 
compartment. A clear link has been established between an individual’s iron status and the 
isotopic composition of the iron in human blood and serum.20–22 The intestinal absorption and 
transfer of iron from the blood into the liver (for storage purposes) seem to be the main 
sources of Fe isotopic fractionation.23,24 The goal of this pilot study was to evaluate the 
isotopic variations of iron in density-separated fractions of erythrocytes and the potential 
effect of in vivo erythrocyte aging on the Hb-bound iron isotopic composition. For this 




6.2.1 Materials and reagents 
Ultrapure water (resistivity ≥ 18.2 MΩ cm) was obtained from a Milli-Q Element water 
purification system (Millipore, France). Pro analysis grade 14 M nitric acid (Pro-Labo, 
Belgium) was further purified by sub-boiling distillation in PFA equipment (PicoTrace, 
Germany). Optima grade 12 M hydrochloric acid used in the chromatographic separation was 
obtained from Fisher Chemicals (UK). Ultrapure 9.8 M hydrogen peroxide used for sample 
preparation was acquired from Sigma-Aldrich (Belgium). Dibutyl phthalate (99%,                  
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 = 1.043 g mL-1) and dimethyl phthalate (99%,  = 1.190 g mL-1) were purchased from 
Janssen Chimica (Belgium). 
The Fe isotopic reference material IRMM-014 (Institute for Reference Materials and 
Measurements, IRMM, Belgium) was used for external correction in a standard-sample 
bracketing approach. The elemental Fe standard solution, further referred to as A&MS-Fe, 
(Inorganic Ventures, The Netherlands; lot D2-FE03110), previously characterized 
isotopically22, was used as an in-house standard to monitor the quality of the isotope ratio 
measurements. Single-element standard solutions used for quantification purposes and Ni 
single-element standard solution (lot G2-Nl02086), used as an internal standard for correction 
for instrumental mass discrimination, were prepared from commercially available 1 g L-1 
stock solutions (Inorganic Ventures, The Netherland). 
AG MP-1 strong anion exchange resin (100-200 mesh) purchased from Bio-Rad (CA, USA) 
was used for Fe chromatographic isolation. 
 
6.2.2 Samples and sample preparation 
Whole blood samples of supposedly healthy individuals (1 female of 29 years and 1 male of 
45 years) were obtained from the Ghent University Hospital (Belgium). Ethical approval was 
obtained for this research from an independent commission connected to the Ghent University 
Hospital. 
Venous blood was sampled by venipuncture in EDTA vacutainer tubes suitable for trace 
element analysis and immediately centrifuged (3000 rpm for 10 min at 4C). The supernatant 
plasma and leukocyte-rich buffy coat were gently aspirated using a Pasteur pipette. Part of the 
plasma was kept in a pre-cleaned 15 mL metal-free tube for further centrifugation and the rest 
was discarded. The total volume whole blood occupied by the erythrocytes was 
approximately 45% for each sample. 
An aliquot of 50 µL of erythrocytes obtained from each individual was placed into a pre-
cleaned Teflon Savillex® beakers for further acid digestion and used as a control sample 
(isotopic composition of the total erythrocyte fraction). The erythrocytes were separated 
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according to their density using two different methods (Fig. 6-1): by direct high-speed 
centrifugation (Method A) and by using a mixture of phthalates (Method B). 
Method A of erythrocyte separation was based on simple centrifugation. The erythrocyte cells 
were re-suspended in plasma and this mixture was subjected to centrifugation in an angled 
rotor (to facilitate circulation of the tube content) as first described by Murphy.12 After 
centrifugation at 4C and separation of the buffy coat, as described above, the cells were re-
suspended in plasma a second time. After a second centrifugation, the plasma and leukocyte-
rich buffy coat were removed. The 1 mL of cells thus obtained were placed in two pre-cleaned 
2 mL Eppendorf tubes (Eppendorf AG, Germany, lot E163631P) as analytical replicates. 
Separation was accomplished by centrifuging the tubes for 15 min at room temperature 
(10000 rcf, Eppendorf 5415D Centrifuge, Eppendorf AG, Germany). The remaining plasma 
was carefully aspirated and discarded, and the target fractions were carefully removed. The 
fractions were taken as the top 10% (v/v) (young cells) and bottom 10% (v/v) (senescent 
cells), while the remainder was considered as middle aged cells. 
 
Fig. 6-1 A schematic illustration of the methods used for RBCs separation according to their density. 
Method B was based on erythrocyte separation according to their density using phthalate 
esters as separation solutions.8,11,14 Phthalate oil mixtures of well-defined density were 
prepared by mixing two phthalate eaters, dibutyl phthalate and dimethyl phthalate, to achieve 
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densities of 1.094 and 1.110 g mL-1 at 20C for separation of young and senescent cells, 
respectively. The specific gravities were chosen according to previous works.8,14,25 0.5 mL of 
phthalate mixture with a specific gravity was added to 1 mL of erythrocytes and the mixture 
was centrifuged for 10 min at room temperature (10000 rcf, Eppendorf 5415D Centrifuge, 
Eppendorf AG, Germany). The target fractions were carefully pipetted from above or under 
the phthalate mixture layer. In Fig. 6-2, the separated senescent (bottom fraction) and young 
(top fraction) erythrocyte fractions are shown. 
The separated fractions (~20-50 µL) and control samples were placed in Savillex® PFA 
beakers and digested at 110 ºC overnight (~16 h) using 2 mL of 14 M HNO3 and 500 µL of 
9.8 M H2O2. The digests obtained were evaporated to dryness and then re-dissolved in 500 µL 
of 6 M HCl + 0.001% H2O2 for chromatographic isolation of Fe. 
 
Fig. 6-2 Separated fractions of senescent (a) and young (b) erythrocytes using the mixture of phthalates with 
specific densities of 1.110 and 1.094 g mL-1 at room temperature, respectively. 
The chromatographic separation was performed according to Anoshkina et al.26 In brief, 1 mL 
pipette tips were filled with 0.5 mL of AG MP-1 (100-200 mesh) strong anion exchange resin. 
A piece of cotton was placed as bed support and as stopper. The resin was pre-cleaned with, 
subsequently, 500 μL of 7 M HNO3, 2 mL of Milli-Q water, 2 mL of 0.7 M HNO3 and 2 mL 
of Milli-Q water and conditioned with 4 mL of 6 M HCl + 0.001% H2O2. After sample 
loading, the matrix components were eluted from the column in two steps, firstly with 2 mL 
of 9 M HCl and secondly with 5 mL of 6 M HCl + 0.001% H2O2. The Fe fraction was then 
eluted with 6 mL of 1 M HCl and collected in a 15 mL Teflon Savillex® beaker. The purified 
Fe fraction was evaporated to dryness at 90 ºC to remove residual chlorides and re-dissolved 
in concentrated HNO3. This procedure was repeated twice. The final residue was re-dissolved 
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in 500 μL of 0.42 M HNO3. An in-house A&MS-Fe standard and procedural blank, treated in 
the same way as the samples, were included in each batch of samples. The separation of 
erythrocytes was carried out in the laboratory of the Department of Clinical Biology, 
Microbiology and Immunology at the Ghent University Hospital and all further sample 
manipulations were carried out in a class-10 clean room at the Department of Analytical 
Chemistry of Ghent University. 
 
6.2.3 Instrumentation and measurements  
A Thermo Scientific Neptune MC-ICP-MS instrument (Germany) equipped with a large dry 
interface pump (130 m3 h-1 pumping speed) and high-transmission ‘jet’ Ni interface cones 
(‘jet’ sampling cone and X-type skimmer cone) was used for Fe isotope ratio measurements. 
A PFA concentric nebulizer (100 μL min-1) mounted onto a double spray chamber with 
cyclonic and Scott-type sub-units was used for sample introduction into the plasma. 
Measurements were performed at medium mass resolution (pseudo mass resolution27), in 
static collection mode, using six Faraday collectors connected to 1011 Ω amplifiers. 
Instrument settings and data acquisition parameters are shown in Table 6-1 (A). Ni was used 
as an internal standard at the same concentration level as the target element (300 μg L-1). The 
in-house A&MS-Fe isotopic standard solution was included in the sequence after each 5 
samples to check quality of the isotope ratio measurements. All solutions (in-house A&MS-
Fe standard and samples) were measured in duplicate. 
The isotopic composition of the samples is expressed in delta notation (56Fe and 57Fe, ‰) 
relative to the reference material IRMM-014 and calculated as follows (eqn. (6-1)), where x is 






− 1) (6-1) 
Mass bias correction was performed through a combination of internal correction with 
admixed Ni relying on the Russell’s law (using a regression line to establish the correlation 
between the correction factors for Fe and Ni) and external correction in a sample-standard 




Table 6-1. Instrument settings and data acquisition parameters for (A) the Neptune MC-ICP-MS instrument and 
(B) the Element XR SF-ICP-MS instrument. 
A. MC-ICP-MS Neptune  
 
RF power (W) 1275 
Guard electrode Connected 
Sample and skimmer cones Jet sampler and X-type skimmer, Ni, 1.1 and 0.8 mm orifice 
diameter, respectively 
Lens settings Optimized for maximum Fe+ signal intensity 
Ar flow rates (L min-1):   
plasma gas 15 
auxiliary gas 0.75 
nebulizer gas 0.9-1.0 
Sample uptake rate (μL min-1) 100 
Resolution mode Medium (pseudo) 
Acquisition mode Static; multi-collection 
Number of blocks 9 
Number of cycles 5 
Integration time (s) 4.194 
Cup configuration L4: 54Fe; L2: 56Fe; L1: 57Fe; C: 58(Fe + Ni); H1: 60Ni; H3: 62Ni 
B. SF-ICP-MS Element XR  
RF power (W) 1250 
Guard electrode Connected 
Sample and skimmer cones Ni, 1.1 mm and 0.8 mm orifice diameter 
Lens settings Optimized for maximum Fe+ signal intensity 
Ar flow rates (L min-1):  
plasma gas 15 
auxiliary gas 0.8-0.9 
nebulizer gas 1.0-1.1 
Sample uptake rate (μL min-1) 200 
Resolution mode Low, medium, high  
Nuclides monitored 23Na (LR), 44Ca (MR), 54,56,57,58Fe (MR), 52Cr (MR), 39K (HR), 
63,65Cu (MR), 64,66Zn (MR), 60Ni (MR), 69Ga (LR, MR, HR)  
Acquisition mode E-scan 
Dwell time per point (ms) 10 
Point per peak 20 
Number of runs 5 
Number of passes 5 
A Thermo Scientific (Germany) Element XR single-collector sector-field ICP-MS instrument 
was used for determination of element concentrations. For the introduction of sample into the 
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plasma, a 200 μL min-1 quartz concentric nebulizer mounted onto a cyclonic spray chamber 
was used. The instrument settings and data acquisition parameters used are summarized in 
Table 6-1 (B). External calibration was performed and Ga was used as an internal standard to 
correct for matrix effects and instrument instability. 
 
6.3 RESULTS AND DISCUSSION 
6.3.1 Analytical method validation 
Sample preparation 
The sample preparation procedure of the biological samples entailed an acid digestion and 
further Fe isolation using anion exchange chromatography to minimize spectral and non-
spectral interferences. A blank and in-house A&MS-Fe isotopic standard were included in 
each set of samples. Element determinations were carried out using SF-ICP-MS in all samples 
and standards before and after the isolation procedure. The recoveries of Fe were quantitative 
in all cases (96 ± 5 %, n = 23), ensuring absence of on-column isotope fractionation. The 
efficiency of the anion exchange chromatography procedure was evaluated by monitoring 
matrix elements, such as Na, Ca, K, Cr in each fraction after isolation. In all cases, the 
concentrations were lower than 0.5 mg L-1 for major matrix elements such as Na and K and 
negligible compared to the Fe concentration in erythrocytes (~ 800 mg L-1). The use of 
medium resolution allows to avoid any effect of the occurrence of Ar-containing polyatomic 
ions on the Fe+ ion signals (spectral overlap). 
The iron content in the phthalate esters used for the separation of the erythrocytes was 
evaluated. The contribution was 72 μg L-1 and 79 μg L-1 from the dimethyl and dibutyl 
phthalates, respectively. This contribution of iron was not significant relative to the iron 
amount in the erythrocytes. 
The contribution of the procedural blanks, treated in the same way as the samples, was less 
than 0.1%. As a result, the maximum bias observed between the results with and without 
blank correction was 0.007 and 0.014 ‰ for 56Fe and 57Fe, respectively. This maximum 
difference was within two times the standard deviation and thus, no blank correction was 
done before mass bias correction. 
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Isotope ratio measurements 
The repeatability and reproducibility of the isotope ratio measurements by MC-ICP-MS were 
evaluated using the A&MS-Fe in-house standard. The repeatability, expressed as two times 
the standard deviation for 14 replicates of the A&MS-Fe in-house standard within one 
measurement session, was 0.06 and 0.10‰ for 56Fe and 57Fe, respectively. The results 
obtained during a 22 h measurement session fall on the normal mass-dependent fractionation 
line (57Fe = 1.48 56Fe), demonstrating absence of spectral overlap. 
The reproducibility, expressed as two times the standard deviation for the A&MS-Fe in-house 
standard over a period of one year (as intermediate precision), was 0.06 and 0.07‰ for 56Fe 
and 57Fe (n = 116), respectively, and for a period of three years (as a long term precision) 
was 0.07‰ and 0.12‰ for 56Fe and 57Fe (n = 256), respectively.  
Table 6-2. Fe isotopic composition of cell fractions obtained using centrifugation only (method A) and using the 
separation procedure with phthalate esters (method B). Delta Fe values are expressed as the average of two 
measurement replicates (in ‰). The absolute deviation between the two measurement values has also been 









Female control  -2.47 0.03  -3.58 0.04 








young  -2.49 0.005  -3.66 0.01 
middle  -2.48 0.005  -3.69 0.01 
senescent  -2.48 0.03  -3.64 0.005 
Aliquot 2 
young  -2.46 0.02  -3.63 0.02 
middle  -2.53 0.015  -3.66 0.02 








young  -2.46 0.02  -3.63 0.04 
senescent  -2.46 0.01  -3.61 0.02 
Aliquot 2 
young  -2.51 0.02  -3.65 0.05 
senescent  -2.44 0.005  -3.57 0.03 
Aliquot 3 
young  -2.47 0.03  -3.60 0.015 






young  -2.60 0.015  -3.84 0.03 
senescent  -2.67 0.01  -3.90 0.02 
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6.3.2 Iron isotopic composition of erythrocytes  
On average, the senescent cell fractions show an Fe concentration that is 8% higher than those 
of the young cells. The average Fe isotopic composition of erythrocytes acquired using the 
two separation methods and control samples are presented in Table 6-2.  
A graphical representation of the Fe isotopic composition in the different cell fractions 
acquired from one subject (female) is shown in Fig. 6-3. The 56Fe value of the control 
sample from the female subject (overall erythrocyte Fe isotopic composition) was                   
-2.47 ± 0.06 ‰ (two times the standard deviation). The average 56Fe value and two times the 
standard deviation obtained for the young and senescent cell fractions were -2.48 ± 0.03 and   
-2.48 ± 0.01 ‰, respectively, using Method A (centrifugation only) and -2.48 ± 0.05 and        
-2.44 ± 0.03 ‰, respectively, using Method B (phthalates mixture). Two-way ANOVA at a 
5% significance level (JMP statistical software, version 12.1.0, SAS Institute Inc., Cary, NC, 
USA) showed that there was no significant difference, neither between the values for the 
young and the senescent fractions of RBC nor as a function of the separation method used.  
 
Fig. 6-3 Fe isotopic composition of erythrocyte fractions obtained from one individual and separated according 
to cell density using centrifugation only (method A) and using the separation procedure with phthalate esters 
(method B). The solid line indicates the isotopic composition of the total erythrocyte fraction (control sample) 
and the dashed lines indicate two times the corresponding standard deviation. 
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In Fig. 6-4, a three-isotope plot of iron (δ57Fe vs δ56Fe) is presented for the RBC fractions 
obtained. All data points define a single mass fractionation curve, the slope of which matches 
the theoretical value (1.48 according to exponential law), therefore demonstrating absence of 
spectral overlap. 
 
Fig. 6-4 Three-isotope plot constructed based on measurement results for separated RBCs fractions. The solid 
line indicates the linear regression line and the dashed lines correspond to 95% confidence interval for the line.  
These results obtained in this preliminary study suggest that the Fe isotopic composition of 
erythrocytes does not change within their lifespan. Therefore, the main source of isotopic 
fractionation is coming from the intestinal iron absorption, with preferential uptake of lighter 
iron isotopes, and from the transfer of iron under the form of ferritin in liver hepatocytes, 
which are known to be enriched with heavier iron isotopes. This finding is in concordance 







In this preliminary study, the erythrocytes were separated according to their density using two 
methods, based on centrifugation only and on using a mixture of phthalates. The results 
obtained for the young and senescent red blood cells suggest absence of differences in the Fe 
isotopic composition between them. Thus, the in vivo aging process of the enterocytes does 
seem to influence the Fe isotopic composition of whole blood. This supports the hypothesis 
that Fe fractionation mainly occurs during intestinal absorption and during the transfer of iron 
to the liver as main iron storage location, under the form of ferritin in the liver hepatocytes. 
All Fe isotope ratio data plot on a single mass-fractionation line, indicating the suitability of 
the analytical method. 
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7.1 ABSTRACT 
Chronic kidney disease (CKD) is a general term for disorders that affect the structure and 
function of the kidneys. Iron deficiency (ID) and anemia occur in the vast majority of CKD 
patients, most of whom are elderly. However, establishing the cause of anemia in CKD and 
therefore, making an informed decision concerning the corresponding therapeutic treatment is 
still a challenge. High-precision Fe isotopic analysis of blood serum samples of CKD patients 
with and without ID/anemia was explored via multi-collector inductively coupled plasma-
mass spectrometry (MC-ICP-MS) for such purpose. Patients with CKD and/or iron disorders 
showed a heavier serum Fe isotopic composition than did controls. Many clinical parameters 
used for diagnosis and follow-up of anemia correlated significantly with the serum Fe isotopic 
composition. In contrast, no relation was observed between the serum Fe isotopic composition 
and the estimated glomerular filtration rate as a measure of kidney function. Among the CKD 
patients, the serum Fe isotopic composition was substantially heavier in the occurrence of ID 
anemia, while erythropoietin-related anemia did not exert this effect. The Fe isotopic 
composition can thus be useful for distinguishing these different types of anemia in CKD 




Impaired kidney function can occur due to (i) a kidney injury or acute renal failure caused by 
dehydration, extensive blood loss and/or the use of medicines or (ii) long-term damage of the 
kidneys (chronic kidney disease, CKD) caused by a variety of reasons.1 CKD is generally 
associated with multiple comorbid conditions, such as anemia, cardiovascular diseases, 
mineral misbalances, diabetes mellitus, and a disturbed bone metabolism. Variations in the 
CKD expression depend on its cause and pathology, severity and rate of progression.2 At an 
early stage, the disease is often asymptomatic and detected during examination for other 
purposes only.3 The prevalence of CKD is considerably higher in the elderly; more than 30% 
of the end stage renal disease patients are 70 years or older.3–7 The combination of the 
deteriorating overall health condition in the old age and the silent condition of CKD 
complicates the diagnosis and determination of the cause(s) of the disease. The definition of 
CKD is typically based on the presence of kidney damage, as detected by an increased urinary 
albumin excretion (> 30 mg per day), and a decreased kidney function during 3 or more 
months, as established by monitoring the estimated glomerular filtration rate (eGFR).2 The 
eGFR is calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-
EPI) equation, which is based on the serum creatinine level, adjusted for gender and race and 
expressed in mL min-1 per 1.73 m².8 Significant kidney dysfunction may be present despite a 
normal serum creatinine level because the latter can also be affected by many factors that are 
independent of kidney injury or kidney function (such as age, gender, race, muscle mass, 
nutritional status, infection and use of some types of medication).9–11 Therefore, the eGFR is 
considered a more reliable clinical parameter for establishing the stage of CKD. According to 
the guidelines of The Kidney Disease: Improving Global Outcomes (KDIGO) organization, 
the stages of CKD based on eGFR values are: ≥ 90 (stage 1), 60-89 (stage 2), 45-59 (stage 
3a), 30-44 (stage 3b), 15-29 (stage 4), and  15 mL min-1 per 1.73 m² (stage 5).12  
The vast majority of CKD patients develop iron deficiency (ID) and anemia.13 ID can occur as 
a result of malnutrition (decreased dietary iron intake), malabsorption, blood loss during 
hemodialysis, frequent blood sampling, gastrointestinal bleeding, multiple vascular access 
surgeries, hepcidin fluctuations, etc,14 resulting in a reduction of the serum iron concentration 
and transferrin saturation (TSAT), while the erythroid iron level is still preserved.13,15 
Persistent ID leads to iron deficiency anemia (IDA) as a more severe condition, characterized 
by a reduction in total body iron content and in erythrocyte production.13,15,16 IDA can be 
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caused by true iron deficiency, e.g., in cases with blood loss from hemodialysis or blood 
sampling, low nutritional iron content or malabsorption.16,17 However, IDA can also be 
caused by inflammation, where iron stores can be normal, but the iron is not available for 
erythropoiesis. This situation is termed functional ID, which is a major component of anemia 
of chronic disease (ACD).18 Another common cause of anemia in CKD is the impaired 
production of erythropoietin (EPO) as a result of kidney damage and/or decreased kidney 
function and, as consequence, a decreased production of RBC precursors in the bone marrow, 
leading to a reduced level of erythroid iron.5,13,15,16,19 Patients with this type of anemia 
(sometimes also termed non-IDA) show a normal iron store and supply. The diagnostic 
criteria for ID and anemia vary between published studies.13,17,20–26 Based on a compilation of 
data available in the literature, the diagnostic cut-off value for anemia used in this study was 
established at ≤ 12.5 g dL-1 for hemoglobin (Hb) for males, while that for ID was a         
TSAT ≤ 20%.  
The presence of ID and anemia aggravates the progression of kidney disease16 and specific 
treatments are required depending on the underlying causes. However, the determination of 
the cause of anemia in CKD and thus, making adequate decisions concerning the patient’s 
treatment, is still a challenge. In general, routine diagnostic tests have low specificity. For 
instance, the level of ferritin, traditionally used as a measure of the iron store, increases with 
age (or more accurately with the iron accumulation) and as a result of chronic inflammatory 
disorders.27 About 50% of the patients following EPO-therapy do not reach a normal Hb level 
due to the presence of ID and/or functional ID.12 
Recently, it has been demonstrated that the Fe isotopic composition of whole blood can be 
useful to assess a healthy individual’s iron status.28–30 In addition, patients suffering from 
hereditary hemochromatosis (HH), showed a heavier whole blood Fe isotopic composition 
than did a gender-matched reference population,28,29,31 while patients suffering from ACD 
showed a lighter whole blood Fe isotopic composition.29 The isotopic analysis of blood 
serum, wherein transferrin is the main carrier of iron, is interesting due to its higher iron 
turnover rate (< 5 days) than that of whole blood erythrocytes (~120 days). 
This study investigated the potential use of the serum Fe isotopic composition for revealing 
iron metabolism changes in CKD patients and for distinguishing between different types of 
anemia, such as IDA and EPO-related anemia. High-precision Fe isotopic analysis was 
accomplished via multi-collector inductively coupled plasma-mass spectrometry (MC-ICP-
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MS) after acid digestion and chromatographic isolation of the target element. The relation 
between the serum Fe isotopic composition and relevant clinical parameters used for 
diagnosis and monitoring of CKD and iron disorders was evaluated. 
 
7.3 EXPERIMENTAL 
7.3.1 Materials and reagents 
Ultrapure water (resistivity ≥ 18.2 MΩ cm) was obtained from a Milli-Q Element water 
purification system (Millipore, France). Pro analysis grade 14 M nitric acid (Pro-Labo, 
Belgium) was further purified by sub-boiling distillation in PFA equipment (PicoTrace, 
Germany). Optima grade 12 M hydrochloric acid used in the chromatographic separation was 
obtained from Fisher Chemicals (UK). Ultrapure 9.8 M hydrogen peroxide used for sample 
preparation was acquired from Sigma-Aldrich (Belgium).  
The Fe isotopic reference material IRMM-014 (Institute for Reference Materials and 
Measurements, IRMM, Belgium) was used for instrumental mass discrimination in a 
standard-sample bracketing approach. The elemental Fe standard solution (Inorganic 
Ventures, The Netherlands; lot D2-FE03110), previously characterized isotopically,32 was 
used as an in-house reference to monitor the quality of the isotope ratio measurements. 
Single-element standard stock solutions (Inorganic Ventures) used for quantification purposes 
and Ni single-element standard solution (Inorganic Ventures, The Netherlands; lot G2-
Nl02086), used as an internal standard for correction of instrumental mass discrimination, 
were prepared from commercially available 1 g L-1 stock solutions. SeronormTM Trace 
Elements Serum L-1 reference material (SERO AS, Norway, lot 0903106) was used for 
method validation. 
Polypropylene chromatographic columns filled with AG MP-1 strong anion exchange resin 






A total of 82 serum samples from males (55-84 years), acquired from the Ghent University 
Hospital, were analyzed. 44 serum samples were from patients suffering from CKD before 
undergoing dialysis (stages 3a, 3b, 4 and 5) without chronic inflammation. Among these 
samples, 14 were from patients with CKD without ID or anemia, 9 from patients with CKD 
and ID, 10 with CKD and EPO-related anemia, and 11 from patients with CKD and IDA 
(Table 7-1). 6 samples were obtained from patients with only ID and 7 with IDA (no CKD). 
Patients with chronic inflammation (i.e. ACD) were not included in this study. The gender-
matched reference population was composed of 25 serum samples from supposedly healthy 
individuals. Patients and control group did not receive EPO treatment or iron 
supplementation. This research project was approved by an independent commission for 
medical ethics connected to the Ghent University Hospital and was performed in accordance 
with the guidelines for good clinical practice and the statement of Helsinki, emplaced to 
protect volunteers participating in experiments. All individuals signed an informed consent 
form concerning this study. 
 
7.3.3 Sample preparation 
Venous blood was drawn between 0900 and 1000 h, allowed to clot, and centrifuged (1000 g 
for 10 min at room temperature). In order to avoid variations in the serum Fe isotopic 
composition related to dietary iron intake, all samples were collected from individuals in 
fasted state.33 The supernatant serum was collected for analysis and was split into two 
aliquots, one for the determination of the clinical parameters (at Ghent University hospital) 
and another of about 500 µL for Fe isotopic analysis (at the Department of Analytical 
Chemistry). The main biomedical indicators of iron status and kidney function are provided in 
Appendix A. Samples were stored at -20 ºC in pre-cleaned Eppendorf tubes until sample 
preparation. 
Ferritin was assayed using electrochemiluminescence immunoassay on a Roche Modular E 
170 analyzer (Roche Diagnostics). Serum sTfR was assayed by fixed-time 
immunonephelometry on a BN II nephelometer (Siemens). Transferrin saturation was 
calculated from measurements of the serum iron concentration by spectrophotometry 
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(ferrozine method) and the serum transferrin concentration by immunoturbidimetry using 
commercial reagents on a Cobas 8000 analyzer (Roche Diagnostics). Assuming that two iron 
atoms bind to one molecule of transferrin, the serum transferrin saturation (%) was calculated 
according to equation 7-134: 
(
𝑆𝑒𝑟𝑢𝑚 𝑖𝑟𝑜𝑛 (µ𝑚𝑜𝑙 𝐿−1)
𝑆𝑒𝑟𝑢𝑚 𝑡𝑟𝑎𝑛𝑠𝑓𝑒𝑟𝑟𝑖𝑛 (𝑔 𝐿−1)
) × 3.98 (7-1) 
For isotopic analysis, the serum samples were digested in Savillex® PFA beakers using 2 mL 
of 14 M HNO3 and 0.5 mL of 9.8 M H2O2 at 110 ºC overnight (16 h). The digest thus 
obtained was evaporated to dryness and the residue was re-dissolved in 5 mL of 8 M HCl + 
0.001% H2O2 and submitted to the chromatographic isolation procedure. 
Fe isolation was accomplished using a modified protocol of Maréchal et al.35 and Van Heghe 
et al.32 Bio-Rad Poly-Prep columns were filled with1 mL of AG MP-1 (100-200 mesh) strong 
anion exchange resin. The resin was pre-cleaned with, subsequently, 3 mL of 7 M HNO3, 5 
mL of Milli-Q water, 5 mL of 0.7 M HNO3 and 5 mL of Milli-Q water and conditioned with 5 
mL of 8 M HCl + 0.001% H2O2. After sample loading, the matrix was eluted with 3 mL of 8 
M HCl + 0.001% H2O2; next, Cu was eluted with 9 mL of 5 M HCl + 0.001%H2O2. Finally, 
Fe was eluted with 7 mL of 0.7 M HNO3 and this fraction was collected in a Teflon Savillex
® 
beaker. The Fe fraction was evaporated to dryness at 90 ºC to remove residual chloride and 
re-dissolved in concentrated HNO3. This procedure was repeated twice. The final residue was 
re-dissolved in 500 µL of 0.42 M HNO3. A procedural blank, treated in the same way as the 
samples, was included in each batch of samples. All sample manipulations were carried out in 
a class-10 clean room. 
 
7.3.4 Instrumentation and measurements  
A Thermo Scientific Neptune MC-ICP-MS instrument (Germany) was used for Fe isotope 
ratio measurements. The sample introduction system consisted of a 100 μL min-1 PFA 
concentric nebulizer and a high-stability dual spray chamber with cyclonic and Scott-type 
sub-units. Medium mass resolution (pseudo mass resolution36) was used to be able to measure 
the Fe+ signal intensities free from spectral overlap. Measurements were performed in static 
collection mode, using six Faraday collectors connected to 1011 Ω amplifiers. Instrument 
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settings and data acquisition parameters are shown in the Supplementary Information     
(Table 7-S1). Procedural blanks were measured at the beginning of the measurement session 
to evaluate their contribution to the Fe+ signal intensities. An in-house Fe standard solution, 
previously characterized isotopically,32 was measured every 5 samples to monitor the quality 
of the isotopic measurements. All solutions were doped with Ni as internal standard. The 
concentrations of Fe and admixed Ni were adjusted to 300 µg L-1 in all samples and isotopic 
standards. Mass bias correction relied on a combination of external correction in a sample-
standard bracketing approach (SSB) and internal correction with Ni using the Baxter-revised 
Russell’s law.37 The isotope ratios were obtained after the 2s-rejection of outliers. The 
isotopic composition is expressed in delta notation (56Fe and 57Fe, ‰) and calculated 






− 1) (7-2) 
A Thermo Scientific Element XR sector field ICP-MS instrument (Germany) was used for 
quantitative determination of the Fe concentration of the samples for quality control purposes 
(see section 7.4.1). For sample introduction into the plasma, a 200 μL min-1 quartz concentric 
nebulizer mounted onto a cyclonic spray chamber was used. The instrument settings and data 
acquisition parameters are shown in Supplementary Information (Table 7-S1). External 
calibration (calibration curve) was relied on for quantification, combined with Ga as an 
internal standard to correct for matrix effects and instrumental instability.  
 
7.3.5 Statistical Methods 
IBM® SPSS Statistics 23 (SPSS Inc. Chicago Illinois, USA) and GraphPad Prism®(GraphPad 
Software Inc., CA, USA) packages for Windows were used for the statistical analysis of the 
data. The non-parametric Kruskal-Wallis test was used for comparison of the results obtained 
for the different groups of patients. Bivariate analysis was used for assessing potential 
correlations between the serum Fe isotopic composition and a series of clinical parameters. 
Multiple regression analysis was performed to identify the parameters governing the serum 
iron isotopic composition variability. 
 
171 
7.4 RESULTS AND DISCUSSION 
7.4.1 Method validation 
Reliable Fe isotope ratio measurements of blood serum by MC-ICP-MS require the efficient 
decomposition of the matrix by acid digestion, and isolation of the target element to minimize 
spectral and non-spectral effects. Both steps have to be performed without Fe isotope 
fractionation and to assure this, a quantitative Fe recovery is mandatory. In each set of 
samples, an in-house Fe standard, the SeronormTM Trace Elements Serum L-1 reference 
material and a blank were included. The quantitative determination of Fe via sector field ICP-
MS was performed before and after the isolation procedure. The recoveries of Fe were 
quantitative in all cases (99 ± 5%). The presence of matrix elements, potentially interfering 
with the Fe isotope ratio measurements, such as Cr, Ca, and K, were determined in the 
purified Fe fractions. The content of these elements was negligible in all samples after 
chemical separation. The procedural blank was ≤ 1 % of the Fe concentration present in the 
serum samples. The differences between the results with and without blank correction were 
0.05 and 0.07‰ for δ56Fe and δ57Fe, respectively and thus, no blank correction was 
performed. 
The combined uncertainty obtained for Seronorm reference material during one year was 0.03 
and 0.12‰ for 56Fe and 57Fe, respectively (n = 9). All results fall on the normal mass-
dependent fractionation line (57Fe = 1.48·56Fe), demonstrating absence of spectral overlap. 
 
7.4.2 Fe isotopic composition in serum samples  
The blood serum samples originated from patients suffering from CKD with and without ID, 
IDA or EPO-related anemia, from patients with ID and IDA without CKD and from 
supposedly healthy individuals. Thus, 7 groups of patients were established on the basis of 
their clinical condition (Table 7-1). The serum Fe isotopic composition obtained for each 
group, expressed in delta notation and calculated against the IRMM-014 reference material, is 
presented in Table 7-1.  
The reference population was formed by 18 aged male individuals (55-84 years) and 7 young 
males (30 years) without inflammation, kidney disease and iron disorders. Since no 
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significant differences were observed between the aged and young cohorts (56Fe values of     
-2.68 ± 0.21‰ and -2.64 ± 0.13‰, respectively), these 25 individuals were considered as 
reference population. This is in concordance with an earlier reported finding for whole blood 
samples from male individuals.28,38 The median 56Fe value obtained for the reference 
population (after removal of one outlier, using the 2s-criterion) was -2.67 ± 0.20 ‰. 
Table 7-1. Isotopic composition of Fe in blood serum from a reference population and from patients with CKD 
and/or a disorder of iron metabolism. Fe values are expressed as median  interquartile range; p is the level of 
significance from the Kruskal-Wallis test that was used to compare each group patients to the reference 
population. 
Diagnosis Description 56Fe 57Fe n p 
Reference population 
eGFR > 90 mL/min/1.73 m²  
Hb > 12.5 g dL-1 
20% < TSAT < 45% 
-2.67 ± 0.20 -3.90 ± 0.38 24  
CKD, no anemia, no ID 
eGFR < 60 mL/min/1.73 m²  
Hb > 12.5 g dL-1 
20% < TSAT < 45% 
-2.34 ± 0.35 -3.35 ± 0.56 13 0.0023 
CKD, no anemia, ID 
eGFR < 60 mL/min/1.73 m²  
Hb > 12.5 g dL-1 
TSAT < 20% 
-1.87 ± 0.52 -2.85 ± 1.04 9 0.0006 
CKD, EPO-related 
anemia, no ID 
eGFR < 60 mL/min/1.73 m²  
Hb < 12.5 g L-1 
20% < TSAT < 45% 
-2.47 ± 0.37 -3.46 ± 0.58 10 0.0058 
CKD, IDA 
eGFR <60 mL/min/1.73 m²  
Hb < 12.5 g dL-1 
TSAT < 20% 
-1.36 ± 0.57 -2.13 ± 0.45 11 < 0.0001 
ID (no CKD) 
eGFR > 90 mL/min/1.73 m²  
Hb > 12.5 g dL-1 
TSAT < 20% 
-2.02 ± 0.36 -2.90 ± 0.81 5 0.0021 
IDA (no CKD) 
eGFR > 90 mL/min/1.73 m²  
Hb < 12.5 g dL-1 
TSAT < 20% 
-1.29 ± 0.67 -1.81 ± 0.78 7 < 0.0001 
The median 56Fe value for the overall population of CKD patients was -2.01 ± 0.50 ‰, that 
is +0.66‰ higher than for the reference population. Fig. 7-1 provides box-plots for the 56Fe 
values of patients suffering from CKD, patients suffering from disorders of iron metabolism 
and a reference population. All patient groups showed a heavier Fe isotopic composition than 
the reference population. The 56Fe values increased (i.e. iron became enriched in the heavier 
iron isotopes) in the following order: reference population < CKD ≈ CKD + EPO-related 




Fig. 7-1 Serum Fe isotopic composition in patients suffering from CKD and iron disorders. The box-plots 
compile the median, quartiles and extreme values. The box-plots are annotated with letters. When two groups 
were given a different letter, there is a significant difference between the corresponding δ56Fe values (p ≤ 0.05). 
The open circles are outliers. 
As can be seen in Table 7-1, the differences between each group and the reference population 
were significant (Kruskal-Wallis test). Among the CKD patients, the groups with ID and IDA 
showed a 56Fe value higher by +0.47‰ and +0.98‰, compared to the CKD group without 
iron disorder. A similar shift towards a heavier serum Fe isotopic composition in the case of 
ID and IDA is also seen in the cohort without CKD (Fig. 7-1). The differences in the 56Fe 
values were +0.65‰ for ID and +1.38‰ for IDA compared to the reference population. The 
IDA group also provided higher 56Fe values than the ID group, as is the case in the CKD 
population. The heavy serum Fe isotopic composition of patients with ID and IDA is 
independent of the renal insufficiency, but is related to the low iron status, characterized by a 
depleted store of iron. This is in agreement with a previously reported finding for whole 
blood.29,31 Iron deficiency in the general population is mainly caused by blood loss and/or 
impaired intestinal absorption of dietary iron with the subsequent reduction in the level of 
serum iron. Isotopically heavier iron stored in the liver or coming from the labile iron pool 
(LIB) is used to compensate for the reduced uptake. Also the iron uptake in the intestine is 
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upregulated, which is accompanied by a lower degree of isotope fractionation (known to favor 
the uptake of the lighter isotopes). 
The serum Fe isotopic composition of the CKD patients with anemia but without iron 
depletion did not significantly differ from that of the CKD group with normal iron 
metabolism (Fig. 7-1). In this case, the anemia is the result of a reduced production of EPO in 
the kidneys and, as a consequence, a downgraded erythropoiesis in the bone marrow without 
shortage of iron supply, and no compensation by heavier iron stores from the liver takes place 
(Tf < 3.6 g/L, 20 < TSAT <50, 54 < Fer < 260 ng mL-1). However, our data also show that in 
patients with CKD stage 3 or higher, heavier Fe isotopes prevail, and this is independent of 
the iron status. In the case of CKD, the blood filtration and reabsorption processes are 
affected, while the disease also might have an effect on the level of components involved in 
iron homeostasis (e.g. hepcidin).39,40 It has been suggested recently that the kidneys are not 
only involved in the synthesis of hepcidin, but also in the elimination of this peptide41,42, 
which can consequently affect intestinal iron absorption and release from store site (LIB, 
macrophages, and hepatocytes).43 The combination of these factors might influence the Fe 
isotope fractionation and therefore to have an effect on the serum Fe isotopic composition. 
However, due to the complicated iron metabolism in patients with CKD,39 further research is 
warranted to explore the source and cause of this shift. 
 
7.4.3 Correlations with clinical parameters  
A timely determination of the causes of anemia is important in the complex therapy of 
patients with stage 3-5 renal disease, especially in the elderly, but this can still be difficult for 
a number of technical and biological reasons.44 There are no specific clinical or biochemical 
parameters to make the differential diagnosis of anemia in patients with CKD stage 3 or 
higher. A large set of biochemical parameters (about 10) are frequently determined for this 
purpose. The clinical conclusion concerning iron status is traditionally based on a 
combination of parameters, related to iron metabolism, and hematologic indices. Correlations 
between the serum Fe isotopic composition and the clinical parameters routinely used for 
diagnosis and follow-up of the CKD progression and those for iron status were evaluated. 
These clinical parameters and a summary of the information they provide are compiled in 
Table 7-2 (the individual correlations are provided in Supplementary Information,              
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Fig. 7-S1-S8). The individual data are provided in the Supplementary Information 
(Supplementary Information, Table 7-S2). Serum EPO measurement was not considered due 
to its poor ability to assess EPO-related anemia. Endogenous EPO is characterized by a short 
biological half-life, making the serum EPO level not very informative due to its biological 
variation.45
Table 7-2. Correlation between the serum Fe isotopic composition and clinical parameters used for the diagnosis 
of CKD and iron disorders. 
Clinical parameter Information 
Correlation 
(95% confidence level) 
Spearman’s rho 
coefficient 
2-tailed level of 
significance  
Serum creatinine (SCr), mg dL-1 Kidney filtration function 0.112 0.299 
Estimated glomerular filtration rate 
(eGFR), mL min-1per 1,73 m² 
Flow rate of fluid filtered 
through the kidney 
-0.250 0.035 
Serum Fe concentration, µg dL-1 
Concentration of circulating 
iron 
-0.671 < 0.0001* 
Hemoglobin (Hb), g dL-1 
Iron-containing oxygen-
transporting metalloprotein in 
the red blood cells 
-0.641 < 0.0001* 
Ferritin (Fer), ng mL-1 Iron storage status -0.705 < 0.0001* 
Transferrin (Tf), g L-1 Body iron requirement 0.632 < 0.0001* 
Total iron-binding capacity 
(TIBC), µg dL-1 
Potential capacity of transferrin 
molecules to bind serum iron 
0.618 < 0.0001* 
Transferrin saturation  
(TSAT), % 
Actual amount of iron bound 
by transferrin 
-0.786 < 0.0001* 
Soluble transferrin receptor 
(sTfR), mgL-1 
Functional iron status 0.716 < 0.0001* 
C-reactive protein  
(CRP), mg L-1 
Inflammation 0.331 0.043 
* Significant correlation 
As can be seen in Table 7-2, no obvious correlations were observed between the Fe isotopic 
composition and the CKD parameters, such as serum creatinine or eGFR. Also with C-
reactive protein (CRP), no correlation was established. In contrast, the serum Fe isotopic 
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composition was clearly correlated with the iron status parameters. Transferrin, the total iron 
binding capacity (TIBC) and the level of soluble transferrin receptor (sTfR) reflect the body´s 
iron requirements. sTfR is related to erythropoiesis and is increased in patients with IDA. 
56Fe values increase when these parameters increase. In the absence of inflammation, ferritin 
and TSAT (calculated based on the serum iron level and the iron-binding capacity), on the 
other hand, reflect the body´s iron store. 56Fe values increase when the levels of ferritin and 
TSAT decrease. Reduced ferritin and TSAT indicate activation of the iron stores to provide 
the required circulating iron and stimulation of intestinal iron uptake. The storage of iron, 
mainly in the liver, is known to be enriched in the heavy Fe isotopes,28,31 while an increased 
intestinal uptake is characterized by a lower level of isotope fractionation, tentatively 
explaining the heavier serum Fe isotopic composition observed for ID and IDA patients 
(with/without CKD). In the case of EPO-related anemia, the uptake of iron from the 
gastrointestinal tract is down-regulated due to an increased hepcidin production and/or 
decreased renal clearance rate.39,46 In addition to the parameters mentioned above, many other 
biochemical indexes are currently explored to evaluate the iron status,20,22,27,44,47–51 such as the 
ratio of sTfR to the logarithm of the ferritin concentration, the ratio of the transferrin level to 
the logarithm of ferritin and the Thomas-plot (reticulocyte hemoglobin content vs the ratio of 
sTfR to the logarithm of the ferritin concentration). Investigation of a bone marrow biopsy is 
the gold standard method to assess stainable iron, but is highly invasive.52 The benefit of the 
sTfR is that its level is unaffected by inflammation or infections, so that it allows to 
discriminate true from functional iron deficiency. The combination of information on the iron 
store (level of serum ferritin) and the Fe supply (soluble transferrin receptor) shows potential 
advantages for discriminating iron deficiency anemia from different other types of anemia, 
however it still can be affected by inflammatory status due to the use of the ferritin 
concentration.47,48 This index correlated significantly with the iron isotopic composition 
(Spearman’s rho coefficient 0.773, p < 0.0001). The higher values of sTfR/log Fer ratio, 
established for CKD patients with ID and IDA, correspond to a heavier serum Fe isotopic 
composition (ranging between -2.35‰ and -0.73‰). 
In Fig. 7-2, a three-isotope plot of Fe (δ57Fe vs δ56Fe) is provided for the CKD patients and 
the reference population. As can be seen, the cohort of CKD patients with ID and IDA is 
clearly separated from those with EPO-related anemia (except one outlier), which coincides 
with the CKD-only cohort.  
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Multiple regression analysis was also performed to reveal the major drivers of the Fe isotope 
ratio variability. It was shown that delta value was only independently related to TSAT         
(β value of -0.026, p = 0.0002), sTfR (β value of 0.24, p = 0.0049) and ferritin (β value of       
-0.001, p = 0.0061). The multiple regression equation obtained was: 
56Fe = -1.81 (± 0.23) - 0.026 (± 0.005)·TSAT + 0.24 (± 0.07)·sTfR – 0.001(± 0.000)·Fer (7-3) 
The Fe isotopic composition in the population studied was governed by the TSAT, sTfR and 
Fer. This equation explained 70.1% of the variability in the Fe isotopic composition. The 
multiple adjusted R2 obtained for the predictors (i.e. TSAT, sTfR and Fer) was 0.84 (F = 53,  
p < 0.000, n = 72) and the standard error of the estimate was 0.36.  
 
Fig. 7-2 Serum Fe isotopic composition for samples from the reference population, CKD patients, CKD patients 
complicated by ID and IDA and CKD patients with EPO-related anemia. The precision expressed as 2 s.d. is 
0.07‰ for δ56Fe and 0.12‰ for δ57Fe.  
Thus, the serum isotopic composition of Fe shows a significant response to iron status in 
CKD. In this pilot study, the serum Fe isotopic composition was demonstrated to be a useful 






High-precision Fe isotopic analysis of blood serum by MC-ICP-MS provided relevant clinical 
information on the iron status of patients with CKD stage 3 or higher. Patients suffering from 
CKD complicated with iron disorders (ID, IDA) showed a significantly heavier serum Fe 
isotopic composition than did patients suffering from CKD only. CKD patients suffering from 
EPO-related anemia did not show a significant difference in serum Fe isotopic composition 
compared to the cohort with CKD only. No significant correlations were found between the 
serum Fe isotopic composition and eGFR or serum creatinine levels, but Fe values showed 
strong positive correlation with Tf, TIBC, and sTfR levels and strong negative correlation 
with serum Fe concentration, Fer, Hb, and TSAT values. The Fe isotopic composition was 
also significantly correlated with sTfR/log Fer index, which is gaining interest as a sensitive 
index for ID/IDA. The factors governing the Fe isotopic composition in the population 
studied were TSAT, sTfR and Fer. The results obtained in this exploratory study indicate that 
Fe isotopic analysis can be a useful complimentary tool for distinguishing between IDA and 
EPO-related anemia in CKD patients. 
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7.9 SUPPLEMENTARY INFORMATION  
Table 7-S1. Instrument settings and acquisition parameters for MC-ICP-MS Neptune (A) and SF-ICP-MS 
Element XR (B) 
(A) Neptune MC-ICP-MS  
RF power (W) 1275 
Guard electrode Connected 
Sample and skimmer cones Thermo jet sampler and X-type skimmer, 1.1 and 0.8 mm of 
orifice diameter, respectively; Ni 
Lens settings Optimized for maximum Fe+signal intensity 
Ar flow-rates (L min-1):plasma gas 15 
auxiliary gas 0.75 
nebulizer gas 0.9-1.0 
Sample uptake rate (μL min-1) 100 
Resolution mode Medium (pseudo) 
Acquisition mode Static; multi-collection 
Number of blocks 9 
Number of cycles 5 
Integration time (s) 4.194 
Cup configuration L4: 54Fe; L2: 56Fe; L1: 57Fe; C: 58(Fe+Ni); H1: 60Ni; H3: 62Ni 
(B) Element XR SF-ICP-MS  
RF power (W) 1250 
Guard electrode Connected 
Sample and skimmer cones Ni, 1.1 mm and 0.8 mm orifice diameter 
Lens settings Optimized for maximum signal intensity 
Ar flow-rates (L min-1):  
plasma gas 15 
auxiliary gas 0.8-0.9 
nebulizer gas 1.0-1.1 
Sample uptake rate (μL min-1) 200 
Resolution mode Low, medium, high 
Acquisition mode E-scan 
Dwell time per point (ms) 10 
Point per peak 20 
Number of runs 5 
Number of passes 5 
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Table 7-S2. Iron isotopic composition and clinical parameters in renal insufficiency and Fe disorders patients. SCr – serum creatinine, eGFR - estimated glomerular filtration 
rate, Hb – hemoglobin, [Fe] – Fe concentration in serum, Fer– ferritin, Tf – transferrin, TIBC - total iron-binding capacity, TSAT - transferrin saturation, sTfR - soluble 





SCr    
mg dL-1 
eGFR mL min-1 
per 1.73 m² 
Hb      
g dL-1 
[Fe]    
µg dL-1 
Fer      
ng mL-1 
Tf         
g L-1 





CRP   
mg dL-1 
CKD,  
no anemia,  
no ID 
1 -2.08 ± 0.03* 1.70 42.9 13.6 90 42 2.39 294 30 1.49 2.4 
2 -2.72 ± 0.01* 2.72 29.8 15.0 - - - - 37 1.15 0.7 
3 -2.34 ± 0.04 2.55 36 15.1 93 91 2.39 294 31 1.67 2.8 
4 -2.54 ± 0.17* 2.05 31.9 14.3 102 95 3 369 27 1.19 5 
5 -2.53 ± 0.11* 2.35 25.5 13.0 76 253 1.94 238 31 1.2 8.3 
6 -2.34 ± 0.04 3.14 17.3 12.7 50 177 1.79 220 22 1.8 6 
7 -2.20 ± 0.08* 2.11 29.7 12.5 86 115 2.21 272 31 1.03 1.1 
8 -2.85 ± 0.05 1.62 40.9 13.1 88 176 2.16 265 32 1.46 2.1 
9 -2.13 ± 0.05 1.58 38.2 13.7 - - - - 31 1.03 3.6 
10 -2.20 ± 0.05* 1.24 53 13.6 91 65 3.06 376 24 1.32 4.2 
11 -2.35 ± 0.12* 1.51 46 14.4 83 54 2.53 311 26 0.82 2.1 
12 -2.17 ± 0.04 1.96 36.2 12.7 73 177 2.64 324 22 1.24 <0.6 
13 -1.30 ± 0.04* 1.89 32.4 12.7 69 125 2.6 319 21 1.89 4.4 




15 -2.02 ± 0.02* 1.65 41.9 13.2 101 42 - - 15 1.92 2.7 
16 -2.35 ± 0.03* 1.69 36.6 14.9 64 91 2.98 366 17 1.73 3.5 
17 -2.35 ± 0.14* 1.78 34.7 13.1 59 46 2.38 292 20 1.68 1 
18 -2.14 ± 0.03 2.19 27 17.7 68 130 3.19 392 17 - 2.5 







SCr    
mg dL-1 
eGFR mL min-1 
per 1.73 m² 
Hb      
g dL-1 
[Fe]    
µg dL-1 
Fer      
ng mL-1 
Tf         
g L-1 





CRP   
mg dL-1 
20 -1.87 ±0.04* 1.43 43 12.7 28 75 3.55 436 6 3.02 11.1 
21 -1.44 ± 0.03 1.31 53 14.5 40 53 3.09 380 11 1.43 11.3 
22 -1.80 ± 0.03 1.31 51 13.1 20 13 3.15 387 5 - 1.8 





24 -1.86 ± 0.04 1.60 39.8 12.1 102 54 2.74 336 30 1.24 3 
25 -2.48 ± 0.05 1.68 38.9 12.3 56 68 2.26 278 20 1.44 0.7 
26 -2.63 ± 0.02* 2.87 21.1 11.6 79 260 2.34 288 27 1.58 - 
27 -2.16 ± 0.03* 1.65 37 10.9 73 - - - 28 1.28 0.1 
28 -2.55 ± 0.13* 1.49 44.5 11.5 119 - - - 28 1.10 1.5 
29 -2.13 ± 0.04 2.19 30.5 11.2 98 220 2.58 317 30 1.05 <0.6 
30 -2.45 ± 0.04 2.49 28.7 11.1 43 - - - 21 2.83 18.5 
31 -2.56 ± 0.05* 2.48 23.3 11.6 66 60 2.72 334 20 1.37 0.2 
32 -2.24 ± 0.04 2.99 18.4 11.7 56 173 2.57 316 32 1.51 2 
33 -2.70 ± 0.05 6.44 8.3 9.9 61 243 2.03 249 24 1.26 0.9 
CKD, IDA 
34 -1.14 ± 0.05 1.73 40.5 10.9 41 33 2.83 348 11 1.76 - 
35 -1.52 ± 0.03 1.95 31 10.8 42 33 3.21 394 10 2.00 14.2 
36 -1.76 ± 0.06 1.67 42.1 11.2 31 - 3.03 372 8 2.74 0.4 
37 -0.73 ± 0.04 2.28 27 8.1 19 23 2.93 360 5 4.00 7.1 
38 -1.79 ± 0.03 2.26 28 10.0 39 10 3.30 405 10 2.23 6.5 
39 -2.09 ± 0.03 1.36 34 11.9 44 177 2.42 297 15 1.37 13 






SCr    
mg dL-1 
eGFR mL min-1 
per 1.73 m² 
Hb      
g dL-1 
[Fe]    
µg dL-1 
Fer      
ng mL-1 
Tf         
g L-1 





CRP   
mg dL-1 
41 -1.99 ± 0.06 1.44 50 9.4 11 180 1.83 225 5 2.26 31.4 
42 -1.14 ± 0.04 1.41 50 12.4 24 9 3.12 383 6 1.12 - 
43 -1.35 ± 0.04 1.43 49 9.4 39 11 3.83 471 8 2.20 <0.6 
44 -1.27 ± 0.03 0.95 54 11.5 25 111 1.90 233 11 2.69 8.3 
ID 
45 -2.76 ± 0.04 0.92 >90 13.8 49 446 2.13 262 18 1 0.7 
46 -2.13 ± 0.08* 0.81 >90 14.4 53 130 2.47 303 17 1.97 21 
47 -1.91 ± 0.09* 1.12 70 13.4 60 22 2.88 354 16 1.34 0.7 
48 -2.11 ± 0.05* 0.98 83 12.6 74 87 3.11 382 19 1.21 3.9 
49 -1.93 ± 0.05* 0.84 89 13.1 52 36 3.45 424 12 1.49 2.5 
50 -1.86 ±0.04 0.69 88 14.2 37 12 3.39 416 9 - - 
IDA 
51 -1.29 ± 0.12* 1.26 61 11.9 28 20 3.01 370 7 - 2.8 
52 -1.80 ± 0.06* 0.95 82 11.9 41 10 3.41 419 9 2.66 <0.6 
53 -0.77 ± 0.03 0.88 86 8.6 18 6 3.00 369 4 4.42 4.5 
54 -1.80 ± 0.03 0.76 76 10.3 45 37 3.05 375 12 - - 
55 -0.32 ± 0.03 0.83 >90 10.3 16 9 2.89 355 5 3.18 2.8 
56 -0.86 ± 0.06 0.98 70 7.5 9 7 3.21 394 2 3.82 <0.6 
57 -1.51 ± 0.04 1.05 67 7.5 18 10 3.36 413 4 3.82 4.5 




a TIBC calculated according to H. Yamanishi et al. Clin. Chem 2003, 175-178. 
- No data available 




Fig. 7-S1 Isotopic composition of Fe in blood serum as a function of serum Fe concentration from a reference 
population and from patients with CKD and/or a disorder of iron metabolism. 
 
Fig. 7-S2 Isotopic composition of Fe in blood serum as a function of hemoglobin concentration from a reference 
population and from patients with CKD and/or a disorder of iron metabolism. 
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Fig. 7-S3 Isotopic composition of Fe in blood serum as a function of serum ferritin concentration from a 
reference population and from patients with CKD and/or a disorder of iron metabolism. 
 
Fig. 7-S4 Isotopic composition of Fe in blood serum as a function of serum transferrin concentration from a 




Fig. 7-S5 Isotopic composition of Fe in blood serum as a function of total iron-binding capacity (TIBC) from a 
reference population and from patients with CKD and/or a disorder of iron metabolism 
 
Fig. 7-S6 Isotopic composition of Fe in blood serum as a function of transferrin saturation (TSAT) from a 
reference population and from patients with CKD and/or a disorder of iron metabolism 
190 
 
Fig. 7-S7 Isotopic composition of Fe in blood serum as a function of soluble transferrin receptor from a reference 
population and from patients with CKD and/or a disorder of iron metabolism. 
 
Fig. 7-S8 Isotopic composition of Fe in blood serum as a function of soluble transferrin / log ferritin index from 
a reference population and from patients with CKD and/or a disorder of iron metabolism. 
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SUMMARY AND CONCLUSI ONS 
 
By developing two analytical approaches that allow the sample preparation prior to high-
precision isotopic analysis of Fe via multi-collector - inductively coupled plasma - mass 
spectrometry (MC-ICP-MS) to be simplified and therefore, the sample throughput to be 
increased, a first goal of this PhD was achieved. A second goal of this PhD then consisted of 
application of the analytical methods developed for high-precision isotopic analysis of Fe in 
human whole blood and serum in a real-life biomedical context. 
It is clear that MC-ICP-MS provides significantly more precise isotope ratio data than other 
ICP-MS techniques, but the availability of the equipment is an important issue. In Chapter 2, 
the suitability of single-collector SF-ICP-MS in the context of a human absorption study 
using isotopically enriched iron isotopic tracers was demonstrated. A good agreement 
between the results for the enrichments in 57Fe and 58Fe in whole blood samples as obtained 
using SF-ICP-MS and MC-ICP-MS was achieved. Since a minimum of 5% oral iron 
absorption is expected for any worthwhile supplementation strategy, SF-ICP-MS can be 
considered as a suitable technique for the routine determination of iron absorption in human 
iron supplementation studies, offering the possibility to track down changes down to 0.3% 
and 0.6% for 57/54Fe and 58/54Fe, respectively. However, it cannot be used for the measurement 
of natural Fe isotope ratio variations due to the significantly lower precision. 
In Chapter 3, the direct isotopic analysis of whole blood iron after acid digestion and 
adequate dilution (0.75 - 1.5 mg L-1 of Fe) of the sample digest without chromatographic Fe 
separation from the matrix was demonstrated to be a viable alternative to the traditional 
sample pre-treatment preceding MC-ICP-MS measurements. Results obtained in such way 
have to be corrected for instrumental mass discrimination using a combination of internal 
correction with 62Ni/60Ni as an internal standard and external correction in a standard-sample 
bracketing approach. As a result, chromatographic Fe isolation preceding the MC-ICP-MS Fe 
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isotope ratio measurements can be avoided. This simple methodology allows to increase the 
sample throughput and reduce the amount of acids, cost and time required. However, long 
term use of this method has to be further evaluated as it might lead to overburdening of the 
instrument. The suggested approach can, however, already be relevant for specific clinical 
applications that require a prompt response. 
In Chapter 4, another methodology, using the volumetric absorptive microsampling (VAMS) 
technique for blood sampling and a miniaturized anion exchange protocol for the separation 
of iron from the blood matrix, was developed. Accurate and precise isotope ratio data were 
obtained using 1 mL of Milli-Q water as extraction solution for liberating the iron from the 
VAMS tip, followed by acid digestion. The stability of the VAMS-collected whole blood was 
evaluated under different storage conditions and it has been shown that the Fe isotopic 
composition and Fe concentrations are not affected during a period of at least 28 days when 
the VAMS device is stored at room temperature and during a period of at least 4 days when it 
is stored at 60 C, 4 C or -20 C. The validated methodology was used to assess the Fe 
isotopic composition of finger-prick blood, which was compared to that of simultaneously 
collected venous whole blood. No differences in the Fe isotopic composition or Fe 
concentration were observed between finger-prick and venous blood. This approach greatly 
enhances the sample throughput and highly reduces the amount of reagents required and 
therefore, it is beneficial in terms of time and cost. The results obtained for the VAMS-
collected finger-prick blood samples demonstrated this approach to be suitable for further 
clinical applications. 
For a better understanding of the origin of the Fe isotope fractionation in the human body, 
some in vitro and in vivo models were studied. An enterocyte model using the Caco-2 cell line 
was used to study intestinal iron absorption as a major source of isotope fractionation in the 
human body. In Chapter 5, the preferential uptake of lighter iron isotopes from a non-heme 
iron source at the luminal (apical) membrane and the preservation of the heavier isotopes in 
ferritin form inside the cells during transport across the basolateral membrane of erythrocytes 
were demonstrated. These results were in good agreement with previously reported data 
showing that the Fe isotopic composition of the blood and intestinal mucosa was lighter than 
that of the diet. The optimum experimental conditions obtained in this study provided results 
with a low contribution from the blank and good repeatability and reproducibility, thus, 
providing reliable results for the Fe isotopic compositions of the separate compartments. 
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Another possible source of natural Fe fractionation, is the multiple biochemical changes that 
erythrocytes undergo during their life span. The possible effect of these changes on the 
isotopic composition of whole blood was investigated and the corresponding results reported 
in Chapter 6. The erythrocytes were separated according to their density, which corresponds 
to their age due to their gradual decrease in diameter and corpuscular volume. This separation 
was accomplished using two methods, one based on centrifugation and another using a 
mixture of phthalates. The results obtained for young and senescent red blood cells using both 
methodologies suggest the absence of measurable differences in the Fe isotopic composition 
between them and thus, the results indicate that no significant fractionation takes place as a 
result of in vivo aging of erythrocytes. These findings support the hypothesis that fractionation 
mainly occurs during intestinal absorption and during processes of iron release and uptake by 
ferritin. 
The possibility of using the Fe isotopic composition of blood serum as a tool for identification 
of Fe-related disorders was demonstrated in Chapter 7 for patients with kidney insufficiency. 
It has been demonstrated that high-precision Fe isotopic analysis of blood serum by MC-ICP-
MS provided relevant clinical information on the iron status of a male cohort of patients with 
CKD stage 3 or higher and without chronic inflammation. Patients suffering from CKD 
complicated with the iron disorders ID and IDA showed a significantly heavier serum Fe 
isotopic composition than did patients suffering from CKD only. The isotopic composition of 
serum obtained from CKD patients suffering from EPO-related anemia did not show a 
significant difference compared to the cohort with CKD only. Delta Fe values showed strong 
correlations with the individual’s iron status parameters such as (i) serum transferrin 
concentration, total iron-binding capacity, and soluble transferrin receptor, reflecting the iron 
supply, and (ii) the concentrations of ferritin and hemoglobin and the transferrin saturation, 
reflecting the iron store. A three-isotope plot clearly demonstrated the utility of the serum Fe 
isotopic composition to distinguish between IDA and EPO-related anemia. 
The promising results promote a raise of the interest in natural variations of the isotopic 
composition of essential metals, such as iron, in human (bio)fluids and tissues related to 
disorders. Based on results for the Fe isotopic composition in human body fluids and tissues 
in health and disease, obtained in previous studies and this one, it can be concluded that the 
differences between individuals reflect the differences in iron absorption efficiency (which, in 
turn, can be altered due to different disorders). The preferential uptake of lighter iron isotopes 
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was demonstrated along a variety of studies, carried out previously or in the context of this 
PhD and based on a comparison of the isotopic compositions of food and whole blood, on 
animal models or on an intestinal cell model.  
Studying natural isotopic variations for essential mineral elements in the context of 
biomedical applications is an important research line at the A&MS group of Ghent university. 
The final aim of this research line is to develop alternative approaches or potential biomarkers 
for the early diagnosis of diseases that can otherwise only be revealed at a later stage or using 
more invasive methods (such as a biopsy) and/or for prognosis. Information on isotope 
fractionation in the human body can also provide a more profound insight into the metabolism 
of metabolically relevant transition metals, such as iron. Studying the processes involved in 
the quite complex human iron metabolism in detail using in vitro and in vivo models provides 
important information on the sources of Fe isotopic variation, which can be further used to 
explain alterations in the isotopic composition of Fe in human blood/serum from patients 
suffering from disorders affecting iron metabolism. Although the methods developed in this 
PhD can still not be immediately used as a diagnostic tool in daily clinical practice, the 
findings contribute to a better understanding of human iron metabolic processes under 
specific medical conditions, such as iron deficiency anemia and EPO-related anemia. 
Although, this research has made significant steps forward, further research is required to 
further explore the sources of Fe isotopic variations related to different medical conditions. 
For instance, studying ID and anemia caused by inflammation (functional ID and ACD) 
would be a logical further step to take to evaluate the utility of Fe isotopic analysis for 
studying Fe-related complications in patients with renal insufficiency. Moreover, studying the 
change in the serum / whole blood Fe isotopic composition in response to specific disorders 
for both genders will provide information on threshold values for diagnosis. In general, the 
combination of extensive in vivo and in vitro experimental research, theoretical modeling, the 
use of mass balances and of mixing calculations are also necessary to improve our insight into 
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APPENDIX A  
THE MAIN BIOMEDICAL INDICATORS OF IRON STATUS AND KIDNEY FUNCTION 
 
Clinical parameter Indication for Commonly used methods 
Transferrin saturation 
(TSAT), % 
percentage of iron bound to transferrin. 
Calculated from1: 
𝑇𝑆𝐴𝑇 =





𝑆𝑒𝑟𝑢𝑚 𝑖𝑟𝑜𝑛 (µ𝑚𝑜𝑙 𝐿−1)




(TIBC), µg dL-1 
maximum amount of iron needed to saturate 
plasma or serum transferrin 
Colorimetric assay of amount of iron that can be bound to unsaturated transferrin in vitro; 
determination from transferrin concentration measured immunologically (serum or plasma)1,2 
the theoretical ratio of TIBC to Tf is:  
TIBC (µmol L-1) = 25.1·Tf (g L-1)  
or 
TIBC (µg dL-1) = Tf (g L-1) /0.008 
Ferritin  
(Fer), ng mL-1 
“size” of the iron stores 
Immunoassay, e.g., enzyme-linked immunosorbent assay (ELISA) or immunoturbidometry 
(serum or plasma)1 
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Clinical parameter Indication for Commonly used methods 
Transferrin  
(Tf), g L-1 




functional iron status Immunoassay, e.g., ELISA or immunoturbidometry (serum or plasma)1 
Hemoglobin (Hb),  
g dL-1 
iron-containing oxygen-transporting 
metalloprotein in the red blood cells 
Cyanmethemoglobin using colorimeter or spectrophotometer or as azide-methhemoglobin using, 




concentration of circulating iron Colorimetry 
Serum creatinine 
(SCr), mg dL-1 
kdney filtration function Colorimetric or fluorometric tests (serum or plasma) 
Estimated glomerular 
filtration rate (eGFR), 
mL min-1per 1,73 m² 
flow rate of fluid filtered through the kidney 
Calculated according to:3 
MDRD (Modification of Diet in Renal Disease) equation for standardized serum creatinine: 
GFR = 175 · Scr-1.154 · age-0.203· 1.212 (if black race) · 0.742 (if female) 
 
CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equations: 
a) White or other race: 
female and Scr ≤ 0.70 mg dL-1 : GFR = 144 · (Scr/0.7)-0.329 · (0.993)age 
female and Scr > 0.70 mg dL-1 : GFR = 144 · (Scr/0.7)-1.209 · (0.993)age 
male and Scr ≤ 0.90 mg dL-1 : GFR = 141 · (Scr/0.9)-0.411 · (0.993)age 
male and Scr >0.90 mg dL-1 : GFR = 141 · (Scr/0.9)-1.209 · (0.993)age 
b) Black race 
female and Scr ≤ 0.70 mg dL-1 : GFR = 166 · (Scr/0.7)-0.329 · (0.993)age 
female and Scr > 0.70 mg dL-1 : GFR = 166 · (Scr/0.7)-1.209 · (0.993)age 
male and Scr ≤ 0.90 mg dL-1 : GFR = 163 · (Scr/0.9)-0.411 · (0.993)age 
male and Scr >0.90 mg dL-1 : GFR = 163 · (Scr/0.9)-1.209 · (0.993)age 
 
where age is expressed in years and standardized serum creatinine (Scr) in mg dL-1 
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Clinical parameter Indication for Commonly used methods 
C-reactive protein 
(CRP), mg L-1 
inflammation Immunoassay (e.g., ELISA), colorimetry (serum or plasma) 
 
1. Assessing the iron status of populations: including literature reviews. Report of a Joint World Health Organization/Centers for Disease 
Control and Prevention Technical Consultation on the Assessment of Iron Status at the Population Level. (World Health Organization, 
2007). at <http://www.who.int/nutrition/publications/micronutrients/anaemia_iron_deficiency/9789241596107/en/> 
2. Yamanishi, H., Iyama, S., Yamaguchi, Y., Kanakura, Y. & Iwatani, Y. Total iron-binding capacity calculated from serum transferrin 
concentration or serum iron concentration and unsaturated iron-binding capacity. Clin. Chem. 49, 175–178 (2003). 
3. Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604–612 (2009). 
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